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Pathological Epithelial Cell Apoptosis and Shedding  
in the Murine Small Intestine 
Jonathan Martin Williams 
The intestinal epithelium represents a critical component of the gut barrier 
and is composed of a single layer of intestinal epithelial cells (IECs) held 
together by tight junctions. This epithelium prevents the entrance of harmful 
microorganisms, antigens and toxins from the gut lumen into the circulation. 
Small intestinal homeostasis is maintained by the rate of shedding of 
senescent enterocytes from the villus tip exactly matching the rate of 
generation of new cells in the crypt. However, in various localised and 
systemic inflammatory conditions, intestinal homeostasis may be disturbed 
as a result of increased IEC shedding. Such pathological IEC shedding may 
cause transient gaps to develop in the epithelial barrier and result in 
increased intestinal permeability. Although pathological IEC shedding has 
been implicated in the pathogenesis of inflammatory bowel disease, 
understanding of the underlying mechanisms remains limited. This thesis 
describes the development of a murine model to study this phenomenon, as 
IEC shedding in this species is morphologically analogous to humans. IEC 
shedding was induced by systemic lipopolysaccharide (LPS) administration 
in wild-type C57BL/6 mice, and mice deficient in TNF-receptor 1 (Tnfr1-/-), 
Tnfr2-/-, Nuclear Factor kappa B1 (Nfb1-/-) or Nfb2-/-. IEC apoptosis and cell 
shedding was quantified using immunohistochemistry for active Caspase-3 
and gut lumen to systemic circulation permeability was assessed by 
measuring plasma fluorescence following fluorescein isothiocyanate-dextran 
gavage. LPS at doses ≥0.125mg/kg induced rapid villus IEC apoptosis and 
cell shedding which was maximal at 1.5h. This coincided with significant 
villus shortening, fluid exudation into the gut lumen and diarrhoea. A 
significant increase in gut to circulation permeability was observed at 5h. 
TNFR1 was essential for LPS-induced IEC apoptosis and shedding and the 
fate of the IEC was also dependent on NFκB, with signalling via NFκB1 
favouring cell survival, and via NFκB2 favouring apoptosis. This model will 
enable investigation of the importance and regulation of pathological IEC 
apoptosis and cell shedding in intestinal and systemic diseases. 
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1.1 The Small Intestine 
The small intestine is lined on its inner surface by millions of villus projections 
covered by a single cell thick epithelium. This epithelium is highly specialised 
to efficiently digest, transport and regulate the absorption of nutrients and 
water into the circulation. It is also a critical component of the gut barrier, 
which as part of the innate immune system, precludes the entry of harmful 
microbes, toxins, and antigens from the intestinal lumen. The arrangement of 
this specialised epithelial monolayer minimises the distance that nutrients 
must be transported from the lumen into the immediately subjacent 
circulatory system of the villus. However, this also dictates that breaches of 
this delicate epithelium potentially expose the underlying tissue and 
vasculature to harmful luminal content. The intestinal epithelium is anchored 
to a basement membrane which overlies a lamina propria composed of 
myofibroblasts and a collagen framework. The basement membrane is 
composed predominantly of laminin and type IV collagen, which epithelial 
cells are capable of secreting in vitro, with contribution of interstitial collagens 
and procollagen 3 by myofibroblasts being required to produce a complete 
basement membrane (Hahn et al. 1987).  
1.2 Epithelial Turnover in the Small Intestine 
The small intestinal epithelium is constantly being renewed and replaced 
every 3-5 days in humans (and every 2-3 days in mice) by intestinal stem 
cells, and therefore has one of the most rapid cellular turnover rates of any 
fixed cell population. The intestinal stem cell compartment is contained within 
the flask like structures at the base of villi, known as the crypts of Lieberkühn.  
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Maintaining tissue homeostasis and a stable cell population is dependent on 
the loss of an equal number of cells as have been generated by cell division. 
Although early histological examinations of the small intestine allowed easy 
identification of mitotic activity in the intestinal crypts, it was not fully 
appreciated until 1948 (Leblond and Stevens), that the mechanism by 
intestinal epithelial cells (IECs) were lost, was by extrusion and shedding at 
the villus tip (Figure 1). 
To put this cell loss into context, it is estimated that in mice up to 1400 
mature enterocytes are shed from a single villus tip in a 24 hour period, 
equating to an estimated 2x108 cells being shed per day from the small 
intestine. In humans, this daily loss has been estimated at 1011 cells (Potten 
1990).  
 
 
Figure 1: Illustration of intestinal epithelial cell turnover in the small intestine. New epithelial 
cells are generated in the crypt, and migrate up the villus until they are shed at the villus tip.  
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These estimates are based on investigation of crypt cell dynamics performed 
in male BDF1 mice (a hybrid strain resulting from crossing C57BL6 with 
DBA2 strains) (Potten 1990). In this study, it was found that there were 
approximately 6 crypts per villus, each containing around 250 cells per crypt. 
These crypts had a lifespan of approximately 2 years, with new crypts 
constantly being formed from fission of existing ones. Crypt cells were found 
to have an 11 hour cell cycle, with up to 60% of cells passing through the cell 
cycle each day. 
These studies suggested that the crypt cell population contained 
approximately 4-16 actual stem cells (cell position 4-5 as counted from the 
crypt base) and up to 30-40 potential clonogenic stem cells which may 
become functional following perturbation of cell turnover. More recent studies 
have however suggested that the stem cell niche is substantially more 
complicated than this, with it being possible to further discriminate between 
proliferating progenitor stem cells, and transit amplifying cells which undergo 
further mitosis and differentiate into the four major types of intestinal 
epithelial cell. These cell types include enterocytes, goblet cells, 
enteroendocrine cells, and Paneth cells. These cells differentiate during their 
migration along the crypt-villus axis, with the exception of Paneth cells which 
migrate to the crypt base. 
The location and identity of the definitive intestinal stem cell is still a matter of 
some debate. It has been recently suggested that crypt base columnar (CBC) 
cells, which reside below cell position 4 within crypts (Bjerknes and Cheng 
1999), and express the stem cell marker leucine-rich repeat-containing G-
19 
protein coupled receptor 5 (Lgr5) (Barker et al. 2007) are the actual stem cell 
population and give rise to transit amplifying cells. The Lgr5 gene is a 
wingless-int (Wnt) target gene, and is expressed in stem cells at other sites 
apart from the intestine, including the hair follicle (Haegebarth and Clevers 
2009), as well as in ovarian and hepatic neoplasia (Shaker and Rubin 2010). 
In vivo, the Lgr5 expressing CBC cell has been demonstrated to fulfil the 
definition of the small intestinal stem cell; being capable of self-renewal, 
multipotency (Barker et al. 2007), and forming crypt-villus organoids in 
culture (Sato et al. 2009). Another quiescent stem cell population has been 
posited to reside at cell position 4, which positively label for B-cell lymphoma 
Mo-MLV insertion region 1 homolog (Bmi-1), homeodomain-only protein 
(Hopx), mouse telomerase reverse transcriptase (mTert), and leucine-rich 
repeats and immunoglobulin-like domains protein 1 (Lrig1). The control of 
proliferation and differentiation of IECs is dependent on the response of 
these cells to Wnt, bone morphogenic protein (BMP), notch, and epidermal 
growth factor (EGF) signalling. This has been reviewed by Sato and Clevers 
(2013). 
The time it takes for an individual enterocyte to be generated in the crypt, 
migrate up the villus axis, and be shed at the villus tip is approximately 3-5 
days in humans and 2-3 days in mice. Major questions remain surrounding 
what controls the migration of IECs towards the villus tip, their differentiation 
and maturation along this migration, and the cell death and shedding they 
undergo at the villus tip. It has been previously demonstrated that the 
migration of IECs is not dependent on forces generated by cell density 
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increases caused by mitosis in the crypt (Kaur and Potten 1986). Migration 
rate is however dependent on other influences, such as circadian rhythms 
(Kaur and Potten 1986), and intestinal flora. The importance of the intestinal 
flora in epithelial migration rate is illustrated in the context of gnotobiotic 
animals, where there is a slower turnover of enterocytes similar to that 
observed in the neonate, resulting in longer villi (Shanahan 2002). It has also 
been shown that gnotobiotic mice fail to absorb monosaccharides or to 
deposit adipose reserves as efficiently as conventionally housed mice. These 
effects were additionally found to be independent of lymphocyte responses 
(Backhed et al. 2004). By contrast, in animals that have achieved a maximum 
adult level of intestinal bacterial flora, epithelial turnover is much increased 
(Gelberg 2007). Differential epithelial expression of some integrins along the 
crypt-villus axis may also influence epithelial cell proliferation, migration and 
differentiation (Beaulieu 1992).  
1.3 Epithelial Cell Types of the Small Intestine 
Constituting the majority of villus epithelial cells, most new cells generated by 
the stem cell niche mature into absorptive enterocytes. These cells are 
responsible for absorbing and transporting amino acids, monosaccharides, 
electrolytes and water from the intestinal lumen into the intestinal capillaries, 
and lipids and lipoproteins into the central lacteal. Mature absorptive 
enterocytes of the villus possess a microvillus brush border at the apical pole 
with up to 3000, 1µm long microvilli, which greatly increase the surface area 
of the apical plasma membrane of the enterocyte. By contrast, immature 
crypt cells have sparse microvilli, little or no absorptive capacity, and are 
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considered to be the source of the secretory component of IgA 
(immunoglobulin A) and IgM (immunoglobulin M) and of chloride secretion 
(Gelberg 2007). Each microvillus has a central core of actin microfilaments 
arranged as a terminal web connected to the cytoskeleton which stabilises 
the apical membrane. Overlying the apical brush border, enterocytes are 
covered by a glycocalyx which contains glycoproteins, carbohydrates and 
enzymes projecting from the microvilli. Overlying and blending together with 
the glycocalyx, is the unstirred water layer consisting of goblet cell secreted 
mucus, acid mucopolysaccharides and trefoil factors. The enzymes attached 
to the microvillus brush border are responsible for the membranous phase of 
digestion, resulting in the breakdown of complex polymers into monomers 
and transcellular absorption through active transport (Herdt 1997). 
Cells that make up the remainder of the population of the small intestinal 
epithelium include Paneth cells which are found together with stem cells 
within the crypts (Figure 2), enteroendocrine (neuroendocrine) cells, goblet 
cells, and microfold cells (also known as M cells). Goblet cells are found both 
in the crypt and villus regions and are involved in mucus secretion, and 
secrete trefoil factors which aid in epithelial gliding and restitution (Brown et 
al. 2007). Paneth cells complete their differentiation at the crypt base, and 
unlike other cell types, do not migrate along the crypt-villus axis. These cells 
are hypothesised to potentially protect the progenitor cells of the crypt from 
infection, and produce antibacterial peptides such as lysosyme, cryptidins 
and lysins, and other substances such as phospholipase, ribonuclease and 
tumour necrosis factor (TNF). In haematoxylin and eosin (H&E) stained 
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histological sections, Paneth cells possess abundant bright eosinophilic 
granules in their apical cytoplasm, and these cells are considered to have 
secretory and phagocytic functions (Gelberg 2007). Of note, Paneth cells are 
completely absent in certain species such as dogs, cats or pigs (Brown et al. 
2007; Gelberg 2007), meaning that at least in some species, these cells are 
not an essential requirement for protection of the stem cell niche. 
Enterochromaffin cells (a type of enteroendocrine cell) form part of the 
neuroendocrine system of the gut, producing hormones such as serotonin, 
catecholamines, gastrin, cholecystokinin, somatostatin, secretin, and 
enteroglucagon (Young 2006). Other specialised cell types include tuft cells 
which reside in the crypt, and are thought to be quiescent stem cells, 
expressing Lgr5 and doublecortin-like kinase (DCKL1) and have also been 
shown to produce opioids (Gerbe et al. 2011). M cells are far less common 
and overlie gastrointestinal associated lymphoid tissue (GALT). They are 
important in mucosal immunity as they perform immunosurveillance functions 
(Mabbott et al. 2013) and as such can be exploited by several pathogenic 
bacteria to invade into the subepithelial tissue. 
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Figure 2: Schematic of possible differentiation pathways of the self-renewing 
intestinal stem cell (red and pink cell) under the influence of Wnt and Notch 
signalling. With the exception of Paneth cells, cells undergo migration out of the 
crypt base and onto the villus. Genes important in differentiation are indicated next 
to relevant cells. Notch signalling represses hairy and enhancer of split-1 (HES-1) 
and allows cells to differentiate into absorptive enterocytes. Reprinted from 
Experimental Cell Research 317(19): 2702-2710. Noah, T. K., B. Donahue and N. F. 
Shroyer (2011). "Intestinal development and differentiation." with permission from 
Elsevier.  
 
1.4 Epithelial Junctional Complexes 
Epithelial cells are attached to each other by a narrow continuous belt, or 
zonule, of tight junctions at their apical poles (Figure 3). This is fundamentally 
responsible for maintaining gut barrier function, i.e. occluding intestinal 
luminal content including bacteria, noxious substances, enzymes and foreign 
antigens from entering the lamina propria and the circulatory system. It is 
therefore also known as the zonula occludens. These tight junctions bring the 
plasma membrane of neighbouring enterocytes into extremely close 
proximity, being stitched together by sealing strands; consisting of a fusion of 
one molecule of the transmembrane protein claudin from each plasma  
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membrane. At their cytoplasmic aspect, these claudins are connected to the 
cytoskeleton. 
Immediately deep to the zonula occludens is a belt of adhering junctions 
known as the zonula adherens, which connects to the actin cytoskeleton. 
Adhering junctions are composed of transmembrane proteins of the cadherin 
family. The cytoplasmic tail of cadherin proteins bind to anchor proteins such 
as catenins, vinculin, and α-actinin, which are respectively bound to 
cytoskeletal actin. Macula adherens/spot adhering junctions are positioned 
immediately deep to the zonula adherens, and although they form focal 
intercellular adhesions rather than a belt, they are otherwise similar to 
adhering junctions. They are composed of cadherin transmembrane proteins, 
anchored by desmoplakin and plakoglobin, which in turn connect to the 
cytokeratin intermediate filaments in neighbouring enterocytes. These cell 
junctions are generally considered together as a functional unit: the junctional 
complex. The junctional complex anatomically delineates the apical 
membrane of the epithelial cell superficial to the circumferential band of tight 
junctions, with the basolateral membrane being the portion of the epithelial 
cell that is located deep to the junctional complexes. 
The narrow belt of junctional complexes tightly adhere neighbouring 
enterocytes to each other, essentially leaving the basolateral portion of the 
enterocyte unattached, except for at the hemidesmosome. This structure 
anchors the enterocyte to the basal lamina, thus creating the lateral space 
between neighbouring enterocytes. Hemidesmosomes are composed of 
transmembrane proteins of the integrin family, which are bound to laminins 
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via their extracellular component. These integrins are attached at their 
cytoplasmic tails to the anchoring protein plectin, which is in turn bound to 
cytokeratins (Young 2006).   
The lateral space formed between neighbouring enterocytes is filled with 
extracellular fluid, which is separated from the lumen by tight junctions, and 
from the capillary network by the basal lamina. Tight junctions, whilst 
excluding macromolecules, are more permeable in the duodenum and 
jejunum, and do allow passive paracellular passage of small inorganic 
molecules such as electrolytes and water into the lateral space (Herdt 1997).   
Gap junctions are also present where enterocytes share areas of closely 
apposed plasma membrane. These gap junctions are studded with 
transmembrane channels called connexons, which are aligned between 
neighbouring cells, each consisting of six transmembrane proteins of the 
connexin family. Connexons permit the passage of small molecules less than 
1.5 nanometers (nm) in diameter, and exclude those of larger size or of 
negative charge. Gap junctions are hypothesised to be important in 
intercellular communication, the coordination of growth, development, 
differentiation, and electrical coupling (Young 2006). There are numerous 
different proteins that constitute the broad family of connexins, each 
conferring specific qualities to connexons. The connexons themselves may 
be open or closed depending on intracellular calcium concentrations, pH, or 
extracellular signals. In apoptotic cell death, when intracellular calcium is 
elevated, connexons become closed, which may prevent apoptotic related 
signals from influencing neighbouring viable cells (Dolowschiak et al. 2010). 
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Figure 3: Diagram demonstrating intercellular and basement membrane adhesion 
of intestinal epithelial cells and the lateral spaces between cells which allow 
paracellular transport. Reprinted from Biochimica et Biophysica Acta (BBA) - 
Biomembranes, Volume 1788, Issue 4, Pages 832–841, (Guttman and Finlay 2009). 
© 2009, with permission from Elsevier.  
1.5 Intestinal Epithelial Cell Shedding 
Original observations in the rat small intestine suggested that enterocytes 
underwent shedding from the villus tip region into the gut lumen from what 
was termed the “extrusion zone” (Leblond and Stevens 1948). However, 
what dictates why mature enterocytes are shed at the villus tip is largely 
unknown, although it has been shown that the amounts of splice variant of 
acyl co-enzyme A synthetase 5 expressed in enterocytes increases towards 
the villus tip, which sensitises epithelial cells to TRAIL receptor mediated 
apoptosis (Gassler et al. 2007). Molecules of the extracellular matrix interact 
via β1-integrins and cadherins to provide constant survival signals through 
their associated adhesion mediated signalling pathways such as focal 
adhesion kinases, p125fak, PI3-K/Akt and Mitogen-activated protein kinase 
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(MAPK) to IECs, and have also been shown to show differential expression 
along the crypt-villus axis (Beaulieu 1992). In a Cryptosporidium parvum 
model of pathological epithelial cell shedding, it was also shown that infected 
enterocytes were prevented from shedding until reaching the villus tip by X-
linked inhibitor of apoptosis (XIAP). An interesting alternative hypothesis is 
that cell shedding is induced by epithelial cells sensing cell crowding through 
stretch receptors such as Piezo1 (Eisenhoffer et al. 2012), which would 
explain the increased amounts of shedding observed at the villus tip. 
Despite villus tip cell shedding occurring across species, the morphological 
features observed during the loss of senescent epithelial cells at the villus tip 
does show inter-species variation. In mice, whole enterocytes are shed, 
whereas in the guinea pig, apoptotic fragments are pinched off effete 
enterocytes leaving junctional complexes intact between neighbouring cells. 
In both reindeer and seals, fragments of shedding enterocytes are lost either 
by extrusion, or by phagocytosis performed by underlying macrophages 
(reviewed by Mayhew et al. 1999). Recent histological studies in humans 
have shown shedding to be of the whole cell extrusion type, and that shed 
enterocytes were not associated with lymphocytes or macrophages (Bullen et 
al. 2006). Therefore the mechanism of epithelial shedding in humans 
appears morphologically similar to the process in the mouse; suggesting that 
this is an appropriate species in which to study the process.  
There are several hypothesised models for the process of extrusion of effete 
epithelial cells from the epithelial monolayer in whole cell extrusion. One of 
these is the zipper model, which is based on evidence from freeze-fracture 
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transmission electron microscopy studies. These showed that the enterocyte 
undergoing extrusion exhibits basolateral movement of tight junctions down 
the plasma membrane it shares with its neighbouring enterocytes (Figure 4). 
Neighbouring cells eventually extend processes underneath the shedding cell 
as it leaves the monolayer to reform tight junctions and maintain epithelial 
contiguity (Madara 1990). 
 
Figure 4: Diagram of a putative mechanism of epithelial cell shedding, showing 
rearrangement of the tight junctions and advancement of lamellipodia underneath 
the extruding cell in the “zipper model”. Reproduced from "Maintenance of the 
macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological 
rearrangement of tight junctions." J Membr Biol 116(2): 177-184. Madara, J. L. 
(1990), Figure 8, with kind permission from Springer Science and Business Media. 
 
In the context of in vivo studies of physiological enterocyte shedding in mice 
utilising confocal microscopy, it has been showed that one of the first events 
to be observed in an enterocyte which is destined to undergo shedding, is 
redistribution of tight junction protein 1 (ZO-1). This occurs approximately 15 
minutes prior to cell shedding, first to the apical, then to the basolateral 
region of the shedding cell (Guan et al. 2011). In this study, it was also 
observed that permeation of the membrane impermeable marker; lucifer 
yellow, only extends around the shedding cell as far as redistributed ZO-1 
protein, and that the whole process of extrusion lasted approximately 14 
minutes. In 15% of these physiological shedding events, it was observed that 
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the neighbouring cells also underwent shedding within 5-10 minutes, 
suggesting that intercellular communication may take place.  
 
Figure 5: Confocal microscopy showing permeation of membrane impermeable dye 
lucifer yellow (green) to the limit of redistributed fluorescently tagged tight junction 
protein ZO-1 (red) around a shedding epithelial cell in the small intestine. 
Reproduced from Guan, Y., A. J. Watson, et al. (2011). "Redistribution of the tight 
junction protein ZO-1 during physiologic shedding of mouse intestinal epithelial 
cells." American Journal of Physiology.  
 
In support of this, in human colonic epithelial cell culture and cultures of rat 
derived small intestinal phenotype IEC-6 cells, it has been shown that Toll-
like receptor 2 (TLR2) ligation amplifies gap junction intercellular 
communication via connexin 43, and that TLR2 deficient mice exhibit 
reduced epithelial healing of erosions in DSS colitis. This study also showed 
that TLR2 agonists act to prevent spontaneous colitis in multi-drug resistance 
protein (MDR1α) deficient mice (Ey et al. 2009). TLR2 which recognises 
diverse pathogen associated molecular patterns (PAMPS) of Gram negative 
bacteria, Gram positive bacteria and yeast (such as lipoteichoic acid, 
peptidoglycan, bacterial lipoproteins and zymosan) has also been shown by 
others to aid mucosal healing (Cario 2008). 
In vivo, studies of TNF induced intestinal epithelial cell shedding have shown 
with the aid of fluorescent tagged ZO-1 transgenic mice, that there is a 
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“funnel” that forms around shedding cells, with redistribution of ZO-1, and 
other tight junction proteins, including claudins. It was also found that E-
cadherin, F-actin, myosin II, Rho-associated kinase (ROCK) and myosin light 
chain kinase (MLCK) were redistributed during the process. Both ZO-1 
redistribution and MLCK activation have also been observed in neighbouring 
enterocytes in histological studies of cell shedding in humans (Bullen et al. 
2006). In the Marchiando et al. 2011 study, caspase activity, myosin motor 
activity (dynamin) and microtubule rearrangement were all required for 
shedding, allowing refinement of the Madara “zipper” model (Figure 6). 
 
Figure 6: Proposed model of cellular events in epithelial shedding induced by TNF. 
Reprinted from “The Epithelial Barrier Is Maintained by in vivo Tight Junction 
Expansion During Pathologic Intestinal Epithelial Shedding” (Marchiando et al. 
2011) Volume 140, Issue 4, April 2011, Pages 1208–1218. © 2011 with permission 
from Elsevier.  
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It has been suggested through observations made in vitro from isolated villi, 
that actin rearrangement actually takes place only in the enterocyte 
undergoing shedding, rather than needing cooperation from neighbouring 
cells (Wang et al. 2011). By contrast, in observations made in chick embryo 
epithelium, apoptotic cells were extruded by actin myosin rings forming within 
both the cell that underwent shedding and in the neighbouring epithelial cells. 
This process was dependent on RhoGTPase, and it is hypothesised that the 
signal for extrusion precedes the activation of caspases with potassium 
channel blockers preventing extrusion (Rosenblatt et al. 2001). This study 
also demonstrated that when apoptotic cells were added to Madin-Darby 
canine kidney cells (MDCK) culture, they induced actin-myosin rings in the 
apical cytoplasm, close to where contact was established between apoptotic 
and viable cells. The plasma membrane of cells that underwent 
extrusion/apoptosis in MDCK cell culture remained intact until extrusion was 
complete, and these cells left the monolayer whilst retaining a long stalk of 
cytoplasm attached to neighbouring cells. 
1.6 Small Intestinal Epithelial Gaps 
The use of in vivo confocal microscopy has allowed the observation that after 
shedding of enterocytes from the apex of the villus, epithelial discontinuities 
or “gaps” develop (Watson et al. 2005; Kiesslich et al. 2007). These have 
also been shown by scanning electron microscopy (Figure 6). These gaps 
are sealed on average by 20 minutes after the extrusion process, and 
residual patches of ZO-1 are retained at the gap left by the departing cell 
(Guan et al. 2011). These gaps were shown to be filled with an unknown 
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substance that reflected laser light, were different to the “en face” 
appearance of goblet cells, which typically exhibit a targetoid appearance, 
and were still present in Math 1-/- mice deficient in goblet cells. When TNF 
was administered at 0.33µg/g, 20% of these gaps at shedding sites resulted 
in increased epithelial permeability.  
The substance which plugs these gaps has been speculated to be secreted 
by adjacent enterocytes or by the underlying myofibroblasts. A candidate 
substance has been proposed as heparan sulphate, as congenital deficiency 
has been linked to protein losing enteropathy (Watson et al. 2005). It is 
uncertain whether these observable gaps represent true gaps in the gut 
barrier. However, it has been shown that despite the physiological formation 
of these discontinuities, the functional pore size has been determined to be 
far smaller than the diameter of a shed enterocyte, at less than 0.6nm (Fihn 
et al. 2000).  
 
Figure 6: Scanning electron micrograph of small intestinal villi demonstrating the 
presence of epithelial gaps (white arrows) in goblet cell deficient (Math-/-) mice. B 
represents magnified boxed area in A. Scale bars: A=30µm, B=5µm. Reprinted from 
"Identification of epithelial gaps in human small and large intestine by confocal 
endomicroscopy." Gastroenterology 133(6): 1769-1778 (Kiesslich et al. 2007).  
© 2007 with permission from Elsevier.  
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Other in vivo studies have reported that physiological (Madara 1990; Watson 
et al. 2005) and pathologic enterocyte shedding (Marchiando et al. 2011) 
does not result in defective barrier function. However, in the context of 
pathological epithelial cell shedding during inflammatory bowel disease (IBD), 
it has been shown by confocal endomicroscopy that shedding events 
correlate with permeability defects and can aid prediction of disease relapse 
(Kiesslich et al. 2012). It has also been shown that epithelial gap density 
correlates with disease severity in IBD (Liu et al. 2011). There is also a 
strong association with increased intestinal permeability in patients at high 
risk of developing intestinal disease (reviewed by Meddings (2008)). 
Although a cause and effect relationship has not been established, this 
temporal relationship suggests that increased gut permeability is important in 
the pathogenesis and progression of these conditions. Increased intestinal 
permeability by measurement of urinary excretion of 99mTc-
diethylenetriaminopentaacetic acid has been reported in intestinal diseases 
such as IBD (Casellas et al. 1986). However, probably the best evidence that 
gut permeability is directly implicated in the pathogenesis of intestinal 
disease, has been described by Arrieta et al. (2009). They showed that 
interleukin-10 (IL-10) knockout mice develop increased small intestinal 
permeability prior to developing spontaneous colitis. When these mice were 
administered AT-1001 (a synthetic peptide which blocks the zonulin receptor 
and reduces small intestinal permeability), they exhibited reduced colitis 
severity.  
In vitro studies, albeit in monolayers of canine kidney epithelial cells (MDCK) 
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have also shown evidence of exploitation of epithelial “gaps” by bacteria, 
demonstrating that Listeria monocytogenes invades sites of epithelial cell 
extrusion via internalin A and E cadherin interaction (Pentecost et al. 2006).   
1.7 Epithelial Cell Death and Shedding in the Small 
Intestine 
The relationship between cell death and cell shedding in the intestine is 
incompletely understood. Without a robust animal model of this process, it is 
difficult to completely resolve whether cell death precedes loss of epithelial 
adhesion or extrusion, or vice versa.  
From a historical perspective, although tissue and cell death had been 
recognised by Virchow, Weigert, and Flemming as early as the 1880s 
(reviewed by Majno and Joris 1995), making clearer distinctions between 
types of cell death only became well accepted when Kerr (1971) proposed 
that a morphologically distinct form of cell death occurred in the hepatocytes 
of rats when the hepatic vein was ligated, a process which he first dubbed 
“shrinkage necrosis”. The term “apoptosis” was later used (Kerr et al. 1972) 
and at this point its characterisation was based on histochemical stains, light 
microscopy and transmission electron microscopy.    
However, apoptosis and necrosis rarely occur in a mutually exclusive 
manner, and further efforts to define the differences between necrosis and 
apoptosis by morphological features, biochemical markers, or genetic 
regulation, have shown there to be considerable overlaps between these 
processes. The discovery of various biochemical differences in cells 
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undergoing cell death according to the inciting stimulus, has further 
complicated this field by the development of designations such as oncosis, 
necroptosis, pyroptosis, and ever newer variations of cell death. The 
relevance of necrosis and apoptosis, and some of the newer developments in 
this field in the context of intestinal pathology will be briefly discussed in the 
following section. 
1.7.1   Necrosis 
Necrosis is the term given to spontaneous, non-programmed, non-energy 
dependent cell death in living tissue. It can be triggered by any noxious 
cellular insult that results in irreversible cell injury, including deprivation of 
oxygen, adenosine-5'-triphosphate (ATP), physical injury or toxins, and has 
therefore been described as accidental cell death (Majno and Joris 1995).  
In the context of cell death in the intestine, necrosis can be broadly 
characterised on a histopathological basis by increased cell volume, cell 
membrane rupture, cytoplasmic hypereosinophilia, and nuclear pyknosis, 
karyorrhexis and karyolysis in large groups of adjacent cells (Myers and 
McGavin 2007).  
1.7.2   Apoptosis  
Apoptosis, or cell death by suicide (Majno and Joris 1995) is a programmed 
form of cell death and may be physiological or pathological. In H&E stained 
sections, apoptosis can be recognised by changes in cellular morphology in 
individual, usually non-adjacent cells. These include features such as cell 
shrinkage, cell rounding and condensation of cytoplasm and chromatin. 
Cytoplasmic fracturing and blebbing of the nucleus and cytoplasm lead 
36 
eventually to the formation of apoptotic bodies.  
By transmission electron microscopy, the hallmark features of apoptosis are 
progressive cellular shrinkage with rounding and condensation of chromatin. 
Chromatin often marginates and forms peripheral crescents, and the nuclear 
membrane may become convoluted or invaginated. Autophagosomes 
accumulate which may contain membranous whorls (myelin figures). 
Cytoplasmic changes occur only in the very late stages of apoptosis, and 
mitochondria may appear small but structurally normal until this point 
(Cheville 1994). The biochemical events that lead to apoptosis have been 
extensively studied in the nematode Caenorhabditis elegans, and it was in 
this organism that caspases or cysteine-aspartic proteases were 
characterised as the critical enzymatic mediators of the process. Caspases 
exist as inactive pro-enzymes or zymogens, that when activated undergo 
proteolytic cleavage at conserved aspartate sites to form a larger and smaller 
subunit which then dimerise to form the functional enzyme (Figure 8). In 
general they consist of an N-terminal pro-domain followed by a large 
approximately 20kDa (p20) subunit and a smaller approximately 10kDa (p10) 
subunit, which in some procaspases may be separated by a small linker 
sequence.  
The caspases are subdivided into those regarded as initiators of apoptosis 
(caspases 2, 8, 9 and 10), which trigger a cascade of events which bring 
about activation of effector or executioner caspases (caspases 3, 6 and 7). 
Through their proteolytic and DNAse properties, executioner caspases 
dismantle the cell cytoskeleton and organelles. The executioner caspase, 
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caspase-3 is encoded for by the CASP3 gene. It exists as a 32kDa zymogen 
which is then cleaved into 17kDa and 12kDa fragments (p17 and p12 
subunits) which form a heterodimer. Two of these heterodimers then join 
together to form an active hetero-tetramer consisting of a twelve stranded 
beta-pleated sheet formed by hydrophobic interactions, surrounded by alpha 
helices (Lavrik et al. 2005). As a terminally activated executioner caspase, 
presence of cleaved caspase-3 is therefore usually interpreted as evidence 
of late stage apoptosis. 
 
Figure 7: Schematic of the caspase family protein structures A). Group I includes 
inflammatory caspases, group II includes initiator caspases, and group III includes 
effector caspases. (B) Procaspase activation. Cleavage of the procaspase at the 
specific Asp-X bonds leads to the formation of the mature caspase, which comprises 
the heterotetramer p202–p102, and the release of the prodomain. (C) Three-
dimensional structure of caspase-3 heterotetramer. Each heterodimer is formed by 
parallel β-sheets. Reproduced with permission of American Society For Clinical 
Investigation from “caspases: pharmacological manipulation of cell death” (Lavrik et 
al. 2005). J Clin Invest.  
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The mechanisms by which caspases are activated have led to two broad 
pathways being defined; these being the extrinsic pathway brought about by 
external cell signals, and the intrinsic pathway which is activated by internal 
cellular signals (Figure 9). The intrinsic pathway can be triggered by a variety 
of cell stressors or death signals such as withdrawal of growth factors, DNA 
damage, mitochondrial damage, lack of ATP production or failure of ion 
pumps. Death signals such as DNA damage work through p53 mediating 
transcription of PUMA (p53 upregulated modulator of apoptosis), which binds 
anti-apoptotic Bcl-2, and Noxa which is an anti-apoptotic member of the Bcl-2 
family. The extrinsic pathway may be triggered by receptor ligand binding of 
FAS ligand to the FAS receptor (CD95 receptor), TNF to TNF receptor 1 
(P55/P60) or TNF related apoptosis inducing ligand (TRAIL) to DR4 or DR5 
receptors.  
Both intrinsic and extrinsic pathways of apoptosis converge and culminate in 
the mitochondrial permeability transition via formation of the mitochondrial 
transition pore. This is mediated through death signals initiating the 
substitution of anti-apoptotic protein members of the B cell lymphoma (Bcl) 
family such as Bcl-x, Bcl-2, and Bcl-w from the outer mitochondrial 
membrane with pro-apoptotic proteins such as B cell associated X protein 
(Bax), Bcl-2 homology interacting-domain death antagonist protein (Bak), 
BH3 interacting-domain death agonist (Bid), Bcl-2-associated death promoter 
(Bad), and B-cell lymphoma 2 interacting mediator of cell death (Bim).  
These events result in the release of cytochrome C from the intermediate 
space of the mitochondrial membrane. Cytochrome C goes on to form a 
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complex with apoptotic protease activator factor-1 (Apaf-1) and pro-caspase 
9 to form the apoptosome, with pro-caspase 9 transitioning to active 
caspase-9 by autocatalytic cleavage, which then activates caspase-3.  
Figure 8: Diagram outlining the extrinsic and intrinsic pathways of apoptosis. 
Reprinted from Biochim Biophys Acta 1830(5) (Mari et al. 2013). Mitochondrial 
glutathione: features, regulation and role in disease" pages 3317-3328. © 2012 with 
permission from Elsevier. 
 
Any of these events trigger the recruitment of TNFR1 Associated Death 
Receptor (TRADD) or FASL associated Death Domain (FADD), Mort1, and 
RIP, and the dimerisation of pro-caspase 8 to form active caspase-8. The 
activation of initiator caspases leads to a cascade and activation of 
executioner caspases. When considering the extrinsic pathway of apoptosis, 
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differentiation can be made between cell types. The anti-apoptotic protein 
Bcl-2 does not regulate apoptosis in type 1 cells such as thymocytes, but 
does regulate apoptosis in hepatocytes; designated type 2 cells, where Fas 
ligation results in activation of the intrinsic pathway through Bid and activation 
via caspase-3. Further differences between cell types are observed in their 
response to ligation of the TNF receptor, which may cause apoptosis in cells 
with a weak nuclear factor kappa B (NFκB) response, and stimulate 
proliferation in cells with a robust NFκB response. Different death signals 
also work by different pro-apoptotic factors; with Bid being activated by 
receptors of the extrinsic pathway, Bad responding to low glucose, and Bim 
responding to cytokines (reviewed by Watson 2004; Elmore 2007).  
Biochemically, the most popular means by which apoptosis can be detected 
by means other than cellular morphology, is by terminal deoxynucleotidyl 
transferase dUTP nick end labelling (TUNEL) of cleaved DNA, or by 
immunohistochemical detection of activated caspase-3. However these 
techniques do not differentiate between activation of the intrinsic and 
extrinsic pathways. 
1.7.3   Necroptosis 
Recently it has been proposed that a third type of cell death referred to as 
necroptosis exists in certain cell types considered to be undergoing 
executioner caspase independent cell death. In this type of cell death, 
receptor mediated cell death is initiated, which is dependent on the formation 
of a protein complex termed the necrosome. This complex includes Fas 
associated death domain (FADD), tumour necrosis factor associated death 
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domain (TRADD), caspase-8, receptor interacting protein kinase 1 (RIP1) 
and RIP3. Necroptosis has been implicated as the mechanism of Paneth cell 
death in Crohn’s disease (Gunther et al. 2011), when it was demonstrated 
that conditionally caspase-8 deficient mice lacked Paneth cells and exhibited 
depleted numbers of goblet cells. These mice developed terminal ileitis and 
were more susceptible to colitis. When TNF was administered to these mice, 
they exhibited increased TUNEL positive and caspase-3 negative cell death 
in the Paneth cell region of the crypt, with up regulated RIP3 expression. 
Mice exhibited a normal intestinal phenotype, suggesting that physiological 
IEC homeostasis is not dependent on extrinsic pathway apoptosis (reviewed 
in Han et al. (2011)).  
1.7.4   Intestinal Epithelial Cell Shedding and Detachment 
The relationship between intestinal epithelial cell shedding and cell death is 
incompletely understood, as it is not known whether cell death precedes 
detachment, or whether detachment triggers apoptosis in a process termed 
anoikis. Supporting the latter theory, Fouquet et al. (2004) showed that early 
loss of the zonula adherens protein E-cadherin in IECs resulted in rapid 
execution of a Bcl-2 and caspase-9 dependent apoptotic pathway in an ex-
vivo mouse small intestine model. Other groups have shown via active 
caspase-3 immunostaining that the apoptotic pathway is activated prior to 
shedding, and that in detached IECs apoptosis begins by activation of 
initiator caspases 2 and 9, with subsequent activation of executioner 
caspases such as caspase-3 (Grossmann et al. 2002).  
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1.8 Stimuli Which Cause Intestinal Epithelial Cell 
Death 
Despite the estimated physiological loss of massive numbers of enterocytes 
from individual villi, when H&E stained sections of the small intestine are 
examined, shedding events are observed relatively rarely, with recent studies 
into cell shedding in the human intestine finding a shedding cell in only 5.35% 
of villus sections (Bullen et al. 2006). For this reason, and the fact that 
physiological epithelial cell shedding does not appear to detrimentally affect 
gut barrier function, a number of varied stimuli have been investigated, and 
shown to increase IEC cell shedding. These include TNF administration 
(Garside et al. 1993; Piguet et al. 1998; Marchiando et al. 2011), ischaemia 
(Brown et al. 2007), ischaemia-reperfusion injury (Ikeda et al. 1998), burn 
injury (Song et al. 2008), trauma (Sodhi et al. 2011), increased lymphatic 
pressure (Lee 1977), cocaine or atropine induced villus contraction (Lee 
1977), Cryptosporidium parvum infection (Foster et al. 2012), Galectin-1 
administration (Muglia et al. 2011) and toxins such as Bacteroides fragilis 
toxin (Wu et al. 2007). The drawbacks encountered with these stimuli include 
technical difficulty, necessity of surgical procedures, animal welfare issues 
such as a need for anaesthesia and recovery, long intervals between the 
stimulus and shedding response, economic expense, and a lack of 
reproducibility. The ideal stimulus to study pathological epithelial cell 
shedding would therefore be one that is economically viable, rapid in onset, 
reproducible, technically simple without a requirement for anaesthesia or 
surgery, minimise detrimental effects on animal welfare, and clinically 
relevant. As this project aimed to investigate lipopolysaccharide as such a 
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candidate stimulus, TNF and ischaemia, as the most clinically related stimuli, 
will be discussed briefly.  
1.8.1 Tumour Necrosis Factor 
TNF is the abbreviation given to tumour necrosis factor alpha, which is 
predominantly produced in activated macrophages and to a lesser extent 
activated T cells, epithelial cells and myofibroblasts. TNF is part of the larger 
TNF family of cytokines, comprising of some 19 different pro-apoptotic 
cytokines which share structural and functional similarities. Other notable 
cytokines of this group include FASL and TRAIL.  
TNF is synthesised as a pro-hormone, with an unusually long amino acid 
sequence, which is not present in the secreted mature cytokine. In mice TNF 
also exists in different glycosylation states. Both the secreted (17kDa) and 
membrane bound forms (18.5kDa) are capable of exerting biological effects 
(Sherry et al. 1990). Membrane bound pro-TNF is capable of juxtacrine 
signalling, but can become solubilised by action of ADAM17 (Black et al. 
1997), otherwise known as TACE (TNF converting enzyme). 
TNF acts via two known receptors: p55/TNFR1 or p75/TNFR2. The cellular 
response to TNF is highly context dependent, and varies according to cell 
type, the relative expression of the two receptors, and the downstream 
responses of these two receptors. Indeed, in cardiac myocytes and 
neurones, TNFR1 has been found to exert pro-death effects, and TNFR2 to 
pro-survival effects. In small intestinal enterocytes, both TNFR1 and TNFR2 
have been alleged to be pro-death. Interestingly, it has been shown that 
TNFR1 deficient mouse strains are resistant to the lethal effects of 
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lipopolysaccharide (LPS) and superantigen (Pfeffer et al. 1993), suggesting 
that this receptor is responsible for the detrimental effects of TNF in this 
context. 
TNFR1 is much more widely expressed than TNFR2, and it has been shown 
by immunohistochemistry that TNFR1 is present in intestinal epithelium 
(Song et al. 2005; Lau et al. 2011). It has also been shown that the response 
to TNF varies in the different regions of the small intestine, with a more rapid 
and greater extent of apoptosis being elicited in the duodenum, than the 
ileum. This correlates with TNFR1 being more highly expressed in the 
duodenum than the ileum, with the opposite situation being true for 
expression of TNFR2 (Lau et al. 2011). It has been shown in histological 
studies that intraperitoneal (i.p.) TNF administration in mice at 105 units per 
animal, caused duodenal villus atrophy that was significant at 60 minutes, 
and fully developed by 120 minutes, with shedding enterocytes being lost 
from the apex of villi (Garside et al. 1993). These findings have also been 
corroborated by others (Piguet et al. 1998), who observed similar effects from 
0.5 hours after administration of 10µg of intravenous TNF. In the Garside et 
al. study, crypt elongation/hypertrophy was also reported from 15 minutes 
(although it would seem unlikely that this could be due to any proliferative 
response within this time frame) and at later time points in conjunction with 
the villus atrophy. Enterocyte loss with villus atrophy was also markedly 
enhanced by addition of interferon gamma (IFNγ), and to a greater extent 
than when either of these cytokines was administered alone. The Piguet et 
al. study also showed that apoptosis and detachment of enterocytes was 
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mediated by the TNFR1 receptor and was independent of the TNFR2 
receptor and p53. It has been demonstrated that following acute TNF 
administration, epithelial specific expression of TNFR1 is necessary to induce 
this apoptosis and shedding, rather than indirect vascular dysfunction 
causing ischaemia/ischaemia-reperfusion. This was shown by analysing the 
small intestinal IEC loss and apoptosis in a villin-Cre Tnfr1flxneo/flxneo mouse 
model of acute TNF administration. These mice expressed a selectively 
reactivated Tnfr1 allele only in IECs, and showed similar TNF induced cell 
shedding to WT. Interestingly, it was also found that this IEC specific 
expression of functional TNFR1 did not however mediate the Crohn’s-like 
lesions associated with chronic epithelial specific TNF over-production in  
TNF∆ARE/+ mice, which lack AU rich TNF regulatory elements within the 
intestinal epithelium (Roulis et al. 2011). What is not clear is whether 
parenteral or luminal TNF is the significant contributor to direct epithelial 
interaction, although it has been shown that direct instillation of TNF into the 
duodenal lumen can cause intestinal damage in rats (Jackson et al. 2000). 
Dramatically increased TNF production, and increased pulmonary 
inflammation has been shown in Tnfr2-/- mice in response to endotoxin 
administration, suggesting that this receptor may be responsible for 
suppressing TNF production (Peschon et al. 1998). 
1.8.2   Intestinal Ischaemia 
Intestinal ischaemia may be induced by any occlusive process of the 
vasculature such as thrombi, volvulus or torsion, or by compromise of 
perfusion in conditions such as cardiac insufficiency, sepsis, alpha 
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adrenergic administration (such as xylazine or medetomadine) or digitalis 
administration (Stoney and Cunningham 1993). It has been widely believed 
that ischaemia causes intestinal epithelial cell death by necrosis, but Ikeda et 
al. (1998) showed that ischaemia-reperfusion for 15-90 minutes in rats 
increased cell death by enterocyte apoptosis and necrosis. This study 
showed by a combination of light microscopy, transmission electron 
microscopy, and examination of DNA fragmentation, that apoptosis was the 
predominant form of cell death, although this occurred in conjunction with 
necrosis. Prior to this, Wagner et al. (1979) performed a transmission 
electron microscopy study on rat small intestine subjected to ischaemia. They 
found that after only 15 minutes of ligation of the vascular arcades of the 
jejunum, there was development of cytoplasmic blebs at the basal aspect of 
enterocytes which led to loss of cell adhesion and shedding. There was also 
accumulation of an amorphous substance beneath subepithelial spaces 
which was hypothesised to be oedema fluid. More recently it has been shown 
that some of these effects are mediated through hypoxia inducible factor 1 
(HIF-1α) (Feinman et al. 2010).   
1.9 Pathogenesis of Sepsis and Endotoxic Shock  
The effects of TNF and ischaemia have been implicated as highly important 
in the multiple organ dysfunction syndrome (MODS) that is encountered in 
sepsis. Sepsis is the clinical term given to the systemic inflammatory 
response syndrome (SIRS) which results from infection, whereas 
septicaemia is more specifically the presence of pathogenic organisms in the 
bloodstream. Evidence suggests that the fundamental mechanisms by which 
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this inflammatory state is induced are via pattern recognition receptors 
(PRRs), especially TLRs of the innate immune system recognising pathogen 
associated molecular patterns (PAMPs). One of the most important clinical 
syndromes encountered in medicine is septic shock as a result of bacterial 
infection. This condition has 25-50% mortality and accounts for ~200,000 
deaths per annum in the United States (Angus et al. 2001). Approximately 
70% of these cases are referred to as “endotoxic shock”, as they are caused 
by Gram negative bacteria which produce endotoxin/lipopolysaccharide 
(LPS) (Mitchell 2004). LPS has been implicated as one of the most important 
molecules in initiating this type of shock (Beutler and Rietschel 2003). 
LPS as a stimulus for intestinal epithelial cell shedding has not been 
previously investigated per se, but it is well established that gut mucosal 
injury and increased gut permeability occur in the latter stages of endotoxic 
shock. As the gut represents an extremely large reservoir of bacteria, 
including Gram negative bacteria and LPS, this has led to the development of 
the gut origin of sepsis hypothesis (Pastores et al. 1996). This proposes that 
endotoxic shock initiates failure of the gut barrier, which in turn allows 
bacteria and/or endotoxin into the circulation in a positive feedback loop 
(summarised in Figure 9 and reviewed by Gatt et al. (2007)). Previous 
studies have shown extensive gut injury with crypt apoptosis, several hours 
after induction of endotoxic or septic shock (Coopersmith et al. 2002; 
Coopersmith et al. 2003; Guma et al. 2011). Additionally, increased intestinal 
permeability has been shown in the ileum, but not the jejunum of rats 2 hours 
after LPS administration, and in mice, bacterial translocation has been 
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detected 24 hours post-LPS administration (Deitch et al. 1991).  
Although the mechanisms of gut injury have not yet been established, it is 
thought to be initiated by the hypoxic and ischaemic conditions brought about 
by blood maldistribution during endotoxic shock; although in reality it is highly 
likely to be a multifactorial process.  
 
Figure 9: Diagram outlining the gut origin of sepsis hypothesis from “Bacterial 
translocation in the critically ill – evidence and methods of prevention” Alimentary 
Pharmacology & Therapeutics 25(7): 741-757. (Gatt et al. 2007). Reprinted by 
permission of John Wiley & Sons, Inc. © 2007. 
 
1.9.1    The Role of Lipopolysaccharide 
The lipopolysaccharide (LPS) molecule is an integral structural component of 
the Gram negative bacterial cell wall which may interact with the host’s 
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immune system either directly in bacterial cell associated form, or as a cell 
free form when liberated. LPS may be liberated when Gram negative bacteria 
replicate, and when they are lysed. This occurs when anti-bacterial proteins 
or plasma complement bind bacteria directly or via antibody adhesion, 
causing bacterial lysis.  
The high level of immunological challenge presented by Gram negative 
bacteria within the gut, therefore represents a fascinating and far from 
understood host-microbial relationship. A typical Gram negative bacterium 
such as E.coli contains approximately 3.5x106 LPS molecules, equating to 
10-15g of LPS. As lipopolysaccharide is a structural component of the 
bacterial cell membrane, it is necessary to employ various extraction 
methods to separate it from other bacterial components and purify it. 
Commonly used methods include phenol extraction, butanol extraction, 
trichloroacetic (TCA) extraction, and ion-exchange chromatography.  
The LPS molecule itself consists of three distinct domains (Figure 11) 
including a lipid A domain, an oligosaccharide core, and an O-antigen. The 
lipid A domain confers much of the toxicity of the LPS molecule, and consists 
of a phosphorylated glucosamine disaccharide backbone with multiple 
hydrophobic fatty acids. The O-antigen is a variable polysaccharide side 
chain which extends from the oligosaccharide core domain, and confers 
antigenic specificity to LPS of different bacteria (reviewed by Van Amersfoort 
et al. 2003). 
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Figure 10: LPS is a critical structural component of the Gram negative bacterial cell 
wall. Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews 
Immunology: Innate immune sensing and its roots: the story of endotoxin." 3(2): 
169-176. Beutler, B. and E. T. Rietschel © 2003 
 
 
The mechanism for LPS toxicity was not identified until a spontaneous 
mutation resulted in a genetic resistance in the C3H/HeJ mouse to the effects 
of LPS, (Watson and Riblet 1974). This was identified as the Lps locus. It 
was subsequently demonstrated that myeloid lineage immune cells were 
necessary to cause morbidity in endotoxic shock, as mice that were 
unresponsive to LPS were rendered sensitive by bone marrow 
transplantation from LPS responsive C3H/HeN mice (Michalek et al. 1980). 
The Lps gene was eventually cloned and the gene product; TLR4, 
convincingly demonstrated to be the conduit for LPS signalling (Beutler et al. 
2001).  
However, LPS signalling via TLR4 ligation was found to be additionally 
dependent on several other molecules. Investigations into the dynamics of 
acute LPS administration in vivo, were performed by administering LPS 
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systemically to rabbits and mice. These experiments showed that LPS was 
quickly bound in the circulation by lipopolysaccharide binding protein (LBP), 
discovered by Tobias et al. (1986). LBP catalyses the transfer and 
subsequent removal of LPS from the circulation to cells of the mononuclear 
phagocyte system bearing surface CD14, including Kupffer cells of the liver, 
and splenic macrophages (Mathison and Ulevitch 1979). This is followed by 
binding of LPS to Toll-like receptor 4 (TLR4), which is a member of the larger 
family of Toll-like receptors, which act as pattern recognition receptors to 
recognise a diverse range of PAMPS. TLR4 is variably expressed within 
many cell populations, but is highly expressed in monocytes and 
macrophages. After surface ligated TLR4 has dimerised, in conjunction with 
the essential adapter molecules CD14 (Wright et al. 1990) and MD-2 
(Shimazu et al. 1999), cytoplasmic myeloid differentiation primary response 
gene 88 (MyD88) is recruited as an adapter protein (Pålsson-McDermott and 
O'Neill 2004). IL-1 receptor associated kinase (IRAK) is then recruited, 
undergoes autophosphorylation and activates TNF-receptor associated 
factor-6 (TRAF-6), which in turn activates the inhibitor of kappa B (IκB) 
kinase cascade and nuclear transcription factor kappa B (NFκB) activation. 
This activation leads to the production of TNF, IL-1, IL-6 and IL-8. In 
endothelial cells, activation of TLR4 eventually leads to down regulation of 
tissue factor pathway inhibitor (TFPI) and thrombomodulin, upsetting the 
balance of haemostasis in favour of thrombosis and disseminated 
intravascular coagulopathy (DIC). TLR4 activation also promotes the 
synthesis of type 1 interferons and inducible nitric oxide synthase (iNOS) in 
immune cells and vascular tissue (Mitchell 2004). It should be noted 
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however, that the signal transduction events subsequent to cell surface 
binding of LPS do not occur immediately, and it has been shown to take 15-
30 minutes for monomeric LPS to become internalised (Detmers et al. 1996).  
  
Figure 11: Signalling pathways induced in dendritic cells in response to Gram 
negative bacteria. All TLRs use myeloid differentiation primary response protein 88 
(MyD88) as an adaptor protein, with the exception of TLR3. Phosphorylation of 
NFκB inhibitor (IκB), leads to activation of nuclear factor κB (NFκB) and consequent 
transcription of a range of genes coding for pro-inflammatory cytokines, including 
tumour necrosis factor (TNF), interleukin-6 (IL-6), pro-IL-1β and pro-IL-18. Reprinted 
by permission from Macmillan Publishers Ltd: Nature Reviews Immunology. “TLR-
dependent T cell activation in autoimmunity." 11, 807-822. Kingston H. G. Mills  
© 2011 
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Investigations into the extraction methods of LPS from E.coli O111:B4 have 
shown that the immunogenic properties of LPS are also dependent on the 
purification technique, as LPS extracted by the phenol method elicited a 
strong mitogenic response in splenic cells of LPS responsive (C3H/St) mice, 
compared to splenic cells from LPS resistant (C3H/Hej) mice. By contrast, 
when LPS was extracted using butanol or TCA, similar mitogenic responses 
were observed in the splenic cells derived from these two strains (Skidmore 
et al. 1975). 
In terms of dosage, an acute systemic inflammatory response may be 
induced by relatively small dosages of LPS, with intravascular (i.v.) doses of 
2ng/kg of E.coli O113 LPS in humans and intraperitoneal (i.p.) doses of 
500ng/kg in mice causing peaks in IL-6 and TNF expression at 2 hours after 
administration. This study also showed that i.v. and i.p. administration in mice 
caused comparable cytokine induction profiles (Copeland et al. 2005). It has 
also been shown that small amounts of oral LPS can stimulate interferon 
production in mice (Youngner 1972). When administered by oral gavage 
however, LPS appears to be minimally toxic, with a lack of clinical or 
pathological evidence of toxicity in mice at doses up to 1,000,000 endotoxin 
units (EU) of LPS from E.coli BL21 (DE3), equivalent to approximately 3.3 
mg/kg (Harper et al. 2011). An earlier study found that an intraperitoneal 
injection of 100mg/kg LPS was lethal in mice and other species, whereas if 
this dose was administered directly into the duodenum, these animals 
survived (Berczi et al. 1966). This is in contrast to LPS derived from 
Salmonella enterica serovar Typhimurium, which does produce toxicity when 
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given orally in mice, albeit with a 10 fold reduced toxicity compared to the i.v. 
route (Youngner 1972). The lack of response caused by LPS within the 
intestinal lumen, has been suggested to be due to the presence of alkaline 
phosphatase at the small intestinal brush border, which has been shown to 
be able to detoxify some forms of LPS (Yang et al. 2012).  
To put exogenous LPS administration into context, in healthy individuals, 
plasma LPS concentrations of up to 0.2ng/ml have been measured. Other 
physiological factors such as stress, heat, and high fat diets can cause 
physiological plasma concentrations of up to 2ng/ml. In patients with impaired 
gut barrier function, such as those suffering from necrotising enterocolitis 
(NEC), acute pancreatitis, alcoholic liver disease, and other forms of critical 
illness, LPS plasma concentrations of up to 10ng/ml have been recorded. In 
mice, it has been shown that basal plasma LPS is approximately 0.017ng/ml. 
When LPS is administered at 0.1mg/kg by i.p. injection, this can induce a 
measurable increase in peak plasma LPS of 2.2ng/ml at 1 hour (Guo et al. 
2013). Estimates of the amount of endotoxin with the gut lumen are relatively 
scant in the literature, but it has been estimated to be approximately 1.8µg/ml 
in the distal ileum of rats.  
Tracking studies have shown that following intravenous administration of 
LPS, the first cells to effectively interact with and phagocytose the molecule 
are tissue macrophages and especially the Kupffer cells of the liver. By 
immunohistochemical labelling, LPS has also been detected from 1 hour to 
beyond 28 days in the macrophages of the intestinal lamina propria, and in 
enterocytes from 8 hours to 7 days (Ge et al. 2000). This led to the authors of 
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this study to suggest the interesting possibility that epithelial cell shedding 
may represent an elimination route for LPS. 
1.9.2   Intestinal Vascular Supply 
One of the major hypothesised mechanisms for gut damage induced by 
endotoxic shock, is through ischaemia and hypoxia induced by cytokine 
storm induced blood maldistribution and reduced cardiac output. In a 
physiological context, the gut receives approximately 20-25% of cardiac 
output, which rises to approximately 30% postprandially. Vascular supply to 
the small intestine is via the gastroduodenal artery (arising from the hepatic 
branch of the coeliac artery) for the duodenum, while the jejunum and ileum 
are supplied by the jejunal and ileal intestinal arteries respectively (arising 
from the superior mesenteric artery) and these are interconnected by straight 
anastomotic arcades within the mesentery.  
The extramural vessels of the serosa enter the submucosa at right-angles to 
form arterioles, the majority of which continue up through the centres of villi 
(Figure 13) and arborize at the villus tip to form a dense, fenestrated capillary 
plexus immediately subjacent to the basal lamina of the intestinal epithelium 
(Vollmar and Menger 2011). The remainder of these arterioles branch into 
capillary plexuses around the crypts of Lieberkühn. One to several venules 
drain the villus and crypt capillary plexuses, flowing into larger submucosal 
veins, mesenteric veins and eventually the hepatic portal vein (Brown et al. 
2007). The venules draining the villus run parallel and in very close proximity 
to the central arteriole, allowing countercurrent exchange of oxygen. This has 
important implications during hypoperfusion, as when flow velocity 
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decreases, more oxygen is transferred from the arteriole to the adjacent 
venules in the basal portion of the villus, exacerbating the sensitivity of the 
villus tip to perfusion deficits (Vollmar and Menger 2011). The endothelium of 
the central lacteal of each small intestinal villus is permeable enough to allow 
the entry of macromolecules and chylomicrons and represents the main route 
of lipid absorption (Brown et al. 2007). The central lacteal drains into the 
lymphatic system and eventually into the thoracic duct and back into the 
bloodstream via the subclavian vein. 
 
Figure 12: Diagram illustrating the vascular supply of the villus and the 
countercurrent exchange mechanism from "Intestinal ischemia/reperfusion: 
microcirculatory pathology and functional consequences”. Langenbeck's Archives of 
Surgery" 396(1), 2011, Vollmar, B. and M. Menger, 13-29, figure 3. © Springer-
Verlag 2010 with kind permission from Springer Science and Business Media 
 
In a porcine model of endotoxic shock, it has been shown that there is a drop 
in arterial oxygen partial pressure after induction of endotoxaemia, with 
acidosis and increased hypoxanthine (a degradation product of adenosine 
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triphosphate via adenosine monophosphate) being found in many tissues 
and blood especially in the gut, increasing to significant levels by 2.5 hours 
and showing a 2.7 fold increase in endotoxaemic animals by 5 hours (Oldner 
et al. 1999).  
The gut also has very high concentrations of xanthine dehydrogenase which 
increase towards the villus tip (Granger 1988). It has been speculated that 
this may contribute to the gut’s sensitivity to ischaemic conditions, through 
xanthine dehydrogenase metabolising hypoxanthine to xanthine and uric 
acid. This causes the formation of hydrogen peroxide and superoxide. The 
generation of these reactive oxygen species results in free radical damage 
and ischaemia reperfusion injury (Kumar et al. 2004). This mechanism was 
advocated by Deitch et al. (1991) who showed that pre-treatment of 
endotoxaemic rats with allopurinol prevented increased gut permeability.  
Inducible nitric oxide synthase (iNOS) has also been implicated in endotoxic 
shock induced intestinal injury (Han et al. 2004), although after LPS 
administration in cats, increased iNOS levels and apoptosis were only 
present after four hours, despite the observation of intestinal epithelial 
necrosis at two hours in the ileal mucosa by transmission electron 
microscopy (TEM) (Crouser et al. 2000). Interestingly, during this study, 
blood flow and oxygen levels in the blood perfusing the ileum over the course 
of the experiment were relatively unchanged. This has also been shown by 
comparing fluid resuscitation and superior mesenteric artery ligation in 
anaesthetised endotoxaemic rabbits (Lobo et al. 2004). These findings 
suggest that gut injury in endotoxic shock is independent of blood flow 
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alterations and blood oxygenation. 
In endotoxaemic mice, iNOS has been implicated in tight junction failure in 
the ileum and colon (Han et al. 2004), with redistribution of the tight junction 
proteins ZO-1, 2, and 3 and occludins being observed in a time dependent 
manner from 6 hours after intraperitoneal administration of LPS. These 
effects were ameliorated in iNOS knockout mice, and by pharmacologic 
blockade of iNOS in wild-type mice with an inhibitor of iNOS; N6-(1-
iminoethyl)-L-lysine, dihydrochloride (L-NIL). In this study, endotoxaemia was 
also associated with increased gut permeability as assessed by fluorescein 
and increased bacterial translocation from 12 hours. However, it has been 
shown that mice lacking iNOS are not resistant to LPS induced death from 
endotoxaemic shock (Laubach et al. 1995). Other transgenic mouse strains 
also show differing sensitivity to septic shock, with survival in a polymicrobial 
model of sepsis (surgical puncture of the caecum) being increased in bcl-2 
over-expressing mice (Husain and Coopersmith 2003). 
1.9.3  Nuclear Factor kappa B Signalling in Endotoxic Shock 
NFĸB is the umbrella term for a family of highly evolutionarily conserved 
cytosolic proteins. On activation, these proteins dimerise in various 
combinations and shuttle to the nucleus. Here they act as transient 
transcription factors to regulate the transcription of a very large array of 
genes. These include genes involved in inflammation, cell stress, apoptosis, 
cell adhesion and many other cellular processes. All the NFκB family 
subunits share an N-terminal Rel homology domain (RHD) which mediates 
dimerisation, and specific DNA binding. Traditionally, these proteins have 
59 
been broadly categorised into two broad pathways by their initiating stimulus 
and interactions with other NFκB subunits. These are the canonical pathway, 
and the non-canonical, also known as the alternative pathway (Table 1). 
However it is becoming increasingly evident that due to the extent of cross-
talk between these pathways, this probably represents a gross simplification 
of the system. Additionally complicating matters, NFκB signalling appears to 
show profound differences between cell types, as in Sertoli cells, B cells, 
some neurones and T cells, and in many cancers, NFκB is constitutively 
located within the nucleus. 
 
Protein/gene Aliases 
Canonical 
Pathway 
NF-κB1 p105 → p50 
RelA p65 
cRel  
Non-
canonical 
Pathway 
NF-κB2 p100 → p52 
RelB 
 
 
Table 1: NFĸB protein subunits by their traditional classification into canonical or 
non-canonical pathway signalling and their aliases. Arrows indicate the processed 
form of the protein.  
 
NFκB1 (p105) is considered part of the canonical pathway and is 
constitutively processed to its active DNA binding protein p50, which is 
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contained within the N-terminal half of the larger inactive p105 protein. p105 
also contains the inhibitor of NFκB: IκBγ in its C-terminal half (Sha et al. 
1995). Whereas NFκB1 is constitutively processed to its active form, NFκB2 
exists as the p100 subunit unless activated, whereupon it is processed to 
p52. However, both p50 and p52 are unable to regulate gene transcription 
independently, and rely on dimerisation with RelA, RelB and c-Rel, which 
possess a C-terminal transcription activation domain (TAD) which facilitates 
gene transcription. The Rel family members are all also capable of forming 
either homodimers or heterodimers, with the exception of RelB which can 
only form heterodimers (www.nf-kb.org (accessed July 2013)). 
1.9.4  Inhibitors of NFκB 
NFκB family subunits are kept within the cytoplasm in an inactive form by 
another family of proteins referred to as inhibitors of NFκB (IκB). Classical 
IκB members include IκBα, IκBβ and IκBε. These proteins possess terminal 
ankyrin repeats, which mediate their function through binding with NFκB 
dimers and preventing their nuclear localisation. Each of the IκB members 
exhibits preferential binding to certain NFκB dimers, with IκBα usually binding 
RelA:p50 dimers, and IκBε binding RelA:RelA and cRel:RelA dimers. It 
should also be noted that both p105 and p100 proteins additionally possess 
C-terminal ankyrin repeats, which exert inhibitory activity on these subunits 
prior to their removal during processing to their active forms of p50 and p52 
respectively. 
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1.9.5  Activation of NFκB 
NFκB dimerisation, nuclear translocation and DNA binding generally occurs 
following any of a great multitude of inducing signals which result in the 
activation of an enzymatic complex of serine specific IκB kinases (IKK) which 
include IKKα, IKKβ and IKKγ (also known as NFκB essential modulator or 
NEMO). These phosphorylate IκB, resulting in the release of NFκB subunits 
from inhibition.  
In the canonical pathway (initiated by Th1 cytokines such as TNF or TLR4 
receptor ligation amongst others), NEMO is recruited onto activated adapter 
molecules such as tumour necrosis factor receptor associated factors 
(TRAFs). Activated IKK (IκB kinase) complexes (consisting of two NEMO 
molecules, one IKKα and one IKKβ molecule) phosphorylate the inhibitory 
protein IĸBα, which is targeted for proteosomal degradation by E2 ligases 
(Figure 13). This allows the release of NFκB family members p50:RelA and 
cRel:RelA dimers in the cytoplasm. They subsequently undergo nuclear 
translocation to bind to DNA binding sites and regulate the transcription of 
target genes.  
Non-canonical NFκB pathway activation is generally thought to occur during 
B and T cell development, through ligation of B-cell activating factor (BAFF), 
or CD40 to their respective receptors, although others have shown that the 
non-canonical pathway can also be activated by the TNF receptor (Kim et al. 
2011). In this pathway, adapter molecules first activate NIK (NFκB inducing 
kinase) which activates two IKKα molecules. These proteins go on to cause 
activation of the p100:Rel B complex, with the p100 molecule being 
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processed to p52, and the p52/RelB dimer translocating into the nucleus 
(reviewed by Vallabhapurapu and Karin (2009) and at www.nf-kb.org 
(accessed July 2013)).  
LPS has traditionally been viewed as activating the canonical NFκB 
activation pathway via ligation of TLR4. However, evidence suggests that 
there may also be simultaneous activation of the non-canonical pathway by 
production of free radicals and heat shock protein 70 (HSP70). This was 
shown to occur in colonic epithelial cells stimulated by LPS in vitro 
(Bhattacharyya et al. 2008) via BCL10 serine 138 and NIK phosphorylation 
(Bhattacharyya et al. 2010). Guma et al. (2011) showed that constitutive 
canonical NFκB activation, specifically within the intestine, does not trigger 
destructive intestinal inflammation unless there is simultaneous activation of 
mitogen-activated protein kinase (MAPK). In this study, constitutively active 
canonical NFκB signalling resulted in increased production of TNF mRNA. 
However, MAPK activation was required to produce TNF. These mice were 
exquisitely sensitive to LPS administration, which resulted in shock and villus 
injury, and crypt apoptosis at 4h. 
Previous studies have shown that p50-/- mice are much more sensitive to the 
enteropathy induced by LPS. p50-/- mice lacking lymphocytes (3XRAG) also 
developed an enteropathy, and this was shown to be TNF mediated 
(Gadjeva et al. 2007), suggesting that the effector cells were within the innate 
immune cell compartment. It has also been shown that NFĸB signalling is of 
great importance in endothelial cells in the context of endotoxic shock, where 
blockade of NFĸB signalling significantly reduced LPS induced hypotension, 
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vascular expression of TNF and endothelial nitric oxide synthase (eNOS) 
(Ding et al. 2009). Despite these observations and broad mechanistic 
studies, very little is understood about how NFκB signals in these situations. 
Figure 13: Diagram summarising NFκB signalling pathways. Reprinted by 
permission from Macmillan Publishers Ltd: Nature Reviews Immunology. Gilmore, T. 
D. (2006). "Introduction to NF-kappaB: players, pathways, perspectives." Oncogene 
25(51): 6680-6684.  
 
1.9.6  Effects of Lipopolysaccharide on Enterocytes 
The mechanisms by which LPS causes gut injury during endotoxic shock 
have not been clearly defined. However, it has been shown that when gut 
commensals are depleted in mice by giving prolonged courses of oral 
antibiotics, enterocyte TLR4 expression in the intestine is reduced and 
increased apoptotic cells are observed within the intestinal epithelium after 
ischaemia-reperfusion injury (Chen et al. 2008). This study concluded that 
commensals and LPS reduce the susceptibility of IECs to apoptosis in an 
ischaemia-reperfusion model. In vitro, in IEC-6 cells (of neonatal rat small 
intestinal lineage), it has also been found that LPS stimulates growth, 
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whereas in cell culture models of non-transformed human intestinal epithelial 
cells, it has been found to be growth inhibiting (Ruemmele et al. 2002). 
These effects were demonstrated to be TNF dependent, and observations 
such as this have led to an argument by some for LPS to be viewed less as a 
detrimental molecule to the host, but as a necessary hormone for healthy 
physiological function of the gut and other organs (Marshall 2005). The 
myeloid differentiation primary response gene 88 (MyD88) molecule, which is 
the adapter molecule critical for TLR4 signalling, has also been shown to be 
important in suppressing the intestinal inflammatory response. Indeed, in 
murine dextran sodium sulphate (DSS) induced colitis, Myd88-/- mice 
developed more severe colitis compared to wild-type mice, implying that TLR 
signalling plays an important protective role in suppressing an over exuberant 
inflammatory response in the development of colitis (Araki et al. 2005). 
There is also some evidence that LPS signalling may differ in enterocytes 
when compared to leukocytes. For example, it has also been shown in vitro, 
that in LPS treated M-ICc12 cells (a murine intestinal epithelial cell line derived 
from L-PK/Tag1 transgenic mice), LPS became internalised into a 
perinuclear location, co-localising with TLR4 (Hornef et al. 2002). Increased 
transient CD14 expression with internalisation was shown in response to LPS 
in IEC-6 cells, and this was also observed in vivo after 3 hours of LPS 
treatment in mice (Mollen et al. 2008). In this study, it was also shown that 
there was increased activation of p38-MAPK with IL-6 production in the 
ileum. It has also been shown that myofibroblasts may also respond to LPS 
with up regulated cytokine secretion (Walton et al. 2009).  
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Enterocytes, as part of the innate immune system, may also amplify the 
cytokine response through intercellular communication. Free radicals 
generated by nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase 4 (NOX4) have been shown to represent a potential communication 
between enterocytes when infected with Listeria monocytogenes. NOX4 was 
shown in this study to mediate intercellular communication between 
neighbouring epithelial cells, and to coordinate synthesis and release of 
increased quantities of proinflammatory chemokines CXCL2 and CXCL5 
(Dolowschiak et al. 2010). 
Interestingly, there may also be differences in epithelial sensitivity to LPS 
between the small and large intestine. This has been demonstrated in colon 
explants cultures, where IL-10 and TGFβ were shown to play crucial roles in 
the relative unresponsiveness of the colon to LPS (Jarry et al. 2008). It has 
also been shown that the colon of weaned rats is more resistant to injury 
induced by systemically administered LPS, with significantly less IL-6, IL-4 
and IL-10 production compared to suckling rats (Adams and Tepperman 
2001). 
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1.10  Hypothesis, Aims and Objectives 
The hypothesis for this PhD project is: 
 That systemic administration of lipopolysaccharide causes increased 
small intestinal epithelial cell apoptosis and shedding in a mouse 
model 
The aims of this project are to test this hypothesis, and to attempt to 
establish: 
 Whether LPS may be used as a simple, consistent, and more 
economical stimulus of small intestinal epithelial cell shedding than 
other methods currently available  
 The mechanism by which LPS induces cell shedding  
 The sites in the gastrointestinal tract which are affected 
 The parts of the villus which are affected 
 The time course of this phenomenon 
 The dose required to cause this effect, and whether there is a dose 
response relationship 
 Whether this effect results in increased gut permeability 
 Genetic, and other factors that may influence this process  
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The objectives of the project include: 
 Performing a time course study and carrying out a histopathological 
assessment of H&E stained sections of the small intestine and other 
organs to characterise the effects of LPS 
 Establishing a quantification method based on histopathological or 
immunohistochemical methods to measure the effects of LPS on the 
gut 
 Quantifying and comparing the time dependent effects of LPS in the 
different segments of the gastrointestinal tract  
 Establishing appropriate time points and LPS dosages for statistical 
comparisons to be made between transgenic mice 
 Comparing and quantifying the severity of LPS-induced intestinal 
injury between transgenic mice 
 Investigating changes in mRNA and protein expression following LPS 
administration using qPCR, IHC and western blotting  
 Performing in vivo confocal microscopy studies in LPS dosed mice 
under an appropriate anaesthetic regimen 
 Determining whether LPS-induced cell shedding causes altered gut 
permeability by performing gut permeability assays 
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2.  MATERIALS AND METHODS 
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2.1 Experimental Design 
Prior to designing the first experiments of this project, an extensive literature 
review was performed to investigate the most suitable mouse strains for LPS 
experiments. This also included review of the most suitable type of LPS to 
induce the systemic responses that might induce IEC shedding (selected 
literature summarised in an Appendix, section 8.1). 
The most appropriate LPS was deemed to be that from Escherichia coli 
serotype O111:B4 as this was the most commonly utilised serotype for 
inducing endotoxic shock responses in mice, with dose response parameters 
having been relatively well investigated. This serotype also has a well 
characterised LPS molecule (Campos et al. 1994), due to its reported 
association with outbreaks of infant gastroenteritis (Tawil and El-Kholy 1959). 
An initial dose of 10mg/kg LPS was chosen, as in the literature this dose was 
generally reported to cause a robust endotoxic shock response, but was non-
lethal. The preparation used was phenol-extracted, as this was the most 
commonly utilised form used in the literature, and in the quantities required 
for a full scale study, higher grade ion exchange chromatography extracted 
LPS would have represented a large escalation in the cost of the study. 
Based on the literature review, and that the transgenic mice to be used in 
later experiments would be on this genetic background, it was decided that 
the most suitable mice to use would be the C57BL/6 strain.  
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Intraperitoneal injection was initially selected instead of intravenous as the 
route of systemic administration, as it is technically a much easier procedure 
for larger animal numbers, and results in a very comparable cytokine 
induction profile (Copeland et al. 2005). 
2.2 Mice Examined 
Wild-type (WT) C57BL/6 female mice were purchased from Charles River 
laboratories (Margate, UK) and transferred to the Biomedical Services Unit 
facility at the University of Liverpool (a conventional non-specific pathogen 
free unit) at 8-9 weeks of age. Mice were housed in groups of 3 or 4 per cage 
with ad libitum food and water, and maintained on a 12 hour light:dark cycle. 
Mice were given at least a 1 week acclimatisation period, prior to being used 
for experiments at a minimum age of 9-10 weeks. Procedures were all 
performed under UK Home Office approval on project license 40/3392, and 
personal license 40/10000. Transgenic mice including Nfb1-/-, Nfb2-/- and 
cREL-/- mice were donated by Jorge Caamaňo of the University of 
Birmingham, UK. Tlr4-/- mice were kindly provided by Mark Taylor and Alice 
Halliday (The Molecular and Biochemical Parasitology Group, Liverpool 
School of Tropical Medicine). Tnfr1-/- and Tnfr2-/- mice were provided by Mark 
Frey and maintained at the Saban Research Institute at Children’s Hospital 
Los Angeles. Procedures were performed by Jennifer Miguel and monitored 
by the Children’s Hospital Los Angeles Institutional Animal Care and Use 
Committee. vil-Cre Myd88-/- mice were maintained at the Disease Modelling 
Unit, University of East Anglia, UK.  Procedures were performed by Kevin 
Hughes with UK Home Office approval.  
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2.3 Generation of Nfb1-/- , Nfb2-/- and cREL-/- mice 
Nfb1-/- mice were originally generated by Sha et al. (1995) on a C57BL/6 
background. This was achieved by targeted disruption of the Nfb1 gene by 
electroporated insertion of a linearised pp50KO construct with a 3-
phosphoglycerate kinase (PGK) neo cassette into exon 6 of the Nfb1 gene 
of embryonic stem (ES) cells. This disruption of p105 prevents production of 
functional p105 and p50, but allows production of functional IκBγ. These 
mice, although phenotypically normal, exhibit defective B cell responses, 
including defective antibody production, failure of LPS induced B cell 
mitogenic responses, and failure to clear Listeria monocytogenes infection in 
vivo, specifically failing to clear intracellular bacteria. They are also more 
prone to sustained bacteraemia following Haemophilus influenzae, infection 
but not E. coli infection, and are more resistant to cytopathic 
encephalomyocarditis infection than WT mice. Further studies of 
macrophage function have showed that phagocytosis, TNF and IL-1 
production were normal in this strain, but IL-6 production was reduced.  
Nfb2-/- mice were generated by insertion of a PGK-neo cassette into exon 4 
of the Nfb2 gene by electroporation into ES cells. It was confirmed that 
mutant mice did not express p100 or p52. These mice exhibit abnormalities 
confined to the lymphoid organs, with reduced B cell populations in the bone 
marrow, spleen and lymph nodes, with lack of organised lymphoid follicles or 
germinal centres. These mice also exhibited reduced proliferative responses 
in B cells to LPS, CD40 and anti-IgD-dextran and reduced antigen specific 
immunoglobulin production, although immunoglobulin class-switching in B 
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cells was normal. They also showed reduced T-cell dependent and T-cell 
independent immunological responses (Caamaño et al. 1998).  
c-REL-/- mice were generated by replacing exons encoding amino acids 145-
588 of the c-REL gene with a PGK-neo cassette by electroporation of a 
linearised pC-REL construct. This resulted in a truncated cREL protein that 
was incapable of dimerisation, DNA binding, or transcriptional activation 
(Kontgen et al. 1995). These mice show normal haematopoiesis and 
lymphocyte development, but do show proliferative defects in stimulated B 
and T cells, and deficient IL-2 production. Mice were on a C57BL/6 genetic 
background. All genotypes were previously confirmed by PCR by Dr. Michael 
Burkitt (Gastroenterology Department, University of Liverpool). 
2.4 Generation of Tlr4-/- mice 
Tlr4-/- mice were generated by Shizuo Akira by targeted disruption of the Tlr4 
gene by electroporation of a targeting vector which replaces a 2.54-kbp 
genomic fragment with a neomycin resistance cassette into ES cells. 
Macrophages from these mice were confirmed to be hyporesponsive to LPS 
(E. coli O55:B5) (Hoshino et al. 1999). Mice were on a C57BL/6 genetic 
background. The genotype of this strain was confirmed by PCR (Figure 15). 
2.4.1   Genotyping of Tlr4-/- mice 
Genotyping was performed according to a previously published protocol 
(Truett et al. 2000). Briefly, 2mm of mouse tail-tip was removed with a sterile 
scalpel blade post-mortem into a 1.5ml Eppendorf tube to which 75µl 
of 25mM NaOH/0.2mM ethylenediaminetetraacetic acid (EDTA) was added 
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and maintained at 98ºC for 1 hour. The solution was cooled to room 
temperature, and 75µl of 40 mM Tris HCl (pH 5.5) was added. Centrifugation 
was performed at 13,400 x g for 3 minutes and aliquots used for PCR. 
Presence of the mutated Tlr4-/- allele was tested by performing a polymerase 
chain reaction (PCR) using the protocol published at 
http://hostdefense.ifrec.osaka-u.ac.jp/ja/other/index.html (accessed July 
2012). Briefly, primers (supplied by Eurogentec) designated "A","B", and "C" 
(as per Table 2 below) were added to ThermoPrime 1.1x ReddyMix PCR 
Master Mix with 2.5 mM MgCl2 (Thermo Scientific: Loughborough, UK) in 
25µL reaction volumes. Cycling was performed in a MultiGene™ OptiMax 
Thermal Cycler (Labnet; Woodbridge, USA).  
Primer Vol. 
(µL) 
Gene Sequence Master
mix 
vol. 
(µL) 
DNA 
vol. 
(µL) 
H2O 
Vol. 
(µL) 
“A” 0.25 Targeted 
portion of 
TLR4 gene 
5'-cgt gta aac cag cca ggt ttt gaa ggc-3' 22.5 1 1 
“B” 0.25 TLR4 gene 
upstream 
of targeting 
construct 
5'-tgt tgc cct tca gtc aca gag act ctg-3' 22.5 1 1 
“C” 0.25 Neomycin 
resistance 
gene 
5'-tgt tgg gtc gtt tgt tcg gat ccg tcg-3' 22.5 1 1 
Table 2: Reaction mixes for PCR. Primers A and B are used to detect the wild-type 
allele, and primers B and C used to detect the mutated Tlr4 allele  
 
Cycles Duration Temperature 
1 5 min 85 ºC 
35 30 sec 
1 min 
1 min 
94ºC 
67ºC 
74ºC 
1 10 min 74ºC 
Table 3: Cycling conditions for TLR4 genotyping.  
74 
 
Figure 14: PCR gel confirming presence of the mutated (tlr4-/- (mut pcr)), and 
absence of the wild-type Tlr4 allele (tlr4-/- wt pcr) in Tlr4-/- mice (lanes 2 and 3) 
compared to wild-type control mice (lane 4 and 5). Gene products are both 
approximately 1200 base pairs.  
 
 
2.5 Generation of Tnfr1-/- and Tnfr2-/- mice 
Tnfr1-/- mice were generated by targeting the p55/Tnfr1 gene by homologous 
recombination. A targeting vector was constructed which replaces a 4-kb 
SpeI fragment encoding exons 2 to 5 (amino acids 30–184) with a PGK-neo 
cassette which was electroporated into ES cells. For Tnfr2-/- mice, targeting 
of the p75/Tnfr2 gene by homologous recombination was achieved by 
replacing a 1-kb KasI-BamHI fragment encoding amino acids 3 to 26 with a 
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PGK-neo cassette which was electroporated into ES cells (Peschon et al. 
1998). Mice were on a C57BL/6 genetic background. 
2.6 Generation of vil-Cre Myd88-/- mice 
Homozygous Myd88fl/fl that express a truncated mutant MyD88 protein 
following removal of the floxed region, were bred with villin-Cre mice which 
conditionally express Cre recombinase under control of the villin promoter 
(kindly provided by Simon Clare and Gordon Dougan, Wellcome Trust 
Sanger Institute, Cambridge). vil-Cre Mice heterozygous for the Myd88 allele 
were used as controls. Offspring were genotyped for presence of the wild-
type Myd88, mutated Myd88, and Cre alleles. Mice were on a C57BL/6 
genetic background.  
2.7 Lipopolysaccharide Administration 
LPS from Escherichia coli O111:B4 purified by phenol-extraction (PE-LPS), 
or ion-exchange chromatography (IE-LPS) (Sigma-Aldrich: Gillingham, UK) 
was diluted in sterile phosphate-buffered saline (PBS) and administered to 
mice by i.p. injection. Briefly, LPS was weighed on a microbalance, and 
dissolved in autoclaved sterile phosphate-buffered saline (PBS) in a biosafety 
cabinet, at a solution concentration of between 2mg/ml and 12.5µg/ml to 
deliver appropriate dosages of between 20mg/kg and 0.125mg/kg body 
weight, in a delivered volume of 10µl/g. Solutions were aliquotted in a 
biosafety cabinet through a 0.2µm syringe filter into labelled Bijou containers. 
Aliquots were then frozen at -20°C. Prior to use, aliquots were thawed and 
warmed to room temperature, then vortexed. Mice were weighed, tail 
marked, and appropriate volumes of LPS solution or vehicle (PBS) were 
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injected into the peritoneal cavity with a BD microfine insulin syringe. 
2.8 Recombinant TNF  
Murine recombinant TNF (Peprotech Ltd: London, UK) was diluted in sterile 
water to a concentration of 33µg/ml and administered by intraperitoneal 
injection to mice at 0.33mg/kg in a delivered volume of 10µl/g body weight. 
2.9 Tissue Sampling and Processing 
After cervical dislocation, the abdominal skin was incised with scissors and 
retracted, a midline incision was made through the abdominal musculature 
with scissors and the intestines exteriorised. The small intestine was then 
separated from the large intestine, the lumen flushed with PBS to remove 
digesta, then fixed in 4% formaldehyde (Sigma–Aldrich) in PBS.  
Stomachs were ligated around the cardia and pyloric sphincter with 4 metric 
sofsilk™ suture material, and instilled with 4% formaldehyde. Other organs 
including spleen and liver were routinely taken, together with brain, lung, 
heart, and kidney in initial studies. After 24 hours fixation, the proximal, 
middle, and distal third of the small intestine (referred to in this thesis as the 
duodenum, jejunum and ileum respectively) were separated, and chopped 
into short, approximately 10mm lengths. These lengths which were placed 
within a loop of 3M Micropore™ tape as a bundle, and cut cross-ways with a 
size 22 scalpel (Swann-Morton Ltd: Sheffield, UK) in order to achieve 
multiple cross-sectional intestinal circumferences for histopathological 
examination (Figure 15). This is an alternative to the “Swiss roll” method of 
embedding longitudinal intestinal sections (as described by Moolenbeek and 
Ruitenberg (1981)). This method was also evaluated for the study, but was 
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regarded as inferior due to the higher likelihood of tissue trauma during 
preparation and processing, and the lack of preservation of shed cells in the 
gut lumen. 
 
Tissues were placed in histological processing cassettes and placed in 70% 
ethanol, before being processed routinely through serially increasing 
concentrations of ethanol solution (70%, 90% and 100%), on an overnight 
programme on a Shandon 2LE tissue processor (Table 4). Tissue was 
embedded in paraffin wax (Leica Surgipath Formula R) using a Shandon 
Histocentre embedder (Thermo Shandon Ltd: Runcorn, UK). Sections of 3-
5µm thickness were prepared with a microtome and floated out on a heated 
waterbath onto glass slides for H&E or onto 3-aminoprpyltriethoxylsilane 
(APES) coated slides for immunohistochemistry. The latter were coated in 
2% APES in acetone and allowed to air-dry. Slide mounted sections are dried 
in an oven at 37ºC prior to staining. 
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Figure 15: Tissue preparation, processing, embedding and sectioning to create a 
glass slide. The small intestine was first separated into thirds. These segments were 
then chopped into shorter 10mm lengths, placed as a bundle within a loop of 
Micropore™ tape and then placed within a tissue processing cassette. After 
dehydration, the tissue was placed in a mould and molten wax added. The original 
tissue cassette was set into the top of the wax block before the wax solidified. This 
wax block was then placed in the microtome to cut 3-5µm sections which were 
floated on a waterbath and onto a glass slide.  
 
Step Reagent Temp Immersion (hrs:min) 
1 70% Ethanol Room temp. 02:00 
2 90% Ethanol Room temp. 02:00 
3 100% Ethanol Room temp. 00:30 
4 100% Ethanol Room temp. 00:30 
5 100% Ethanol Room temp. 01:30 
6 Xylene Room temp. 00:30 
7 Xylene Room temp. 00:30 
8 Xylene Room temp. 00:40 
9 Xylene Room temp. 01:30 
11 Wax 60 02:00 
12 Wax 60 03:00 
Table 4: Overnight tissue processing schedule. 
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2.10 Transmission Electron Microscopy 
Small intestinal samples were fixed in 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer for transmission electron microscopy. Samples were then 
processed and imaged at the Electron Microscopy Unit, Veterinary 
Pathology, University of Liverpool, Leahurst Campus. Briefly, samples were 
washed in 0.1M sodium cacodylate buffer and secondarily fixed in 1% 
osmium tetroxide for 90 minutes. Tissues were washed in distilled water, 
stained en bloc with 2% uranyl acetate in 0.69% maleic acid for 90 minutes 
and dehydrated in ascending concentrations of ethanol, followed by acetone, 
then resin embedded. Semi-thin sections (0.5μm) and ultrathin sections (60 
nm) were prepared with a diamond knife. The latter were mounted on copper 
grids, stained with Reynold's lead citrate and viewed with a Philips 208S 
electron microscope (Philips Electron Optics; Eindhoven, The Netherlands). 
2.11 Haematoxylin and Eosin (H&E) Staining 
Sections mounted on glass slides were placed in a slide rack, dewaxed in 
xylene for 10 minutes, followed by 5 minutes in 100% ethanol, 2 minutes in 
90% ethanol, 2 minutes in 70% ethanol, and rehydrated in water for two 
minutes. Slides were placed in Gill no.1 haematoxylin (Sigma-Aldrich) for 2.5 
minutes, then “blued” in running tap water for 10 minutes. They were then 
placed in eosin (Accustain:Sigma-Aldrich) for 3.5 minutes, followed by a rapid 
immersion in water for 5 seconds, then rapid dehydration in 70%, 90% and 
100% ethanol each for 15 seconds, and finally transferred into xylene for 10 
minutes. DPX mounting media was added to section surfaces and 22x50mm 
coverslips were applied. 
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2.12 Active Caspase-3 Immunohistochemistry 
Two immunohistochemical methods were evaluated for the purpose of 
quantifying apoptotic cells. Both used antigen affinity purified, rabbit 
polyclonal anti-active caspase-3 primary antibody AF835 (R&D systems, 
Abingdon, UK). To produce this antibody, rabbits are immunised with keyhole 
limpet haemocyanin (KLH) coupled human caspase-3 synthetic peptide 
(CRGTELDCGIETD: corresponding to amino acids 163-175 of human 
caspase 3; accession number P42574). This antibody binds the p17 subunit 
of cleaved human or mouse caspase-3. These methods both followed  
stage 1 of immunohistochemistry, and were followed by either the avidin 
biotin complex (ABC) or Envision™ protocol as described. Sections were 
then counterstained with haematoxylin for 2.5 minutes, dehydrated and 
coverslipped as for H&E sections. All incubations were carried out in the 
dark.  
2.12.1 Stage 1 of Immunohistochemistry 
Sections underwent standard dewaxing from xylene to 100% ethanol, 5 
minutes endogenous peroxidase block in 0.9% hydrogen peroxide (Sigma-
Aldrich) in methanol followed by standard rehydration steps from 100% 
ethanol to water. Sections were microwaved at 800 Watts for 20 minutes in 
0.01M pH6 citrate buffer to achieve heat induced antigen retrieval. Slides 
were allowed to cool slowly over twenty minutes, cold tap water was then 
added slowly and slides were washed in tris-buffered saline, 0.1% 
Tween®20 (TBST). 
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2.12.2 ABC Method for Active Caspase-3 Immunohistochemistry 
The avidin biotin complex (ABC) method utilises a biotin labelled secondary 
antibody raised to bind to the fragment crystallisable (Fc) region of the 
primary antibody. Avidin conjugated with peroxidase has a strong affinity for 
the biotin label, and forms large avidin-biotin molecular complexes. The 
protocol following on from stage 1 for the ABC method was as follows: 
epitopes were blocked with 10% goat serum in TBST for 45 minutes, then 
incubated with primary antibody in 10% goat serum in TBST overnight at 
4°C.  
Slides were washed in TBST then incubated with 1/200 secondary polyclonal 
biotinylated goat anti-rabbit immunoglobulins (Dako: Ely, UK) in 10% goat 
serum in TBST for 30 minutes. Slides were again washed in TBST then 
incubated with Vectastain ABC elite (Vector Labs: Peterborough, UK) for 30 
minutes. After slides had been washed in TBST, sections were incubated 
with 0.7mg/ml Sigmafast Diaminobenzidine (DAB) and 0.03% H2O2 (Sigma-
Aldrich) in PBS in the dark for 5 minutes. 
2.12.3 Envision™ Method for Active Caspase-3  
Immunohistochemistry 
This method utilises a polymer conjugated to multiple secondary antibodies 
and horse-radish peroxidase (HRP) molecules, thereby greatly improving 
sensitivity and specificity. This method avoids the need for blocking epitopes 
and is not affected by endogenous biotin. The protocol, following on from 
stage 1, was as follows: sections were incubated for 2 hours at room 
temperature with primary antibody. Slides were washed in TBST, then 
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incubated with Envision™ HRP labelled polymer anti-rabbit (Dako) for 30 
minutes at room temperature. Slides were again washed in TBST then 
incubated with DAB chromogen and substrate liquid solution (Dako)  
2.12.4 Immunohistochemistry Method Comparison 
By assessing immunohistochemical labelling qualities of the two methods, it 
was possible to discern better definition of positive labelled epithelial cells 
with the Envision™ method, which also resulted in consistent labelling of 
morphologically apoptotic detached epithelial cells (Figure 17). This method 
also exhibited less background non-specific staining of sections compared to  
the ABC method, and provided considerably less labour and increased 
throughput.  
 
 
 
2.12.5 Active Caspase-3 Antibody Titration  
After selection of the Envision™ method, a titration was performed as the 
greater sensitivity of this staining system can often allow for more dilute 
primary antibody concentrations to be employed. However, concentrations 
Figure 16: Immunohistochemistry was compared between the ABC method and 
Envision™ method using 1/800 concentration of anti-active caspase-3 primary 
antibody. The ABC method gave less consistent and less distinct immunostaining of 
apoptotic cells compared to the Envision™ method. Bars=25 µm. 
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more dilute than 1/1000 resulted in more inconsistent immunolabelling 
(Figure 18). For the first study, including the time course and dose response, 
lot CFZ3207011 of the AF835 rabbit polyclonal anti-caspase 3 primary 
antibody was used at 1/800 dilution. For subsequent studies, titration was 
performed with a new batch of primary antibody (lot number CFZ3410111), 
for which it was found that 1/2000 gave optimal staining. 
 
 
2.13  Active Caspase-3 Scoring Criteria 
For quantification of apoptotic and shedding IECs, individual epithelial cells 
were counted from the base of the villus (above crypt level) to the mid-point 
of the villus tip in 18-20 well orientated “hemivilli” at 400x magnification 
(delineated by the red line in Figure 19). The hemivilli selected for scoring 
Figure 17: Titration of AF835 rabbit polyclonal anti-caspase 3 primary antibody (lot 
number CFZ3207011) showed greatest definition of positively labelled epithelial cells at 
1/800, and more vague and inconsistent staining at concentrations more dilute than 
1/800. Bars=50µm.  
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were chosen based on the criteria that they were the first encountered during 
microscopic examination with correct orientation (similar to height of 
neighbouring villi, correct shape including shape of villus tip, continuous 
section) and that they exhibited a resolvable monolayer of epithelium along 
their axis. IECs were categorised according to the following criteria: 
 “Normal” if there was no/weak diffuse non-specific brown staining and 
cells had a basally located basophilic nucleus. 
 “Apoptotic” if there was defined positive staining which was confined to 
cytoplasmic or nuclear borders when compared to any background 
staining of neighbouring IECs.  
 “Shedding” if there was defined positive staining which was confined 
to cytoplasmic or nuclear borders and in addition there was apical 
elevation of the cytoplasmic membrane, and/or an apically positioned 
nucleus.  
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Figure 18: Active caspase-3 IHC. Duodenal villus tip, indicating the 3 possible 
categories into which cells are designated during counting. Arrows indicate active 
caspase-3 positive IECs with a “shedding” morphology, and IECs with positive 
immunolabelling for active caspase-3 with unaltered morphology, designated as 
“apoptotic”. Unlabelled cells are designated as “normal”.  
 
Crypt IECs were similarly counted from the crypt base to the crypt-villus 
junction in 19-20 well-orientated duodenal hemicrypts per mouse. Crypt IECs 
were simply categorised as “normal” or “apoptotic” based on active caspase-
3 staining. 
2.13.1 Quantification of Active Caspase-3 Immunohistochemistry 
A method for quantification of active caspase-3 positively immunolabelled 
cells by microscopic analysis was devised utilising SCORE software (Version 
1, Beta 1, developed by Steve Roberts, at the Paterson Institute for Cancer 
Research, Manchester, UK 1996). This program allows categorised cell 
counting according to the scoring criteria described above. Cell category was 
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assigned a keyboard character on a cell positional basis in 18-20 well 
orientated villi from the duodenum, jejunum and ileum of the small intestine. 
IECs were counted with each keystroke from the base of the villus to the 
apex for each hemivillus or hemicrypt at 400x magnification. Individual files 
created in the score program were transferred to WinCrypts© software 
(Version 1.00, Release 1.9, Cancer Research Campaign 1999) for data 
analysis. 
2.14 Cell Positional Data for Active Caspase-3 
Immunohistochemistry 
To allow comparison of cell positional data, villi were adjusted to a fixed 
length of 100 cells using WinCrypts© software. Data are then represented as 
percentage of villus length, with 0% therefore representing the villus base, 
and 100% representing the villus tip. 
2.15 Consistency of Active Caspase-3 
Immunohistochemical Scoring 
There is an obvious degree of subjectivity to assessment of 
immunohistochemistry, as positive DAB labelling must be interpreted in 
relation to background non-specific staining levels, and by comparison to 
neighbouring cells. There is also unavoidable variability in section quality, 
and in different batches of immunohistochemistry in larger studies, which 
must be judged and interpreted to confirm that sections are suitable for 
further assessment. The author and principal observer (PO), as a trained 
veterinary pathologist has experience in the assessment of 
immunohistochemistry in the context of diagnostic histopathology. However, 
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the reproducibility of the scoring method, and both inter-observer, and intra-
observer variation were tested (Figure 19). This was achieved by repeat 
scorings made on active caspase-3 stained duodenal sections on separate 
occasions. These data demonstrated relative consistency between repeated 
scoring by the principal observer, and relative agreement with the 
independent observer (IO) for individual slides at indicated time points post-
LPS (Figure 20). There is also overall agreement between the independent 
observer and principal observer on the overall trend in peak apoptosis and 
shedding at 1.5h. 
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Figure 19: Bar charts demonstrating scoring consistency of active caspase-3 for the 
same set of 5 slides for duodenal sections at indicated time point post LPS by an 
independent trained observer (IO) compared with 2 separate scorings by the author 
(POa and POb). Unt=untreated. 
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2.16 Consistency of LPS Induced IEC Apoptosis and 
Shedding Between Laboratories 
As well as confirming relative consistency and agreement between 
independent scorings and observers, it was necessary to confirm that LPS 
treated WT responses were consistent between different laboratories. LPS 
treated WT mice at the University of Liverpool (UoL) and University of 
Southern California (UoSC) were therefore compared. When administered 
10mg/kg PE-LPS for 1.5h, mice at UoL and UoSC showed very similar 
duodenal villus height reduction to 260.5µm±15.0µm and 278.4µm±15.8µm 
respectively (Figure 20A). They also showed very comparable combined 
apoptosis and shedding indices (Figure 21B) at 12.8%±1.34% at UoSC 
compared to12.5%±1.7% at UoL.  
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Figure 20: Villus heights (A) and percentage of apoptotic and shedding IECs (B) in 
vehicle (PBS) treated and LPS treated mice in University of Liverpool (UoL) and 
University of Southern California (UoSC) laboratories. n=3-6 mice per group. N.B. 
UoSC PBS treated mice represent mean villus height of n=1 for PBS treated WT, 
Tnfr1-/- and Tnfr2-/- mice. *=P<0.05 based on ANOVA with Holm-Sidak post-hoc test.  
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2.17  Image Analysis of Active Caspase-3 
Immunohistochemistry 
In an attempt to avoid the issues surrounding the effects of observer 
subjectivity in assessment of immunohistochemistry quantification, an 
automated IHC analysis method was also tested. This was achieved by 
utilising photomicrographs at 100x magnification and using ImageJ software 
(Schneider et al. 2012). Briefly photomicrographs were edited in ImageJ to 
remove positively labelled luminal content, and 10 well orientated villi were 
selected. Photomicrographs were then split into component red, green and 
blue channels. The blue channel image was then utilised as this largely 
cancelled out blue haematoxylin counterstaining and gave good contrast for 
brown DAB labelled cells. A threshold intensity for positive labelling was set 
manually, and the program was utilised to calculate the percentage of villus 
area positively labelled by DAB. The results for the time course experiment 
(Figure 21) showed broad agreement with the time course pattern assessed 
by human scoring, but with larger inter-animal variation. This method was 
also highly labour intensive, as it demanded a great deal of human 
intervention in villus selection, image editing, and setting threshold 
intensities, thereby introducing elements of human bias that were hoped to 
be avoided in computer based image analysis. It was therefore not pursued 
further as a suitable quantification method. 
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Figure 21: Bar chart of percentage duodenal villus area positively immunolabelled 
for active caspase-3 measured by ImageJ analysis at set time points post LPS, 
demonstrating maximum labelling at 1.5h. * =P<0.05 based on Kruskal-Wallis with 
Dunnett’s post-hoc test. n=6, Unt.=untreated.  
2.18  Villus Height By Graticule Measurement 
An eyepiece graticule was calibrated by measurement against a 1x1mm 
haemocytometer, and length measurements made of 10 well orientated villi 
from the villus base to the villus tip. Data were inputted directly into Microsoft 
Excel. Mean villus length was calculated for the group of animals at each 
time point and for each intestinal segment. 
2.19  Measurement of Villus Height by Image J 
Image J was used to assess images captured by a Leica DMLA microscope, 
by setting the scale with a haemocytometer at 100x magnification. All images 
were captured at 100x magnification, and villi were measured by using the 
segmented line tool. Each segmented line was placed to originate at the 
base of the villus, above the level of adjoining crypts, and a segmented line 
extended to the villus tip, following any curvature of the villus. The mean of 
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these segmented line lengths for 10 well-orientated villi was calculated for 
each animal, and a mean value was then calculated for each group. The 
ImageJ assessment method was utilised for villus height measurements 
unless otherwise stated. 
2.20  Gut Permeability Assays 
Fluorescein isothiocyanate (FITC) conjugated dextran (FD4:Sigma-Aldrich) 
represents a fluorescent labelled dextran of molecular weight between 3-
5KDa. This molecule should not in normal conditions be absorbed via the 
gastrointestinal tract into the circulation unless there is increased gut 
permeability. All animals were fasted overnight, then administered 22mg/ml 
FD4 in PBS at a dose of 20ml/kg by oral gavage with a blunted curved 
gavage needle. In order to allow the FD4 to be distributed throughout the 
intestinal tract, FD4 was administered 5 hours prior to them being 
euthanased via a rising CO2 concentration, and blood taken by cardiac 
puncture. To assess the effect of LPS on permeability, it was administered at 
set time points prior to the end of the experiment, i.e. gut permeability at 1.5h 
post LPS was achieved by LPS administration at 1.5h prior to euthanasia. 
Plasma was separated from heparinised whole blood by centrifugation at 
2000 x g. Plasma fluorescence was measured by an Infinite F200 plate 
reader (TECAN: Reading, UK) at excitation wavelength 485nm, and emission 
wavelength 535nm, from blood collected post-mortem, 5h after gavage. 
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2.21  Tissue for RNA and Protein Extraction 
Treated and untreated mice were euthanased by a Home Office approved 
method. The small intestine was removed at necropsy and flushed with 
chilled chelation buffer as described by Flint et al. (1991). Briefly, the small 
intestinal content was flushed out with chilled PBS, and the small intestine 
incised longitudinally with scissors. The small intestine was placed in chilled 
chelation buffer on ice for 20 minutes in 50ml Falcon™ tubes (Oxford, UK). 
Contaminated buffer was discarded and replaced with fresh solution, while 
the samples were maintained on ice with frequent agitation and vortexing. 
This was followed by centrifugation at 300 x g at 4ºC for 5 minutes to 
produce an epithelial enriched pellet containing crypt villus units. These 
samples were stored at -80ºC until further analysis. 
2.22  RNA Extraction 
RNA was isolated with a High pure RNA Tissue Kit (Roche; Burgess Hill, UK) 
from small intestinal epithelial enriched extracts isolated using the above 
method. Approximately 30mg of tissue was placed in denaturant/chaotropic 
guanidine hydrochloride solution and lysed by mechanical homogenisation. 
Homogenate was transferred into glass fleece containing spin columns, and 
in the presence of chaotropic salt solution, nucleic acids were selectively 
bound to this glass fleece. Nucleic acids were then eluted from the spin 
column into buffer and RNAse free water. The concentration of extracted 
RNA was quantified by absorbance spectrophotometry of a sample volume of 
1µl using a Nanodrop Lite (Thermo Scientific: Loughborough, UK) at a 
wavelength of 260nm, and purity was assessed by the 260/280 absorbance 
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ratio. A ratio of ≥1.7 was considered adequate for further experiments. 
2.23  Reverse Transcription 
Reverse transcription was performed with 500ng RNA from individualised 
samples using a RT2 First Strand Kit (SABiosciences; Crawley, UK) as per 
the manufacturer`s instructions. Briefly, samples were incubated with a 
genomic DNA elimination mix for 5 minutes at 42ºC in a heat block. Samples 
were then incubated with reverse transcriptase mix at 42ºC for 15 minutes 
and the reaction was stopped by incubation at 95ºC for 5 minutes. The 
resulting cDNA samples were stored at -20ºC. 
2.24  Real-time PCR (qPCR) 
cDNA sample quality was assessed by running individual samples on a 
murine RT2 RNA QC PCR array plate (SABiosciences; Crawley, UK). 
Evaluation of these samples for transcription efficiency, genomic DNA 
contamination, and house-keeping gene expression concluded that the 
samples were of adequate quality for real-time PCR analysis. Two 89 gene 
Cell-Death Pathway Finder array (SABiosciences) plates were run, each with 
an n=4 pooled sample for untreated and 1.5 hour LPS treated samples. 
Reverse transcribed cDNA samples were equally weighted. Amplification 
was performed on a LightCycler 480 instrument (Roche: Burgess Hill, UK) as 
per the conditions outlined in Table 5, with quantification of SYBR green 
fluorescence.  
Threshold cycle (Ct) values were calculated by the maximal second 
derivative algorithm using the 480 LightCycler software release 1.5.0. Gene 
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expression ratios were calculated by normalising genes to house-keeping 
genes, and using the ΔΔCt method via web based analysis software at 
www.sabiosciences.com/pcrarraydataanalysis.php (accessed October 2012) 
and comparing gene expression ratios between treated and untreated 
groups. Gene Primers for the following genes were included in this array: 
Pro-apoptotic genes: Abl1, Apaf1, Bcl2l11, Birc2 (c-IAP1), Casp1 (ICE), 
Casp6, Casp7, Casp9, Cd40 (Tnfrsf5), Cd40lg (Tnfsf5), Cflar (Casper), Dffa, 
Fasl (Tnfsf6), Gadd45a, Nol3, Tnfrsf10b 
Anti-apoptotic genes including: Bcl2a1a (Bfl-1/A1), Birc3 (c-IAP2), Casp2, 
Igf1r, Mcl1, Tnfrsf11b, Traf2, Xiap 
Apoptosis and autophagy associated genes: Akt1, Bax, Bcl2, Bcl2l1 (Bcl-
x), Casp3, Fas (Tnfrsf6), Tnf, Trp53 
Apoptosis and necrosis associated genes: Atp6v1g2, Cyld, Spata2, 
Sycp2, Tnfrsf1a  
Autophagy associated genes: App, Atg12, Atg16l1, Atg3, Atg5, Atg7, 
Becn1, Ctsb, Ctss, Esr1 (ERa), Gaa, Htt, Ifng, Igf1, Ins2, Irgm1, Map1lc3a, 
Mapk8 (Jnk1), Nfkb1, Pik3c3 (Vps34), Rps6kb1, Snca, Sqstm1, Ulk1 
Necrosis associated genes: 9430015G10Rik, Bmf, Ccdc103, Commd4, 
Defb1, Dennd4a, Dpysl4, Eif5b, Foxi1, Galnt5, Grb2, Hspbap1, Jph3, Kcnip1, 
Mag, Olfr1404, Parp1 (Adprt1), Parp2, Pvr, Rab25, S100a7a, Tmem57, 
Txnl4b  
Triplicate samples were used to validate array plate findings for Tnf and cd40 
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using TaqMan® mouse gene expression assays (Life Technologies; Paisley, 
UK) for β-actin (Mm01205647_g1), Tnf (Mm00443260_g1) and Cd40 
(Mm00441891_m1;). cDNA and primers were added to TaqMan® Gene 
Expression Master Mix (Life Technologies; Paisley, UK). Amplification was 
also performed on the Roche 480 Lightcycler machine, with fluorescence 
measured for 6-carboxyfluorescein (FAM) probe. Cycling conditions were as 
above. The ΔΔCt method was again used in combination with REST© 
software for data analysis.  
Cycles Duration Temperature 
1 10 min 95ºC 
45 
 
15 sec 
1 min 
95ºC 
60ºC 
Table 5: Cycling conditions for qPCR analysis performed on Roche Lighcycler 480 
with ramp rate of 1ºC/sec. 
 
2.25  Protein Extraction and Western Blotting 
Epithelial enriched extracts were isolated as previously described. Cell lysis 
was achieved by suspending cell pellets in radio immunoprecipitation (RIPA) 
buffer with 2x1mm diameter steel beads and performing cell lysis on a 
Qiagen Tissue Lyser II at 25hz for 2 minutes. Protein was quantified by 
Bradford assay against bovine serum albumin (BSA) at standard 
concentrations. Protein was denatured in Laemmli buffer at 95ºC for 5 
minutes and loaded into 5% acrylamide stacking gel overlying a 10% 
acrylamide running gel (both used 30% acrylamide/bis-acrylamide solution; 
Sigma-Aldrich, UK). Samples were electrophoresed for approximately 90 
minutes at 120V. Transfer and immobilisation of proteins onto nitrocellulose 
paper was achieved by electrophoresis at 100V for 60 minutes. Imaging was 
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performed with a Biorad Chemidoc Imager (Biorad; Hempstead, UK). 
Polyclonal rabbit antibodies for RelB (1:1000; SC-226 Santa Cruz, 
Heidelberg, Germany) and p100/p52 (1:1000; #4882 Cell Signaling 
Technologies, Danvers, USA) were incubated with nitrocellulose membranes 
overnight at 4ºC, and for 2 hours at room temperature with mouse 
monoclonal pan-actin (1:2000: ACTNO5; Neomarkers, Freemont, USA). This 
was followed by 2 hours incubation at room temperature with goat anti-rabbit 
horse-radish peroxidase (HRP) labelled immunoglobulins (1:10,000; SC-
2004 Cell Signaling Technologies, Danvers, USA) or rabbit anti-mouse HRP 
labelled immunoglobulins (1:2000; P0161; Dako, Ely, UK) as appropriate. 
Nitrocellulose paper was then incubated with SuperSignal West solution 
(Thermo Scientific: Loughborough, UK). 
2.26  Anaesthetic Protocol Evaluation 
In order to perform confocal microscopy, it was necessary to establish an 
injectable anaesthetic protocol that did not cause any form of intestinal injury, 
and which also provided a stable surgical plane of anaesthesia to allow 
laparotomy. A combination of medetomidine (Domitor®; Pfizer, Germany) 
and ketamine (Vetalar®; Pfizer, Germany), was initially tested as a potential 
anaesthetic protocol. Medetomidine is an alpha 2 adrenoreceptor agonist, 
which binds with neuronal receptors predominantly in the pons and lower 
brainstem to prevent release of the excitatory neurotransmitter noradrenaline. 
This causes central nervous system depression and sedation, but also 
causes depressed sympathetic tone, reduced cardiac output and peripheral 
effects of systemic hypertension (Sinclair 2003). Ketamine represents a non-
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competitive N-methyl D-aspartate (NMDA) receptor antagonist. The NMDA 
receptor is a cation gated channel receptor which is particularly important in 
cortical-cortical and cortico-subcortical interactions. Ketamine therefore 
causes dissociative anaesthesia and largely leaves reflexes intact (Bergman 
1999).  
A mixture of 0.16 mg/ml medetomidine and 20 mg/ml ketamine in sterile PBS 
was administered at a dose of 100µl i.p. for induction, and subsequent doses 
of 30µl were given intramuscularly (i.m.) every 30 minutes or as required to 
maintain surgical anaesthesia. This anaesthetic regimen did not provide a 
stable plane of surgical anaesthesia, with animals in general exhibiting 
inconsistent tail pinch and foot pinch reflexes, and gradually declining 
respiratory rate and perfusion as assessed by mucous membrane colour. 
These anaesthetised animals would frequently die prior to the predetermined 
time point. On analysis of the gut, the duodenum exhibited marked apoptosis 
and shedding, suggesting that this anaesthetic combination was highly 
unsuitable for further investigations. Instead, Hypnorm (0.315mg/ml fentanyl 
citrate; VetaPharma Ltd, Leeds, UK) and diazepam (5mg/ml; Hameln, 
Gloucester, UK) were tested as an alternative combination. Fentanyl at 13µg 
(0.04ml) with 150µg diazepam (0.03ml) were administered for induction by 
i.p. injection, followed by 6µg (0.02ml) fentanyl i.m. as required to maintain 
surgical anaesthesia. Fentanyl represents a potent and short-acting agonist 
of µ opioid receptors. Diazepam represents an agonist of GABAA receptors. It 
potentiates the inhibitory neurotransmitter γ-aminobutyric acid (GABA) 
causing central nervous system depression and muscular relaxation.  
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This combination gave stable surgical anaesthesia and histopathological 
analysis showed absence of apoptosis and cell shedding that were observed 
with the medetomidine and ketamine combination. This anaesthetic regimen 
was therefore utilised to perform confocal microscopy. Tests were also 
performed whereby anaesthetised animals were simultaneously administered 
LPS, followed by histopathology after euthanasia to confirm that similar 
apoptosis and shedding was caused in anaesthetised animals and in a 
similar time course to conscious animals. 
2.27  In vivo Confocal Microscopy 
Confocal microscopy is a technique whereby laser light at specific 
wavelengths is focused onto a specimen, stimulating electron excitation in 
fluorescent dyes which then emit photons of a specific wavelength. Photons 
at the specific emission wavelength are then collected by photomultiplier 
tubes to generate an image. By collecting only in focus and not scattered 
photons through a pinhole aperture, and using image deconvolution, this 
technique offers great benefits over traditional fluorescent microscopy by 
allowing three-dimensional optical sectioning through a thicker biological 
specimen. 
Briefly, mice were administered fentanyl and diazepam i.p., with or without 
10mg/kg LPS administered 10 minutes prior to induction. When a surgical 
plane of anaesthesia was considered to have been attained, the animal was 
placed on a heat mat in dorsal recumbency and a 1 cm midline abdominal 
incision made and laparotomy performed. The jejunum was externalised, and 
an approximately 2cm length segment was incised with a cauterizer along its 
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anti-mesenteric border and opened to expose the mucosal surface. The 
mouse was then transferred to a custom made metal stage insert in ventral 
recumbency, and the mucosal surface was then placed on a coverslip with a 
small amount 3.85mM acriflavine hydrochloride made up in Hank`s balanced 
salt solution (both Sigma-Aldrich, UK). Acriflavine stains both nuclei and 
cytoplasm and fluoresces on stimulation with laser light. Photons of laser light 
at approximately 416nm were used to stimulate emission of photons from 
acriflavine at approximately 514nm. Images were taken with a Leica True 
Confocal Scanner SP2 operated with Leica LCS software package at 200x 
magnification at scan speed of 400hz over a typical tissue depth of 
approximately 20µm.  
2.28  Data and Statistics 
Data represent mean±standard error of the mean (SEM). Comparisons were 
made between equivalent intestinal segments in treatment groups and 
controls using SigmaPlot 12© (Systat Software: London, UK). Normally 
distributed data were assessed by analysis of variance (ANOVA) with Holm-
Sidak post-hoc test, and non-parametric data were analysed by ANOVA on 
ranks (Kruskal-Wallis) with Dunn’s or Dunnett`s post-hoc test. P<0.05 was 
considered significant and indicated by an asterisk. REST© software was 
used for comparison of qPCR data from individualised samples by 
randomisation test as previously described (Pfaffl et al., 2002). n numbers 
indicate the total number of mice studied per group.  
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3.1 Introduction  
Characterisation of the cell death occurring in intestinal injury brought about 
by sepsis or endotoxic shock in mice has previously concentrated on 
intestinal pathology at time points beyond 4 hours (Alscher et al. 2001; 
Coopersmith et al. 2003; Han et al. 2004; Guma et al. 2011). Other animal 
studies in rats have given limited descriptions of the most acute lesions of 
endotoxic shock, having described small intestinal red streaks, which by in 
vivo microscopy appear to be congested vessels. These lesions have been 
reported as early as 20 minutes after intravenous injection of endotoxin, with 
haemoglobin leakage into the gut lumen (Shindo et al. 1996). One hour after 
the start of a constant intravenous infusion of endotoxin, gross evidence of 
“erosions, hyperaemia and haemorrhage” and histological evidence of 
“partial destruction of the upper part of the villi” have also been observed 
(Miura et al. 1996).  
Intestinal permeability has previously been shown to increase in endotoxic 
shock in multiple studies, but the most rapid increase in intestinal 
permeability in a mouse model was recorded 2 hours after initiation of 
endotoxic shock by measurement of 51Chromium labelled EDTA clearance 
(Deitch et al. 1991). This study implicated the ileum in this increased 
permeability but not the jejunum. Marginally increased levels of apoptosis 
(but primarily necrosis) have been observed at the villus tip in a feline model 
of septic shock within the ileum, also at 2 hours after LPS administration 
(Crouser et al. 2000).  
Establishing when and where significant epithelial cell death and cell 
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shedding occur in the murine gastrointestinal tract following systemic LPS 
administration was therefore critical in order to study pathological villus 
epithelial shedding, and to develop this model for investigation of this 
phenomenon. We also aimed to characterise the early clinical signs in LPS 
treated mice, and compare the sensitivity of other organs compared to the 
gastrointestinal tract by taking additional visceral samples and examining 
them by histopathology. By ultrastructural and immunohistochemical study 
we aimed to characterise the cell death and/or shedding that occur in acute 
endotoxic shock. We also aimed to correlate pathological alterations in the 
gut with detrimental effects on gut barrier function by performing gut 
permeability assays. 
3.2 Systemic LPS administration caused clinical signs 
and gross pathological alterations from 1.5 hours  
Initial investigations focused on establishing the time dependent pathological 
effects of LPS. PE-LPS was administered at 10mg/kg by i.p. injection to adult 
female WT C57BL/6 mice, and they were euthanased by cervical dislocation 
at 1, 1.5, 2, 3, 4 and 6 hours later. Animals began to exhibit clinical signs 
such as crouching gait, piloerection and huddling behavior indicative of 
hypothermia, and ptosis anywhere between 15 minutes to 1.5 hours after 
LPS administration. Mucoid brown to yellow diarrhoea was observed in 
animals from 1.5-2 hours after LPS administration. At necropsy, gross 
pathological changes included serosal pallor of the small intestine (Figure 
22B), which exhibited distension with watery yellow fluid. These observations 
showed that LPS caused acute onset diarrhoea in this murine model of 
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endotoxic shock, with gross evidence of fluid exudation into the small 
intestine.   
3.3 LPS caused small intestinal injury manifested by 
villus IEC shedding from 1.5 hours  
Histopathological examination of H&E stained sections was performed to 
characterise the intestinal injury following LPS administration. Small intestinal 
sections from animals euthanased at 1.5 hours (Figure 22D and F), and at 2 
hours, demonstrated marked villus atrophy characterised by villus stunting, 
blunting, and clubbing. Large numbers of IECs were observed within the 
intestinal lumen, characterised by cell shrinkage and rounding, with 
hypereosinophilic cytoplasm, and a round, centrally located, pyknotic nucleus 
(consistent with apoptotic epithelial cells). IECs at the villus tip exhibited 
variable separation and detachment from neighbouring cells with either 
cytoplasmic swelling, vacuolation and an apically positioned nucleus 
(consistent with hydropic degeneration and shedding), or a teardrop 
morphology with cell shrinkage, hypereosinophilic cytoplasm, and an apical 
hyperchromatic nucleus (consistent with apoptosis and shedding). Large 
numbers of shed epithelial cells were present within the lumen. The small 
intestine also exhibited some patchy oedema of the lamina propria, and 
dilation of blood vessels with margination of neutrophils.  
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Figure 22: Untreated control (A) and 1.5h LPS treated WT mouse (B),exhibiting fluid 
filled small intestine devoid of digesta (blue arrow) with diarrhoeic faeces at anus 
(blue arrowhead). H&E stained sections of duodenum showing normal villi in 
untreated control (C) and shortened, blunted villi with shed IECs in lumen at 1.5h 
(D). Villus tips in untreated control (E) and shedding IECs (F) at 1.5h (arrows). 
Bars=200µm in (C) and (D), and 25µm in (E) and (F). 
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3.4 LPS caused highly dynamic small intestinal 
epithelial cell apoptosis and cell shedding with 
concomitant activation of caspase-3 
After finding histopathological evidence of cell death and cell shedding, 
sections were examined for biochemical evidence of programmed cell death 
(apoptosis). Immunohistochemistry for active caspase-3 was therefore 
performed, which is a generally accepted method for detecting apoptosis in 
tissue sections. Active caspase-3 immunolabelled sections (Figure 24) 
demonstrated the amount of IEC apoptosis and shedding that was induced 
by LPS at the time points investigated. These representative 
photomicrographs demonstrate that the quantity of IECs positively 
immunolabelled for active caspase-3, was negligible in untreated animals, 
markedly increased at 1 hour post LPS administration (predominantly within 
the epithelium), was maximal at 1.5 hours (with many positively labelled IECs 
within the lumen), and declined markedly by the 3 hour time point, without 
further changes at 4 or 6 hours. At higher magnification (Figure 25) apoptotic 
IECs that were positively labelled for active caspase-3, and shedding IECs 
that were both positively labelled and undergoing extrusion from the epithelial 
monolayer were observed.  
Quantification of this effect was achieved by manual counting (see Materials 
and Methods). Maximal active caspase-3 labelling of 12.5%±1.7% villus IECs 
was found in the duodenum 1.5 hours after LPS administration (Figure 26), 
representing a 21 fold increase compared to untreated mice (0.6%±0.2%, 
P<0.05: Kruskal-Wallis). Comparable IEC apoptosis and cell shedding were 
107 
also observed at 1.5 hours in the jejunum and ileum (12.1%±2.4% and 
11.2%±1.3% respectively). Comparable apoptosis was not observed in the 
stomach, colon, liver, kidney, lung or brain 1.5h following LPS administration 
(Figure 26). 
Figure 23: Active caspase-3 IHC in sections of duodenum, demonstrating negligible 
labelling in untreated mice, increased IEC labelling at 1 hour, and maximum positive 
labelling of IECs at 1.5 hours post LPS. Large numbers of positively labelled shed 
cells were present within the lumen. Minimal labelling was observed from 3 hours 
onwards. 50x bars=200µm, 630X=25 µm. 
 
 
Figure 24: Active caspase-3 IHC showing typical duodenal villus tips at 1.5 hours 
post LPS. Red arrows indicate active caspase-3 positive IECs with a shedding 
morphology (A and B), blue arrows indicate IECs with positive immunolabelling for 
active caspase-3 with unaltered morphology (B), interpreted as apoptotic. 
Bars=25µm.  
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Figure 25: Quantification of categorised IECs by manual counts of active caspase-3 
IHC at set time points post LPS in duodenum (A), jejunum (B), and ileum (C). 
P<0.05 based on Kruskal-Wallis comparison with Dunnett’s post-hoc test. n=6 
mice/time point. Unt.=untreated 
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Figure 26: Other target organs commonly damaged in endotoxic shock did not show 
evidence of cell death. IHC for active caspase-3 shows lack of immunolabelling in 
lung (A), kidney (B), or other localisations of the gastrointestinal tract; colon (C) from 
1.5h 10mg/kg LPS treated mice with confirmed apoptosis in the small intestine. 
Bars=50µm.  
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3.5 LPS did not cause significant apoptosis in the 
small intestinal crypts 
From initial study of H&E stained sections of the small intestine, it was 
apparent that during the early phases of endotoxic shock in our model, the 
crypts did not exhibit the same magnitude of cell death as villi. However, as 
many studies of small intestinal injury induced by LPS have focused entirely 
on the effects caused in the crypts, generally from 4h onwards, investigation 
and quantification of the amount of apoptosis that occurred in the crypts was 
undertaken. 
Crypt IEC apoptosis as interpreted by active caspase-3 IHC did not show a 
comparable magnitude of increase to that observed in villi at 1.5h (Figure 
28A), although there was a ~3 fold increase by 6h post LPS compared to 
untreated mice (1.2%±0.3% versus 0.4%±0.1% in untreated). Accordingly, 
crypt counts did not alter significantly throughout the time course studied 
(Figure 28B), in contrast to villus IECs counts. Crypt apoptosis did not exhibit 
an obvious cell positional dependent pattern along the crypt axis (Figure 28).  
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Figure 27: Quantification of active caspase-3 labelled IECs (A) and relative IEC 
counts in hemivilli compared to hemicrypts (B) in the duodenum at time points 
indicated after 10mg/kg PE-LPS. 
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Figure 28: Crypt apoptosis quantification did not demonstrate an obvious pattern 
along the crypt axis at time points indicated after LPS administration. n=6 mice per 
group.  
3.6 LPS caused rapid villus atrophy in the duodenum, 
jejunum, and ileum  
As shortening of the villus (villus atrophy) is commonly observed in small 
intestinal damage, villus heights were measured as an additional means of 
assessing LPS induced injury. Villus height assessment was made by three 
different modalities, including IEC counts (Figure 29A), graticule 
measurement (Figure 29B), and ImageJ analysis (Figure 29C). The mean 
villus height was decreased in all intestinal segments from 1 hour post LPS, 
with the largest proportional and significant reduction in villus height being 
measured in the duodenum from 1.5 hours and minimum heights being 
observed at 3 hours. By ImageJ analysis (Figure 29C), mean villus height in 
the duodenum was reduced by 29% to 260.5µm±15.0µm, 1.5 hours after 
LPS administration, compared to untreated (365.9µm±6.6µm (P<0.01: 
ANOVA)). Maximal villus atrophy was also measured by this method at the 3 
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hour time point (252.2µm±22.2µm), representing a relative percentage 
reduction in villus height of approximately 31%. Villus heights did not exhibit 
further changes at the 4 and 6 hour time points.  
Villus shortening was also associated with lower numbers of IECs lining the 
duodenal villi, with a 21% reduction in mean cell number observed at 1.5 
hours post LPS administration (62.7±3.7 versus 78.5±1.8 cells in untreated 
mice), reaching significance at 3 hours, with a 40% decrease observed at 
47.0±4.7 cells (P<0.05; Kruskal-Wallis: (Figure 30A)). This correlated with 
large numbers of shed IECs within the intestinal lumen, implying that cell 
shedding correlates with shortening of the villus and decreased villus IEC 
number.  
ImageJ analysis was utilised to measure LPS induced villus atrophy in 
subsequent experiments, as this method can measure villus height to the 
nearest µm, and this can be done by measuring along the central core of the 
villus with the segmented line tool. This can take into account any subtle 
curvature of the villus when it is not perfectly straight or perpendicular to the 
muscularis. It was also considered superior to hemivillus IEC counts, as 
Wright et al. (1989) showed that although good correlation has been 
demonstrated between total villus population and villus height when counted 
by microdissection, this correlation was considerably diminished when there 
was altered villus morphology, such as we observed following LPS 
administration.  
Taken in conjunction with the analysis of IEC apoptosis and shedding, these 
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data were utilised in selecting the duodenum at 1.5 hours as the most 
appropriate intestinal site and time point for comparisons to be made 
between LPS dosages and mouse genders, and genotypes in subsequent 
experiments.  
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Figure 29: Villus heights for duodenum, jejunum, and ileum by IEC count (A), 
graticule measurement (B) and ImageJ analysis (C). n=6 mice per time point, 
statistical comparisons by Kruskal-Wallis with Dunnett`s post-hoc test in A and B, 
and by ANOVA with Holm-Sidak post-hoc test in C.*=P<0.05, **=P<0.01. 
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3.7 LPS induced apoptosis and cell shedding which 
increased in frequency towards the villus tip 
Having measured the amount of IEC apoptosis and shedding that occurred in 
the duodenum, jejunum and ileum and the coexistent villus atrophy, cell 
positional data collected by IHC quantification was used to determine where 
along the villus axis IEC apoptosis and shedding occurred. These data 
showed that IECs positively immunolabelled for active caspase-3 without 
altered morphology, designated “apoptotic” (Figure 30), and “shedding” IECs  
(Figure 31), showed similar distributions along the villus axis at different time 
points in the duodenum. Similar distributions were also observed in the 
duodenum, jejunum and ileum at 1.5 hours. The duodenum, jejunum, and 
ileum exhibited broadly similar trends in the overall pattern of apoptosis and 
shedding along the villus axis. Both events markedly increased in frequency 
in the apical 50% of the villus at 1.5 hours, with increased IEC shedding 
being seen at the villus tip.   
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Figure 30: Cell positional graphs showing quantification of “apoptotic” 
immunolabelled intestinal epithelial cells along the villus axis for duodenum (A), 
jejunum (B) and ileum (C). All villi were artificially adjusted to 100 cells in length to 
allow comparison. n=6 mice per time point. 
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Figure 31: Cell positional graphs showing quantification of intestinal epithelial cells 
with “shedding” morphology along the villus axis for different intestinal segments. All 
villi were artificially adjusted to 100 cells in length to allow comparison. n=6 mice per 
time point. 
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3.8 In vivo confocal microscopy allowed identification 
of shedding cells in real time 
In the context of investigating intestinal epithelial cell shedding, histological 
studies have been criticised as being inferior when compared to in vivo 
confocal microscopy, due to artefactual changes induced by tissue 
processing. The potential appeal of confocal microscopy is that tissue can 
firstly be resolved in the x, y and z directions to image through a limited depth 
of tissue, whereas traditional microscopy only allows examination of a 3-5µm 
tissue section in a single focal plane in the x and y dimensions. By repeatedly 
scanning a limited depth of tissue, confocal microscopy additionally allows 
cellular imaging over time, theoretically allowing a four-dimensional (x,y,z and 
t) imaging modality.  
A protocol was therefore developed to image LPS induced small intestinal 
IEC shedding by confocal microscopy. Mice were administered 10mg/kg LPS 
i.p., anaesthetised with fentanyl and diazepam, and a midline laparotomy 
was performed. The jejunum was incised and the mucosal surface placed on 
a coverslip with acriflavine dye. Photons of laser light at approximately 
416nm were used to stimulate the emission of photons from acriflavine at 
approximately 514nm (for further information see Materials and Methods). 
Through utilisation of confocal microscopy during LPS induced IEC shedding, 
it was possible to identify shedding cells moving beyond the epithelial 
borders of individual villi when the villus tip was viewed en face. Figure 33 
shows a time-lapse series of images from a 10mg/kg LPS treated mouse, 
taken in a single focal plane at approximately 3 minute intervals over 30 
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minutes. Several IECs moved centrifugally from the villus, being extruded 
from the epithelial monolayer and entering the lumen. This confirmed that this 
imaging modality could be used to capture the same cell shedding process 
that was observed by histopathological examination. However, achieving 
good quality images and videos by this method was extremely technically 
challenging for many reasons. These included performing surgery that was 
completely free of bleeding, maintaining adequate anaesthesia in mice 
undergoing imaging, finding a suitable part of mucosa and a suitable villus to 
image, optimising image capture settings, preventing z axis drift in the focal 
plane, and achieving images without movement blur, as in many experiments 
there was excessive tissue movement due to respiration and/or peristalsis. 
This imaging technique also represented an extremely poor modality in terms 
of the potential for measurement or quantification of shedding events, as 
image stacks had to be screened through the depth of the tissue in order to 
identify shedding cells. This imaging technique was therefore not extensively 
used during the remainder of the project.  
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Figure 32: Confocal image series taken of the surface of a single jejunal villus tip 
viewed en face at approximately 3 minute intervals, from approximately 50 to 80 
minutes after LPS administration (acriflavine staining). The red, yellow and blue 
arrows trace the movement of several individual IEC nuclei moving outwards and 
leaving the epithelial border of the villus. Bar (A)=20µm. 
 
3.9 LPS caused a significant increase in gut 
permeability by 5h  
Having established the pathological lesions induced by systemic LPS 
administration in mice, it was next investigated whether there was a 
correlation between small intestinal injury and increased intestinal 
permeability. Fluorescein-isothiocyanate-conjugated dextran (FD4) 
represents a fluorescent labelled dextran of molecular weight between 3-
5KDa which should not, in normal conditions be absorbed via the 
gastrointestinal tract to any significant extent unless there is increased gut 
permeability. In order to allow the FD4 to be distributed throughout the 
intestinal tract, all animals were given FD4 by oral gavage for 5 hours prior to 
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them being euthanased by a rising CO2 concentration, and blood taken by 
cardiac puncture. Untreated control mice received gavage only, and LPS 
treated mice received an i.p. injection of PE-LPS either 1.5h or 3h prior to the 
end of the experiment, or at the time of the gavage for the 5h time point (see 
Materials and Methods for further information). Plasma fluorescence was 
then measured. At 5h post-LPS (also 5h post FD4), there was a 5-fold 
increase in gut permeability (P<0.05: Kruskal-Wallis) with plasma 
fluorescence measured at 76.3±21.7 fluorescent units (Figure 33) versus 
16.4±2.9 fluorescent units in untreated animals (5hrs FD4), suggesting  
that gut barrier dysfunction occurs at around 5h post-LPS administration. 
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Figure 33: Plasma fluorescence measured after 10mg/kg PE-LPS and gavage of 
FD4. At 5h post-LPS (5hrs FD4), there was a 5-fold increase in gut permeability. 
*=P<0.05 (N=6, 1 outlier excluded at 1.5hr). Comparisons by Kruskal-Wallis. 
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3.10 Ultrastructural examination of LPS induced IEC 
cell death and shedding 
In an attempt to examine the process of LPS-induced apoptosis and 
shedding in greater detail, transmission electron microscopy (TEM) was 
performed. Tissue was examined from the duodenum of a 10mg/kg LPS 
treated C57BL/6 female mouse 1.5 hours after administration, and compared 
against equivalent tissue taken from an untreated C57BL/6 (not shown). 
Adjacent small intestine was confirmed to exhibit extensive IEC apoptosis 
and cell shedding by active caspase-3 IHC. Transmission electron 
micrographs (Figure 34), showed several morphological changes in IECs at 
the villus tips consistent with apoptosis, but also features of cellular 
degeneration and necrosis with occasional examples of IEC detachment and 
shedding. Changes in morphology in individual epithelial cells included 
electron lucency of the cytoplasm without obvious changes in mitochondria, 
loss of surface microvilli, margination of condensed and clumped 
heterochromatin to the borders of the nuclear envelope, and increased 
electron lucency of central euchromatin. Changes more typically consistent 
with cellular degeneration and necrosis included increased cell volume, 
electron lucency of the cytoplasm and organelles (suggesting failure of ion 
exchange pumps and hydropic degeneration), detachment of ribosomes, 
mitochondrial swelling and membrane rupture.  
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Figure 34: Transmission electron microscopy images from 10mg/kg 1.5h LPS 
treated C57BL/6 female mouse. A) IEC with loss of apical microvillus brush border 
(arrow), marginated and slightly clumped heterochromatin of the nucleus (arrow 
head). B) Deformed IEC with some apical microvilli still present, an eccentric apical 
nucleus, markedly electron lucent cytoplasm, and mitochondrial swelling (arrow). C) 
Marked disruption of epithelial monolayer with IECs showing detachment from 
neighbours with cell rounding and shrinkage (arrows) and ruptured cell membranes 
(arrow head). D) Fragmentation of IECs, with occasional IECs exhibiting shrunken 
electron dense nuclei or nuclear fragments (arrows), or cellular rupture and 
liberation of mitochondria (arrow head). Bar=2µm in A) & B), and 5µm in C) and D). 
 
3.11 Effects of LPS dosage and purification on small 
intestinal epithelial apoptosis and cell shedding 
Having characterised the time dependent small intestinal epithelial apoptosis 
and shedding within the small intestine caused by 10mg/kg phenol extracted 
LPS (PE-LPS), the dose response relationship of this effect, and method of 
LPS purification was tested. It was assumed that the time course for 
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apoptosis and shedding in the small intestine would not be affected by 
dosage, and therefore an endpoint of 1.5h was chosen for n=4-6 LPS 
administered adult female mice. Active caspase-3 immunohistochemically 
labelled duodenal sections were utilised to compare relative apoptosis and 
shedding between LPS dosage and LPS purification. 
3.11.1 LPS purity did not significantly affect IEC apoptosis and 
cell shedding in WT mice 
To assess whether the LPS purification/extraction method altered IEC 
apoptosis and cell shedding, 10mg/kg high-purity ion-exchange 
chromatography extracted LPS (IE-LPS) was administered to WT mice which 
were euthanased at 1.5h. The IE-LPS preparation caused similar villus 
shortening to that seen in 10mg/kg PE-LPS treated animals 
(298.0µm±39.1µm compared to 260.5µm±36.8µm) (Figure 36A). IEC 
apoptosis and cell shedding post IE-LPS administration were also 
significantly increased (10.8%±2.8%) as observed for PE-LPS (12.5%±1.7%) 
(Figure 35B).  
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Figure 35: Bar chart demonstrating that both and ion exchange chromatography 
extracted LPS (IE-LPS) and phenol extracted LPS (PE-LPS) caused comparable 
villus atrophy (A) and IEC apoptosis and cell shedding (B) at 1.5 hours after 
administration of 10mg/kg i.p. n=6, *=P value<0.05 based on ANOVA against 
untreated with Holm-Sidak post-hoc test in (A) and by Kruskal-Wallis and Dunnett`s 
post-hoc test in (B). No statistical difference was detected between IE-LPS and PE-
LPS in (A) or (B). 
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3.11.2 Dose dependent effects of LPS on the small intestine  
As IE-LPS and PE-LPS caused similar amounts of small intestinal apoptosis 
and cell shedding, PE-LPS was utilised in the majority of further experiments, 
as this purification grade was considerably more economical. Dose 
dependent effects of PE-LPS on the small intestine were therefore quantified. 
A vehicle treated (PBS) control was also included to rule out intraperitoneal 
injection or handling stress in induction of observed intestinal injury. C57BL/6 
female mice were administered with doses of 20, 5, 2.5, 1.25, 0.25 and 
0.125mg/kg PE-LPS by i.p. injection (n=4-6/group) and were euthanased at 
1.5h. Comparisons were made with the n=6 untreated groups, and 10mg/kg 
dosage groups from the prior time course experiment in an effort to reduce 
the animal numbers required. 
 
LPS at 0.125mg/kg caused a 10-fold observed increase in IEC apoptosis and 
cell shedding compared to untreated mice at 6.0%±1.7% (P<0.05: ANOVA) 
(Figure 36A) but with a minimal (5%) reduction in villus height at 
348.1µm±17.1µm versus 365.9µm±6.6µm in untreated control animals 
(Figure 36B). LPS at doses ≥0.25mg/kg caused ~30% reduction in villus 
height compared to controls, and IEC apoptosis and cell shedding of ~12%. 
These data suggest that the intestinal effects of LPS seem to be caused at a 
threshold dose, as all dosages greater than 0.125mg/kg caused comparable 
amounts of villus atrophy, apoptosis, and cell shedding. These results 
suggested that this threshold dose was approximately 0.125mg/kg, with the 
caveat that this was the lowest dose utilised, and the effect may be further 
abrogated by even lower doses. The comparison between apoptotic and cell 
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shedding indices with the villus height data, additionally suggested that IECs 
appear extremely sensitive to LPS induced apoptosis and cell shedding, 
whereas concomitant villus shortening only occurs following administration of 
higher dosages of LPS. In assessing small intestinal injury by these 
methodologies, it would also suggest that although apoptotic and cell 
shedding indices are a potentially more subjective means of assessment, this 
technique has greater sensitivity in detecting more subtle degrees of injury. 
These dose response data were also important in selecting a “low dose”, i.e. 
0.125mg/kg for investigating differences between genotypes of mice in 
subsequent investigations. Dose response data for PBS treated mice also 
confirmed that small intestinal injury was not caused by intraperitoneal 
injection or by the stress of the procedure. 
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Figure 36: Dose response 1.5h post PE-LPS administration. Quantification of IEC 
apoptosis and cell shedding in active caspase-3 IHC labelled duodenal sections (A) 
and villus heights in duodenal sections (B). *=P<0.05, n=6 female mice/group for 
PBS, 0.125mg/kg and 10mg/kg, and n=4 female mice for all other groups.  
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3.11.3 There was no significant gender difference in LPS 
response 
An important point to address in developing this model was whether gender 
had any influence on the small intestinal injury caused by LPS, as gender 
differences have been shown in the immunological responses to LPS in 
some studies (Aoyama et al. 2009). The amount of IEC apoptosis and cell 
shedding (Figure 38), and villus heights (Figure 38), in male and female WT 
mice following LPS administration were therefore compared. It was possible 
to ascertain that the extent of small intestinal injury induced by both low 
(0.125mg/kg) and high dose (10mg/kg) PE-LPS was broadly similar in both 
genders, with no significant differences being detected between genders 
within treatment groups. In both genders 0.125mg/kg LPS caused apoptosis 
and cell shedding in approximately 6% of IECs, whereas 10mg/kg LPS 
resulted in a marked increase in apoptosis and shedding (12.5% and 10.4% 
in females and males respectively). Villus heights showed a similar trend in 
males as already discussed in females, with 0.125mg/kg causing an 
approximately 5% reduction (384.7µm±30.0µm), and 10mg/kg causing an 
approximately 34% reduction (266µm±14.9µm) in villus height compared to 
untreated animals (405.4µm±19.7µm). 
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Figure 37: Bar chart of relative percentages of apoptotic and shedding IECs in the 
duodenal villi of male and female mice, at 10mg/kg and 0.125mg/kg of LPS. No 
significant difference was detected between genders based on comparisons by 
Kruskal-Wallis (n=6 per group).  
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Figure 38: Bar chart of relative villus heights measured by ImageJ analysis in the 
duodenal villi of male and female mice, at 10mg/kg and 0.125mg/kg doses of LPS. 
No significant differences were detected between genders based on comparisons by 
Kruskal-Wallis (n=6 per group). Unt.=untreated. 
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3.12 Discussion 
The data presented in this chapter provide a detailed characterisation of 
acute LPS induced intestinal injury in a murine model. Histopathological 
examination showed that systemic LPS administration caused rapid and 
specific small intestinal injury. No evidence of comparable cell death or injury 
was observed at any other location in the gastrointestinal tract, or any other 
organ systems examined, a phenomenon which has been partly investigated 
by others at later time points. For example, Julian et al. (2011) showed that 
the intestinal epithelium was indeed more susceptible to cytopathic injury and 
altered permeability than the pulmonary epithelium in acute sepsis. This 
group showed that in a feline model of E.coli induced sepsis, IECs exhibited 
evidence of mitochondrial injury by TEM. Intestinal epithelial cell death and 
degeneration in our own studies also appeared to show a mixture of 
morphological changes, including mitochondrial swelling, by TEM. They also 
showed that the intestinal epithelial cell death caused in this context was not 
related to intestinal hypoperfusion or hypoxia.  
By assessment of cell morphology by light microscopy, TEM and by 
immunostaining for active caspase-3, the predominant form of cell death 
appeared to be apoptosis. Cell shedding appeared, on morphological and 
biochemical grounds to be dependent on the prior activation of apoptotic 
pathways, as both cells in the process of extrusion, and the vast majority of 
detached IECs were positively immunolabelled for active caspase-3. This 
supports the hypothesis that apoptosis precedes IEC shedding, at least in the 
pathological context. However, TEM findings such as membrane rupture, and 
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other features of necrosis, suggest that in some cases either a different cell 
death pathway is activated, or apoptosis; which is an energy dependent 
process, may degenerate to necrosis in instances where there is lack of ATP. 
A possible mechanism by which this may occur would be villus tip hypoxia 
due to the vascular disturbance caused by endotoxic shock. It was possible 
by in vivo confocal imaging to appreciate villus intestinal epithelial cell 
shedding in real time, and by this method it appeared that whole cells were 
being extruded without obvious membrane rupture. However examples of 
cytoplasmic “stalks” extending from IECs undergoing extrusion, which must 
presumably be ruptured during the process of cell shedding were frequently 
observed by IHC.  
Consistent with observations made in physiological shedding, and shedding 
induced by TNF, a very small minority of intestinal epithelial cells appeared to 
undergo the conformational changes associated with cell shedding, but did 
not appear to be positively labelled with active caspase-3, or were only 
labelled very weakly. Similarly, in studies of physiological shedding in 
humans, 0.3% of shedding cells did not positively stain for activated caspase-
3 (Bullen et al. 2006). In our own study, these cells were not recorded by cell 
counting, due to the rarity of their occurrence and difficulty in assigning them 
to pre-established categories of unaltered, apoptotic, or apoptotic and 
shedding. It is not entirely clear why these rarely observed cells do not stain 
for active caspase-3, but these cells may be undergoing necrosis, as has 
been observed by TEM in the perfused cat ileum model 2 hours after LPS 
administration (Crouser et al. 2000). Alternatively, necroptosis may be 
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occurring in these cells, as this form of cell death is not dependent on the 
activation of executioner caspases such as caspase-3.  
Maximal intestinal epithelial apoptosis and shedding as assessed by active 
casapse-3 IHC occurred at around 1.5 hours after LPS administration.  
Terminal apoptotic pathways therefore appeared to be activated in a large 
percentage of IECs at 1 hour post LPS administration, whilst shedding was 
only beginning to occur in a small percentage of IECs at this early time point. 
When analysed on a cell positional basis, positively labelled IECs occurred 
with increased frequency approximately 50-90% along the villus length from 
the base of the villus, and cell shedding occurred from 60-100% along the 
length of the villus, with a sharp rise in shedding frequency being observed 
towards the villus tip.  
Activation of executioner caspases is generally assumed to be a terminal 
event in apoptosis, and if this assumption is made it would be reasonable to 
suggest that all IECs that are positively labelled for active caspase-3 should 
be destined to undergo apoptosis and cell shedding. However, at least one 
mechanism by which cells may be rescued from apoptosis at this point is by 
X-linked inhibitor of apoptosis (XIAP), which is capable of completely 
blocking the activity of caspase-3 through structural changes in its active site 
(Eckelman et al. 2006). In Cryptosporidium parvum induced IEC shedding, it 
has been shown that XIAP binds to active caspase-3 and prevents apoptosis 
from occurring until IECs have reached the villus tip (Foster et al. 2012). It 
was also shown that XIAP, in conjunction with activation of NFĸB and 
proteasome activity, were necessary to control cell shedding and restrict it to 
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the villus tip, and also to control intestinal barrier function. 
The time course study also demonstrated that LPS caused villus shortening 
in association with IEC apoptosis and cell shedding, suggesting that active 
villus contraction is induced. Intestinal injury that induces cell death in various 
different situations usually occurs in conjunction with other rapid pathological 
changes in the mucosa. For example, after 5-10 minutes of intestinal 
ischaemia, subepithelial spaces referred to as Gruenhagen’s spaces 
develop, with separation of the apical villus epithelium in sheets from the 
basement membrane, and contraction of the villus core (Brown et al. 2007). 
This is similar to what is observed ex-vivo, where there is energy dependent 
villus contraction with rapid restitution of the epithelium, and microfilament 
condensation of the underlying myofibroblasts in response to denudation of 
the overlying epithelium. Villus contraction has also been found to be 
dependent on neuronal action potentials, as tetrodotoxin blocked this 
phenomenon. This active contraction of the villus core during acute injury is 
hypothesised to aid epithelial restitution, as the process effectively reduces 
the size of the epithelial defect (Moore et al. 1989). Subsequently, epithelial 
cells adjacent to these defects undergo flattening and attenuation as they 
spread to cover defects, with complete restitution usually taking several days 
(Brown et al. 2007). 
Small intestinal IEC apoptosis, cell shedding and shortening of the villus 
correlated temporally with fluid effusion into the small intestinal lumen and 
diarrhoea. This suggests that the pathophysiology of the diarrhoea that these 
mice exhibit may be caused directly by the rapid and uncoordinated shedding 
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of IECs, potentially in conjunction with increased vascular permeability, which 
may cause disruption of tight junctions and the paracellular space.  
Supporting this hypothesis, Gadjeva et al. (2007) attempted to characterise 
this LPS-induced fluid effusion into the gut, and found that there was 
significant leakage of intravenously administered Evans blue dye and FITC 
labelled albumin into the gut lumen in p50 deficient mice 4 hours after LPS 
administration. This implies that the gut permeability that occurs in endotoxic 
shock is of a severity that allows passage of very large proteins, with the loss 
of albumin suggesting that there is accompanying loss of oncotic pressure 
further complicating fluid loss. This loss of oncotic pressure also suggests 
that fluid absorption into the intestinal vasculature will be reduced during this 
phase. Other possibilities to account for LPS-induced acute diarrhoea would 
include reduced villus absorption capacity due to lost absorptive enterocytes, 
although the very short time period between cell shedding and onset of 
diarrhoea suggests that this hypothesis is less plausible. Alternatively, 
increased epithelial secretion into the intestine may occur. It seems less likely 
that increased intestinal motility is responsible, as endotoxin is reported to 
cause ileus (Buchholz et al. 2009). Interestingly, it was also observed by 
periodic acid Schiff (PAS)/Alcian blue staining, that goblet cells are 
preferentially retained and do not undergo cell shedding to the same extent 
as absorptive enterocytes in this model (Luke Asquith, Physiology BSc 
honours student project, University of Liverpool), in agreement with 
observations in haemorrhagic shock (Chang et al. 2005) and following 
methotrexate administration to rats (Verburg et al. 2000). In this latter study, 
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the selective sparing of goblet cells at the villus tip was hypothesised to be an 
adaptive protective response following villus injury to preserve mucus 
secreting function and to aid restitution through trefoil factor 3 (TFF3). We 
also observed morphological changes in the goblet cell theca which 
suggested goblet cell secretion may occur in our model.  
It is possible that goblet cells do not exhibit activation of cell death pathways 
in response to TNF receptor ligation, or to metabolic insults in the same way 
as enterocytes. In support of this, it was not possible to discern instances of 
active caspase-3 labelled goblet cells in our time course study. It may also be 
possible that goblet cells are more tightly bound to other epithelial cells or to 
the basement membrane by tight junctions and hemidesmosomes 
respectively.  
It has previously been demonstrated in our laboratories that barrier loss in 
the intestine occurs at sites of excessive cell shedding in response to TNF 
(Kiesslich et al. 2012), and that the direction of fluid movement through 
epithelial defects is highly dependent on the osmotic and hydrostatic 
gradients across the epithelium. It was not until 5 hours after LPS 
administration in this model however, that we found movement of larger 
molecules (FD4) from the lumen to the plasma. This is in agreement with 
findings from in vivo confocal microscopy that from 5.5 hours after LPS 
administration, FD4 entered cell-free gaps and paracellular spaces (Lai et al. 
2013). This may be a consequence of the net fluid and protein effusion into 
the intestinal lumen up until this point. Alternatively, it may be due to a later 
failure of tight junction regulation. In support of this latter concept, by staining 
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of small intestinal sections for junctional adhesion molecule A (JAM-A) by 
IHC, we observed tight junction redistribution at 4h and 6h post-LPS (Ross 
Fuller, Physiology BSc honours student project, University of Liverpool). This 
suggests that this later phenomenon may contribute to gut permeability 
defects. 
In summary, these studies suggested that LPS represents a robust stimulus 
of pathological villus epithelial cell apoptosis and cell shedding throughout 
the small intestine. This response was initiated at a threshold dosage of 
≥0.125mg/kg, and maximal apoptosis and cell shedding was observed at 1.5 
hours after LPS administration. 
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4. Mechanisms by which LPS Causes 
IEC Death and Cell Shedding 
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4.1 Introduction 
Having established the time and dose dependent effects of LPS on the small 
intestine, further experiments to investigate the mechanisms by which LPS 
caused cell death and shedding were performed. TLR4 signalling is critical in 
mediating the innate immune response to LPS (Beutler et al. 2001). It was 
therefore hypothesised that peripheral TLR4 ligation by LPS in immune cells 
(particularly macrophages and dendritic cells) leads to the production of 
cytokines, and it is these circulating cytokines that mediate and induce the 
apoptotic response either directly or indirectly within intestinal epithelial cells. 
To test this hypothesis, LPS was first administered by several different routes 
including direct intestinal instillation in WT mice, and the small intestinal 
response in terms of IEC apoptosis and cell shedding was analysed by 
immunohistochemistry for active caspase-3. The aim of these experiments 
was to exclude the possibility that LPS was acting directly on IECs, or that 
intraperitoneal LPS was somehow acting on the intestine in a localised 
transmural manner to induce epithelial apoptosis.  
To test whether LPS-induced small intestinal apoptosis and cell shedding 
was TLR4 dependent, different purities of LPS from E.coli O111:B4 were 
then administered to Tlr4-/- mice, and the small intestinal response in terms of 
apoptosis and cell shedding was assessed by immunohistochemistry for 
active caspase-3.  
TLR signalling (with the exception of TLR3) is further dependent on the 
MyD88 adapter molecule (Kawai and Akira 2011), as this molecule provides 
a critical link between TLR4 ligation, NFκB signalling and gene induction 
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(Hirotani et al. 2005). By using transgenic mice that lacked MyD88 
specifically within intestinal epithelial cells, it was therefore possible to test 
whether intact intestinal epithelial TLR signalling was required to produce 
LPS induced IEC apoptosis and cell shedding. An understanding of whether 
LPS induced epithelial cell apoptosis and shedding were entirely epithelial 
regulated events could then hopefully be achieved by considering responses 
in Tlr4-/-, and vil-Cre MyD88-/- mice in conjunction with those elicited by 
different routes of LPS administration in WT mice.  
As it had been previously demonstrated by our own laboratories that 
systemic TNF administration caused IEC apoptosis and shedding, and it had 
been shown that TNF causes IEC apoptosis via TNFR1 (Piguet et al. 1998), 
it was also tested whether this same mechanism was the critical mediator of 
IEC apoptosis and cell shedding following systemic LPS administration. In 
collaboration with the University of Southern California, we investigated the 
response of mice deficient in TNFR1/p55 or TNFR2/p75 receptors to LPS.  
By utilising quantitative PCR it was also aimed to further analyse and more 
specifically categorise the type of cell death occurring in our LPS model by 
investigating the expression of an array of genes involved in cell death 
pathways, including those involved in apoptosis, autophagy and necrosis.  
By examining the effect of LPS purity, the importance of TLR signalling, the 
cytokines and cytokine receptors responsible, and type of cell death 
occurring, we hoped to gain important insights into how the immunological  
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response to LPS causes cell death and cell shedding in the murine small 
intestine.  
4.2 IEC apoptosis and shedding is caused by systemic 
LPS but not by LPS administered within the 
intestinal lumen 
To establish whether IEC apoptosis and cell shedding were initiated by 
epithelial, peritoneal, or peripheral innate immune responses, 10mg/kg PE-
LPS was administered to C57BL/6 female mice intravenously (i.v.) as an 
alternative means of systemic administration, or subcutaneously (s.c.). These 
routes both caused IEC apoptosis at the 1.5 hour time point (Figure 39). To 
establish whether direct intestinal epithelial interaction with LPS was 
responsible, LPS solution (1mg/ml in PBS) was instilled into the ileum of mice 
which had been terminally anaesthetised with fentanyl and diazepam. This 
resulted in negligible amounts of IEC apoptosis and cell shedding at 1.5 
hours post administration (Figure 39). It has been previously shown that 
ketamine suppresses TNF production in post-operative sepsis (Takahashi et 
al. 2010). To therefore exclude the possibility that anaesthetic agents were 
interacting to prevent LPS-induced apoptosis and shedding, systemic LPS 
was administered by i.p. injection to terminally anaesthetised mice. This 
again induced IEC apoptosis and cell shedding comparable to that observed 
in non-anaesthetised mice (Figure 40). These data supported the hypothesis 
that peripheral immunological signalling in response to LPS mediates small 
intestinal injury. 
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4.3 LPS-induced apoptosis and cell shedding were 
significantly decreased in Tlr4-/- mice 
Toll-like receptor 4 (TLR4) is necessary for the innate immune system to 
respond to LPS (Beutler et al. 2001). To establish whether this was the 
critical signalling mechanism by which LPS induced IEC apoptosis and cell 
shedding, the small intestinal response to LPS was examined in Tlr4-/- mice. 
When 10mg/kg high-purity IE-LPS was administered to Tlr4-/- mice, it resulted 
in a negligible change in villus height at 375.3μm±21.9μm compared to 
untreated Tlr4-/- mice at 364.3μm±10.62μm, and a much reduced amount of 
IEC apoptosis and cell shedding at 1.4%±0.5% compared to WT mice at 
10.8%±2.8% (Figure 41 and Figure 42). However, it should be noted that 
when Tlr4-/- mice were administered 10mg/kg of the lower purity PE-LPS, 
although this resulted in a negligible change in villus height at 
365.4μm±17.1μm (Figure 42A), a moderate increase in IEC apoptosis and 
cell shedding of 7.0%±1.0% was seen (Figure 42B). These results suggested 
that while small intestinal injury due to highly purified LPS was almost entirely 
dependent on TLR4 signaling, other bacterial products present in PE-LPS 
were responsible for the difference between the response to IE-LPS 
(1.4%±0.5%) and PE-LPS (7.0%±1.0%). Additionally, even when 
administered IE-LPS, there was a small, although non-significant increase in 
IEC apoptosis and shedding at 1.4%±0.5% when compared to untreated Tlr4-
/- mice at 0.2%±0.1%, which again points to some off-target effects either 
through impurities, or possibly by mechanisms alternate to TLR4, even when 
highly purified IE-LPS has been administered. 
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Figure 39: Photomicrographs of active caspase-3 IHC demonstrating villus tips of 
WT female mice 1.5h following PE-LPS administration by subcutaneous or 
intravenous routes exhibited villus IEC apoptosis and cell shedding. Negligible IEC 
apoptosis/shedding was seen when LPS was instilled intraluminally. Duodenum 
shown for s.c. and i.v. LPS (n=3 per group), ileum shown for intraluminal 
administration instilled with 1mg/ml LPS (n=4 per group). Bars=25µm.  
 
 
 
 
 
 
Figure 40: Photomicrographs of active caspase-3 IHC in duodenum from WT 
female mouse anaesthetised for 1.5h (A) demonstrating that IEC apoptosis and 
shedding was not caused by anaesthesia, and from a terminally anaesthetised 
WT mouse administered 10mg/kg PE-LPS for 1.5h (B), demonstrating that LPS 
induced IEC apoptosis and cell shedding was not inhibited by anaesthesia. 
Bars=100µm 
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Figure 41: Photomicrographs of duodenal active caspase-3 IHC, 1.5h after 
treatment with 10mg/kg LPS purified by ion-exchange chromatography (IE-LPS). 
Whilst IEC apoptosis and shedding were induced in WT mice (A), the same dose 
given to Tlr4-/- mice failed to cause the same degree of IEC apoptosis and shedding 
(B). n=6 female mice per group, bars=100µm.  
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Figure 42: Villus heights in WT or Tlr4-/- mice 1.5h after phenol-extracted (PE-LPS) 
or ion exchange extracted (IE-LPS) at 10mg/kg i.p. (A). Quantification of IEC 
apoptosis and cell shedding in active caspase-3 IHC labeled duodenal sections (B). 
n=6 female mice/group. *=P<0.05, comparisons by ANOVA in (A) and by Kruskal-
Wallis in (B).  
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4.4 Peripheral TLR signalling mediates LPS-induced 
IEC apoptosis and shedding 
Villin represents a 92.5kDa protein which is expressed in cell lineages with a 
microvillus brush border, notably the intestinal and renal epithelium. It is an 
actin binding protein, which controls actin rearrangement (Friederich et al. 
1999). Cre is a DNA recombinase enzyme that is capable of excising 
intervening DNA between floxed (loxP) sequences (Abremski and Hoess 
1984). As villin represents a relatively tissue specific protein to the intestine, 
Cre expression can therefore be linked to the villin promoter in order to 
achieve relatively intestinal specific gene activation or deactivation in vil-Cre 
mice (El Marjou et al. 2004). vil-Cre MyD88fl/fl mice exhibit a non-functional 
truncated form of the MyD88 protein following removal of the intervening 
DNA between the floxed regions. These mice therefore lack functional TLR 
signalling within IECs. In collaboration with the University of East Anglia, the 
small intestinal response of these mice to LPS was tested. 
Adult female vil-Cre MyD88-/- mice were administered 10mg/kg PE-LPS by 
intraperitoneal injection. Analysis of villus height in duodenal sections 
demonstrated similar villus atrophy in vil-Cre MyD88-/- mice at 
232.8µm±12.42µm both compared to heterozygous vil-Cre MyD88+/- mice at 
285.5µm±58.94µm (Figure 43A) and compared to LPS treated WT mice in 
our own laboratories at the University of Liverpool at 260.5µm±15.0µm. 
Active caspase-3 IHC showed that LPS caused comparable IEC apoptosis 
and shedding in vil-Cre MyD88-/- lacking IEC TLR signal transduction at 
14.1%±0.61% compared to 13.7%±2.8% in heterozygous vil-Cre MyD88+/- 
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mice (Figure 44B) which express wild-type MyD88 and therefore intact IEC 
TLR signalling. These data suggested that intact IEC TLR signalling is not 
required for LPS-induced villus IEC apoptosis and cell shedding. 
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Figure 43: Intact intestinal epithelial TLR signalling is not required to mediate LPS 
induced small intestinal injury. Villus heights (A) and percentage apoptosis and 
shedding of villus IECs (B) in the duodenum of vil-Cre MyD88-/- mice and vil-Cre 
MyD88+/- mice 1.5h following 10mg/kg PE-LPS. n=3 female mice/group. 
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4.5 LPS induced changes in small intestinal cell death 
associated gene transcription 
To further understand the type of cell death that was induced in the small 
intestinal epithelium in response to LPS, a gene array analysis of 89 genes 
associated with various cell death pathways was performed. These included 
genes that were classed as pro-apoptotic, anti-apoptotic, or associated with 
autophagy or necrosis. We performed this array on small intestinal epithelial 
enriched samples extracted as described in Materials and Methods. These 
extracts were taken from 10mg/kg 1.5h PE-LPS treated and untreated WT 
animals (pooled n=4 female C57BL/6 mice per group). Gene expression was 
then compared between LPS treated and untreated groups. The Tnf gene 
showed a marked +40.4 fold up regulation in mRNA expression (Figure 44) 
as did Cd40 which exhibited a +37.4 fold increase. These two pro-apoptotic 
genes were therefore analysed further by qPCR using triplicate samples from 
individual animals. qPCR showed a mean normalised gene expression ratio 
of +32.0 in Tnf mRNA (P<0.05: randomization test). Real-time PCR however 
only showed a non-significant increase of +2.1 in Cd40 expression.  
Other genes that showed a greater than 2 fold change in regulation, included 
the down regulation of anti-apoptotic nucleolar protein 3 (Nol3) which 
encodes the apoptosis repressor with caspase recruitment domain (ARC) 
protein. This protein has been shown to interact with and down regulate the 
activities of caspase 2 and 8, and has been shown to be up-regulated in 
hypoxic SW480 cells (human colon cancer cell line) via transcriptional 
activation by HIF1α (Ao et al. 2012). The -3.8 fold down regulation of this 
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anti-apoptotic gene would tend to suggest an ultimately pro-apoptotic effect.  
Bcl2l11 or BIM (O'Connor et al. 1998), which is part of the Bcl family and 
encodes for three protein isoforms which are activators of apoptosis, 
exhibited a +2.7 fold up regulation. Birc3 (baculoviral IAP repeat containing 3; 
also known as c-IAP2) which has been shown to be up regulated in 
conjunction with TNF, and to inhibit caspase-3 and caspase-6 activity in 
transected peripheral nerve Schwann cells (Wang et al. 2012) exhibited a 
+3.0 fold up regulation. Tumour necrosis factor receptor superfamily member 
11B (TNFRSF11B) or osteoprotegerin, which is anti-apoptotic and a decoy 
receptor of receptor activator of nuclear factor kappa B ligand (RANKL), 
thereby inhibiting NFκB activity, exhibited a +2.9 fold up regulation. Polio 
virus receptor (Pvr), also known as CD155 exhibited a +2.8 fold up 
regulation. This gene has been shown to undergo increased transcription in 
cancer cell lines and is associated with increased proliferation and migration 
(Atsumi et al. 2013). These data, in conjunction with histopathological 
findings and activation of caspase-3, suggest that apoptosis is the 
predominant form of cell death occurring in the small intestine following 
systemic LPS administration. It also identified several genes which may play 
important roles in regulating LPS-induced IEC apoptosis and cell shedding. 
Additionally, these data suggest that the small intestinal epithelium itself may 
be an important source of TNF production in LPS induced IEC apoptosis and 
cell shedding.  
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Figure 44: LPS induced genes predominantly involved with apoptosis in the small 
intestine. (A) selected qPCR array data for genes that exhibited ≥2-fold LPS-treated 
versus untreated expression ratios out of 89 genes examined in a cell-death 
pathway array. n=4 mice per group with pooled epithelial enriched extracts 
examined. (B) qPCR performed on Individualised samples in triplicate for Cd40 and 
Tnf expression (n=4). *=P<0.05 based on randomisation test.  
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4.6 TNF caused small intestinal injury equivalent  
to LPS 
As TNF is implicated as a key mediator of endotoxic shock, and following the 
finding of increased small intestinal Tnf mRNA in LPS treated animals, 
exogenous TNF administration was tested, to examine whether it caused 
equivalent IEC apoptosis and cell shedding to LPS. Adult C57/BL6 female 
mice were therefore administered murine recombinant TNF at 0.33mg/kg by 
i.p. injection. This dosage had been previously established as capable of 
inducing small intestinal epithelial cell shedding in mice (Kiesslich et al. 
2007). TNF caused equivalent duodenal villus shortening at 
268.4µm±20.9µm to that seen following 10mg/kg PE-LPS at 
260.5µm±15.0µm (Figure 46A). Although less IEC apoptosis and cell 
shedding were observed following TNF, at 7.0%±1.0% compared to LPS-
treated mice at 12.5%±1.7% (Figure 46B) this was attributed to a faster small 
intestinal response to TNF. This was confirmed by additionally administering 
TNF to WT female mice which were euthanased at 1h. This demonstrated 
that 0.33mg/kg TNF caused very similar amounts of IEC apoptosis and cell 
shedding at 1h, at 12.3%±1.0% (Figure 46C and Figure 47) compared to that 
seen 1.5h following 10mg/kg PE-LPS administration at 12.5%±1.7%. It is 
highly likely that the reason for this more rapid TNF induced IEC apoptosis 
and cell shedding compared to LPS, is that direct administration of 
exogenous TNF effectively bypasses TNF induction in cells of the innate 
immune system by LPS. 
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These data, together with significant induction of intestinal Tnf mRNA by 
LPS, suggest that TNF is the key mediator of LPS induced small intestinal 
injury.  
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Figure 45: Villus heights and IEC apoptosis and cell shedding 1.5h after 10mg/kg 
PE-LPS or 0.33mg/kg TNF in WT mice (A, B) and after 1h of TNF in (C). n=4-6 
female mice per group. 
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Figure 46: TNF caused more rapid small intestinal apoptosis and shedding than 
LPS. Photomicrograph of TNF treated female mice euthanased at 30 min (A) 1 hour 
(B) and 1.5 hours (C) post administration (bars=100µm). TNF caused very similar 
amounts of apoptosis and shedding at 1h to that caused by LPS at 1.5h. By 1.5h, 
maximum apoptosis and shedding had subsided in TNF treated animals (n=4-6). 
 
4.7 Tnfr1-/- mice were completely resistant to LPS-
induced apoptosis and cell shedding 
To further examine the role of TNF in LPS induced IEC apoptosis and cell 
shedding, the small intestinal responses of mice deficient in TNF receptors 
TNFR1/p55 or TNFR2/p75 were tested. When Tnfr1-/- mice were 
administered 10mg/kg PE-LPS for 1.5h, there was significantly less villus 
shortening at 363.4µm±17.32µm (Figure 47A and Figure 48A) and IEC 
apoptosis and cell shedding by active caspase-3 IHC (Figure 47B) at 
0.1%±0.1%, relative to WT animals (P<0.05:Kruskal-Wallis, Figure 48B). By 
contrast, the same dose administered to Tnfr2-/- mice caused 68% of the 
response caused in WT in terms of IEC apoptosis and cell shedding at 
8.5%±1.0% (Figure 48B). These findings suggest that TNFR1 signaling is 
required to drive LPS induced IEC apoptosis and cell shedding, with potential 
enhancement by TNFR2. 
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Figure 48: Bar charts of villus heights (A) and IEC apoptosis and cell shedding (B) in 
1.5h, 10mg/kg PE-LPS treated WT, Tnfr1-/-, and Tnfr2-/- mice. *=P<0.05, 
comparisons by Kruskal-Wallis and Dunn`s post-hoc test. n=6 female mice per 
group. 
Figure 47: TNFR1 is required to produce LPS-induced IEC apoptosis and cell shedding. 
Photomicrographs of active caspase-3 IHC labelled duodenum demonstrating lack of 
IEC apoptosis and cell shedding in 10mg/kg, 1.5h PE-LPS treated Tnfr1-/- mice (A), and 
moderate IEC apoptosis and cell shedding in Tnfr2-/- mice (B). Bars=100μm 
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4.8 Discussion 
Through the combination of experiments outlined in this chapter, important 
insights were gained into the mechanism by which LPS causes pathological 
IEC apoptosis and shedding in the murine small intestine. By demonstrating 
a lack of response when LPS was administered directly into the small 
intestinal lumen, this demonstrated that LPS-induced pathological IEC 
apoptosis and cell shedding was not mediated by direct apical epithelial LPS 
interactions. LPS additionally caused IEC apoptosis and cell shedding when 
delivered by i.v. or s.c. routes which also helped to demonstrate that this 
effect was not due to a localised peritoneal phenomenon following i.p. 
administration.  
These data were further supported by testing LPS responses in vil-Cre 
MyD88-/- mice which lack intact TLR signalling within the intestine. These 
mice exhibited very similar amounts IEC apoptosis and cell shedding to WT 
mice, thereby further demonstrating the necessity of peripheral TLR 
signalling to mediate this affect in the small intestine. Similarly, Poly I:C, a 
synthetic viral RNA TLR3 agonist which signals independently of MyD88, has 
also been shown to cause IEC apoptosis and cell shedding when 
administered systemically, but not when given orally (McAllister et al. 2013).  
The lack of direct epithelial response to LPS represents an important concept 
in immune tolerance and compartmentalisation of pathogen associated 
molecular patterns (PAMPS). Suppression of the immune response to the 
large intraluminal bacterial population and the bacterial products therein, is 
theoretically essential for preventing intestinal damage and establishment of 
158 
active inflammation. There are a number of potential mechanisms by which 
this prevention of microbial/microbial product interaction with the epithelium 
and/or the immune system may be achieved. They include: the intestinal 
mucus acting as a physical barrier, luminal or membrane associated proteins 
either enzymatically destroying or inactivating microbes/microbial products, 
compartmentalisation or mechanistically different PAMP recognition in the 
gut, or cytokine mediated suppression of mucosal immune responses in the 
subepithelial tissue.  
Luminal and membrane associated defences which would reduce potential 
LPS interactions include mucus and IgA secretion, but an additional 
mechanism by which the intestinal mucosa may detoxify the abundant LPS 
within the lumen, is by the action of intestinal alkaline phosphatase (IAP). IAP 
has been shown to dephosphorylate and reduce the toxicity of the toxic lipid 
A component of LPS, but this enzyme is also highly important in dictating 
luminal pH, and in lipid metabolism. It is expressed at the brush border in the 
small intestine in well differentiated absorptive enterocytes in an increasing 
gradient towards the villus tip, and in a decreasing gradient from the 
duodenum to the ileum in rodents. It is minimally expressed in the stomach 
and colon. This pattern of expression therefore runs counter to the bacterial 
population of these localisations of the gastrointestinal tract (reviewed by 
Lalles (2010)). Intriguingly, IAP knock-out mice fail to establish a normal 
microbiome (Malo et al. 2010). These mice exhibit an abnormal intestinal 
bacterial flora which fails to be colonised by commensal E.coli, even when 
mice are orally supplemented with these bacteria. IAP knock-out mice 
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additionally exhibit metabolic endotoxaemia (a syndrome of sub-clinically 
increased circulating endotoxin) when fed on a high fat diet (Kaliannan et al. 
2013) and exhibit more severe colitis in response to dextran sodium sulphate 
(DSS), which is attenuated by oral supplementation with calf IAP (Ramasamy 
et al. 2011). IAP expression has also been shown to be reduced in 
starvation, to inhibit NFκB expression in vitro, and also to reduce bacterial 
translocation in vivo, in an ischaemia reperfusion model (Goldberg et al. 
2008). It could be therefore be hypothesised that stimuli which cause 
damage to the upper villus may result in reduced expression of IAP, as it is 
the well differentiated IECs in this region of the villus which predominantly 
express IAP. This could then predispose to increased bacterial growth or 
dysbiosis and chronic inflammation. In support of this concept, lower 
expression of IAP has been shown in the intestines of patients with ulcerative 
colitis (UC) and Crohn`s disease (CD) (Tuin et al. 2009).  
LPS signalling is additionally dependent on delivery of LPS to the cell 
membrane in a bioactive form by lipopolysaccharide binding protein (LBP) 
and the adapter molecules CD14 (Wright et al. 1990) and MD-2 (Shimazu et 
al. 1999). TLR4 and CD14 have been found to be expressed throughout the 
gastrointestinal tract of the mouse, with an increasing expression gradient 
from the proximal to distal intestinal tract; the highest expression being found 
in the distal colon (Ortega-Cava et al. 2003). It has additionally been shown 
that TLR4 and CD14 are confined to the crypt base, suggesting a further 
microanatomical compartmentalisation of this pattern recognition receptor, to 
a site that may be more physically protected by both distance and mucus, 
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from exposure to the luminal bacterial content.  
The high expression of TLR4 in the distal colon, possibly in conjunction with 
very low expression of IAP, may explain why it has been demonstrated that 
luminal LPS delivered by enema into the colon of CD-1 mice causes small 
intestinal damage 2 days after administration (Eunok et al. 2012). In these 
experiments, it was found that TLR4 signalling was required, but intriguingly 
LPS enema did not cause colitis. These findings could therefore point 
towards different TLR sensing in the colon as opposed to the small intestine, 
and/or a different immunological response in the two sites to LPS.  
Immune tolerance to what would be constant stimulation by the luminal Gram 
negative bacterial population in the gut, may additionally be achieved through 
localisation of TLRs to the basolateral, rather than apical membrane of the 
IEC. In support of this, it has been shown in humans that both TLR2 and 
TLR4 are expressed on the basolateral side of foetal ileal crypt enterocytes 
(reviewed by Abreu (2010)). Alternatively, fundamentally different TLR 
signalling in small intestinal IECs may occur. Indeed, in cell culture of m-ICcl2 
murine IECs, TLR4 was found to reside within the Golgi apparatus, rather 
than at the cell membrane (Hornef et al. 2002).  
Although the healthy human gut predominantly contains Gram positive 
bacteria, there is often a shift towards a predominantly Gram negative 
bacterial population in IBD (Seksik et al. 2003). This is also accompanied by 
increased IEC TLR4 expression in IECs of IBD patients (Cario and Podolsky 
2000), suggesting that the relative expression of this receptor may be 
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important in predisposing to the onset of inflammation. 
At the subepithelial level, it has been shown that there may be important 
roles for intestinal dendritic cells in maintaining gut immune tolerance. In 
support of this, human intestinal dendritic cells of the lamina propria have 
been shown to lack the co-receptor molecule for TLR4; CD14 (Smith et al. 
2001) further compartmentalising responses to luminal LPS.  
Having established that luminal LPS did not appear to trigger IEC apoptosis 
and cell shedding (by 1.5h) in contrast to systemic LPS, it was demonstrated 
that high purity IE-LPS caused IEC apoptosis and shedding via an almost 
entirely TLR4 dependent mechanism. However, lower purity PE-LPS 
administered to Tlr4-/- mice caused a moderate amount of IEC apoptosis and 
cell shedding. This suggests that other constituents of the PE-LPS 
preparation may interact with the immune system and may also contribute to 
this effect.  
Potential interactions could include the recognition of other bacterial products 
representing impurities in the PE-LPS preparation, by alternative TLRs. Such 
bacterial products likely to be present include bacterial RNA, which may 
represent a major constituent of the phenol extracted LPS. Bacterial RNA is 
recognised by TLR7 in murine plasmacytoid dendritic cells, but interestingly it 
has also been shown that other immunoreceptors may also be activated by 
this ligand to cause TNF secretion (Eberle et al. 2009).  
Other impurities could also include lipopeptides which can be recognised via 
TLR2 (Buwitt-Beckmann et al. 2006), peptidoglycans which may also be 
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recognised by TLR2/TLR6, and intracellular nucleotide-binding 
oligomerization domain-containing (NOD) proteins NOD1 and NOD2 
(reviewed by Royet and Dziarski (2007)). In support of other PAMPs causing 
this phenomenon, it has been demonstrated that in mice apoptosis in the 
intestinal villus can be triggered by the TLR3 agonist poly I:C (McAllister et al. 
2013). TLR3, in contrast to other TLRs, signals exclusively via the TIR-
domain-containing adapter-inducing interferon-β (TRIF) rather than MyD88 
pathway (Kawai and Akira 2011). As such, this agonist represents an 
unusual TLR mediated inflammatory response. In the McAllister study, it was 
demonstrated that poly I:C caused apoptosis by a TRIF dependent and in 
contrast to our own model, TNF independent mechanism. IEC apoptosis 
peaked at 2h post administration, possibly reflecting delayed activation of the 
TRIF pathway compared to the MyD88 pathway (Pålsson-McDermott and 
O'Neill 2004). The authors of this study hypothesised that the apoptotic and 
shedding response may be some kind of host defence mechanism to 
eliminate pathogens. However, if this were the case, it perhaps would be 
expected that luminal pathogen sensing would be more effective, and in this 
model oral poly I:C failed to cause a response. 
The rapid increase in plasma TNF concentration after LPS administration has 
been previously characterised (Copeland et al. 2005). In the current study, a 
large fold change in Tnf mRNA abundance in small intestinal epithelial 
enriched extracts 1.5h after LPS administration was demonstrated compared 
to untreated mice. These qPCR data also show that LPS administration 
caused changes in transcription of genes predominantly involved in 
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apoptosis. As the samples analysed by qPCR were epithelial enriched, this 
would suggest that the predominant cell type responsible for this increased 
transcription of Tnf mRNA is the intestinal epithelial cell. This is supported by 
research by Guma et al. (2011) who showed IEC TNF production in the small 
intestine by immunofluorescence, and increased Tnf transcription by in situ 
hybridisation, in mice with epithelial specific constitutively active IKKβ, when 
challenged with LPS for 4h. This TNF production was additionally dependent 
on MAPK activation. This suggests that once triggered, epithelial TNF 
production can proceed to autocrine and paracrine TNF signalling to cause 
severe IEC apoptosis and cell shedding. However, in our own experiments 
epithelial enriched extracts did not represent a purely epithelial population, 
and so it cannot be discounted that there could be contributions by intestinal 
dendritic cells, other leukocytes, endothelial cells, or myofibroblasts. 
The significance of TNF as the critical mediator in our model was further 
demonstrated by TNF administration causing IEC apoptosis and cell 
shedding consistent with previous results (Garside et al. 1993; Piguet et al. 
1998), and equivalent to that caused by LPS. Moreover, it was shown that 
lack of TNFR1 caused complete blocking of LPS induced pathological IEC 
apoptosis and cell shedding. Although it was hypothesised that TNF could be 
the most important mediator of LPS-induced apoptosis and cell shedding, we 
did not expect this cytokine, via TNFR1 to be entirely responsible for this 
effect.  
Indeed, research conducted on endotoxic shock induced gut injury has 
implicated many other mediators such as platelet activating factor (PAF), 
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thromboxane, inducible nitric oxide synthase (iNOS), IL-1 and interferon 
gamma (IFNγ), the production of all of which should not be affected in Tnfr1-/- 
mice in response to systemic LPS administration.  
However, this dependence on TNFR1 is in keeping with those that have 
investigated the mechanism of exogenous TNF mediated small intestinal 
apoptosis, where the effect is entirely mediated through TNFR1 (Piguet et al. 
1998). This form of TNF induced apoptosis also appears to be critically 
dependent on dosage, as it has been shown that a dose of 5µg TNF in adult 
WT mice caused significant IEC apoptosis in the small intestine by 1h, 
whereas 1µg TNF did not (McAllister et al. 2013). This can be compared to 
the dose studied in this project of 0.33mg/kg TNF (equating to 6.6µg per 
mouse). In the McAllister study, when comparison was made after 1h 
between 20mg/kg LPS, 1µg TNF, and 5µg TNF, this resulted in serum TNF 
concentrations of around 10,000pg/ml, 20,000pg/ml, and 100,000pg/ml 
respectively. The 10 fold lower concentration of TNF induced by 20mg/kg 
LPS compared to 5µg TNF probably again reflects the early time point 
examined (1h), and presumably continues to increase further by 1.5h post 
administration. 
Limitations do however exist in the interpretation of the LPS response in 
Tnfr1-/- mice, as they do not exhibit IEC specific absence of TNFR1. Although 
highly probable, and in keeping with other investigations (Jackson et al. 
2000; Guma et al. 2011), it cannot be stated categorically in our model 
whether TNFR1 ligation is occurring at the level of the IEC or whether TNF is 
causing IEC apoptosis and shedding by indirect mechanisms distant to the 
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IEC. These could include effects of TNFR1 ligation at the level of 
myofibroblasts, leukocytes, neurones, or endothelial cells. In the case of the 
latter, this could contribute to serious haemodynamic disturbances, and 
reduced perfusion of the villus. However, strong evidence for direct IEC 
TNFR1 ligation initiating apoptosis and shedding comes from elegant 
experiments by Roulis et al. (2011). In this study, it was shown that following 
exogenous TNF administration, mice which express functional TNFR1 
specifically within IECs, exhibited apoptosis and shedding at 1h after 
intravenous administration of 12µg TNF. This suggests that direct TNFR1 
ligation does indeed occur at the level of the IEC.  
It is well established that TNF binding with TNFR1 leads to multimerisation 
and autocleavage of caspase-8 in extrinsic pathway apoptosis. When the 
TLR3 agonist poly I:C is administered systemically, this results in activation 
of caspase-8 and caspase-3 in IECs. However, if poly I:C is administered to 
mice specifically lacking caspase-8 in IECs, caspase-3 is not activated and 
there is massive destruction of the villus, with complete loss of villus 
epithelium by 2.5h, and the death of these mice occurring by 6h post-
treatment (McAllister et al. 2013). This cell death occurs by alternative cell 
death pathways, possibly culminating in necroptosis, as it does not seem 
dependent on executioner caspase activity. It is not entirely clear what the 
secondary mediator of IEC apoptosis was in the McAllister study, as it was 
concluded that although TLR3 and TRIF were required to cause villus 
apoptosis, this process was independent of all cytokines tested, including 
TNF, IL-1, IL-6, IFNγ and IL-15. It was also shown to be dependent on cells 
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of non-haematopoietic origin. It may therefore be speculated that in the case 
of TLR3 agonists, pro-apoptotic IEC signalling may arise from basolateral 
IEC TLR3 signalling, or possibly by endothelial, myofibroblast or neural TLR3 
signalling. 
LPS-treated mice specifically lacking caspase-8 in IECs also exhibit β1 
integrin depletion in IECs (de Chambrun et al. 2013). It was shown in this 
study that in addition to obvious apoptotic functions, caspase-8 regulates 
clathrin dependent endocytosis. These mice were resistant to LPS-induced 
small intestinal damage when treated with an endocytosis inhibitor; 
chlorpromazine, or when crossed with mice lacking autophagy related protein 
7 (Atg 7). These mice were also completely protected from LPS-induced 
damage by crossing with mice lacking Tnfr1-/-.  
In the intestinal epithelium, and in intestinal cell lines, TNFR1 is expressed to 
a greater extent than TNFR2 (Mizoguchi et al. 2002; Lau et al. 2011), 
although the latter can be induced by inflammatory cytokines (Mizoguchi et 
al. 2002). Although TNFR1 has well defined pro-apoptotic effects (Locksley 
et al. 2001), the role of TNFR2 has been less well characterised. 
Interestingly, the intestinal epithelial response to LPS was moderate in Tnfr2-
/- mice, suggesting that this receptor does participate in LPS-induced IEC 
apoptosis, possibly by enhancement of TNFR1 signals through degradation 
of TRAF2, resulting in termination of NFκB signalling (Rodríguez et al. 2011). 
Interestingly, in the context of colitis, it has been shown that TNFR2 can 
induce myosin light chain kinase (MLCK) to cause tight junction 
dysregulation, which leads to colonic epithelial cell apoptosis and gut barrier 
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defects (Su et al. 2013). This may imply that the reduced apoptosis and 
shedding that was observed in TNFR2 deficient mice may be due to the lack 
of MLCK activation, and thereby reduced detrimental effects on tight-
junctions. In a more chronic model of TNF induction, it has been shown in 
mice that lack the autoregulatory elements which control and suppress 
excessive TNF production, that a spontaneous intestinal inflammation similar 
to Crohn`s disease develops, which is TNFR1 dependent. In keeping with our 
model, this affect was enhanced by presence of TNFR2 (Kontoyiannis et al. 
1999). 
Although Cd40 also showed marked up regulation in the array, this was not 
corroborated when individual replicate samples were analysed by qPCR. 
This was probably due to the fact that this increased transcriptomic 
abundance was measured at a late qPCR cycle number in both treated and 
untreated animals. This is consistent with very low level transcription found in 
both groups, and therefore reflects a more unreliable result. The array also 
did not detect significant transcriptional alterations to other caspases 
including caspases 1-3,6,7, and 9. This is perhaps not unsurprising, as the 
activation of these enzymes largely occurs at the protein level through 
cleavage, conformational changes, and dimerisation (see Introduction).  
In summary, the findings outlined in this chapter suggest that LPS initiates a 
rapid process of peripheral TLR4 ligation, most likely within peripheral 
macrophages and dendritic cells. This triggers a cascade of pro-inflammatory 
gene induction.  
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Of the cytokines produced, it is TNF via TNFR1 which induces the rapid 
activation of caspase-3, likely via caspase-8, resulting in IEC apoptosis and 
cell shedding. It also seems likely that initial TNF production from the 
periphery stimulates epithelial TNF production. 
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5. NFκB Regulation of Pathological IEC 
Apoptosis and Cell Shedding 
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5.1 Introduction 
Having established the mechanisms by which LPS induced IEC apoptosis 
and cell shedding in the small intestine of WT mice, the influence of NFκB 
signalling pathways downstream of LPS and TNF were investigated. As 
NFκB is a major transcriptional regulator downstream of TLR, it was first 
investigated whether mice lacking NFκB subunits, specifically Nfb1-/- which 
lack p50 and its precursor p105 protein, Nfb2-/- which lack p52 and its 
precursor p100 protein, and cRel-/- mice, would exhibit altered sensitivity to 
LPS induced IEC apoptosis and cell shedding. As NFκB is also a major 
transcriptional regulator downstream of TNFR1, the response of these mice 
to TNF would also be tested. 
The relative sensitivities of these genotypes to LPS were investigated 
utilising previous data on time and dose responses to LPS in WT mice. By 
administering PE-LPS at high dose (10mg/kg) and low dose (0.125mg) by i.p. 
injection for 1.5h, it was hypothesised that by measurement of duodenal 
villus height, and IEC apoptosis and cell shedding by active caspase-3 IHC, 
that differing sensitivities between genotypes would be detected. By 
examining these differences between genotypes when administered TNF, it 
was hypothesised that this would effectively bypass the upstream influence 
of the differing innate immune response in these genotypes. This would 
thereby reveal events relating to regulation of apoptosis occurring 
downstream of TNFR1 (and possibly TNFR2) ligation. Finally, the role of 
NFκB proteins was also investigated by performing western blotting on small 
intestinal epithelial enriched extracts, and immunohistochemistry on 
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duodenal sections from treated and untreated mice of these genotypes, to 
further clarify the influence that these signalling pathways exert on 
pathological IEC apoptosis and cell shedding in the murine small intestine.  
5.2 Nfb1-/- mice were more sensitive, and Nfb2-/- 
mice more resistant to LPS induced intestinal 
injury 
PE-LPS was administered to male and female Nfb1-/-, Nfb2-/-, and c-Rel-/-
mice. Data were analysed separately for males and females, and were 
combined following absence of observable, or statistically significant 
differences being detected between genders following either high dose 
(10mg/kg), or low dose (0.125mg/kg) PE-LPS, as had been established to be 
the case in WT mice (see 3.11.3). Results are therefore described for 
“combined genders” unless otherwise stated. This is with the exception of  
c-Rel-/- mice following 0.125mg/kg LPS, due to apparent and statistically 
significant differences between genders (discussed later).  
Following 10mg/kg LPS for 1.5h, Nfb1-/- mice exhibited a mean villus 
shortening of 31%; reduced to 261.1µm±24.6µm when compared to 
384.9µm±12.9µm in untreated Nfb1-/- mice (Figure 50). This was 
comparable to the 32% villus shortening observed following 10mg/kg LPS in 
WT mice, reduced to 263.6µm±10.1µm compared to 385.7µm±11.5µm in 
untreated animals (Figure 50). Following 10mg/kg LPS, Nfb1-/- mice also 
showed similar amounts of IEC apoptosis and cell shedding at 12.3%±4.2% 
compared to WT mice at 11.5%±3.1% (Figure 51). In contrast, mean villus 
height was only reduced by 11% in Nfb2-/- mice administered 10mg/kg LPS, 
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to 347.5µm±12.4µm compared to 389.7µm±14.0µm in untreated Nfb2-/- 
animals.  
This represented a significantly attenuated villus shortening when compared 
to the 32% observed in WT mice administered this dose (P<0.05: Kruskal-
Wallis, Figure 51). Nfb2-/- mice given 10mg/kg LPS also exhibited a trend 
towards reduced IEC apoptosis and cell shedding at 8.5%±4.2%, compared 
to similarly treated WT mice at 11.5%±3.1%, although this difference was not 
statistically significant (Figure 51). 
Interestingly, when administered a low dose of LPS (0.125mg/kg), villus 
height in Nfb1-/- mice was reduced by 27% to 283.6µm±19.6µm when 
compared to 384.9µm±12.9µm in untreated Nfb1-/- animals. This 
represented almost the same degree of villus shortening as when 
administered 10mg/kg LPS (31%; Figure 50) and was significantly greater 
than the 5% villus shortening observed in 0.125mg/kg LPS treated WT mice 
[365.6µm±19.0µm when compared to 385.7µm±11.5µm in untreated WT 
animals (P<0.05: Kruskal-Wallis)]. Nfb1-/- mice administered 0.125mg/kg 
LPS also exhibited significantly greater amounts of IEC apoptosis and cell 
shedding (Figure 51) at 12.9%±1.7% (P<0.05: Kruskal-Wallis) compared to 
WT mice at 6.0%±1.7%. By contrast, when administered this low dose 
(0.125mg/kg of PE-LPS), no villus shortening was observed in Nfb2-/- mice 
(414.5µm±5.7µm compared to 389.7µm±14.0µm in untreated Nfb2-/- 
animals; Figure 50), and negligible IEC apoptosis and shedding of 
0.8%±0.2% was detected (P<0.05: Kruskal-Wallis; Figure 51).  
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Of note, when administered 10mg/kg LPS, c-Rel-/- mice showed villus 
shortening of 47%, to 230.1µm±12.7µm compared to 430.5µm±11.5µm in 
untreated c-Rel-/- animals (Figure 50). This represented the greatest degree 
of villus shortening observed in any of the genotypes. However, when c-Rel-/- 
mice were administered 0.125mg/kg PE-LPS, differences were detected 
between the responses of males and females, with females exhibiting greater 
sensitivity to LPS, comparable with Nfb1-/- mice. This was firstly shown in 
terms of villus shortening (Figure 50) to 331.2µm±28.2µm compared to 
430.6µm±16.0µm in untreated c-Rel-/- females (23%). By contrast, c-Rel-/- 
males exhibited a villus height reduction of only 4% to 415.3µm±17.4µm 
compared to 430.3µm±18.1µm in untreated c-Rel-/- male animals. c-REL-/- 
female mice treated with 0.125mg/kg LPS also exhibited greater amounts of 
IEC apoptosis and cell shedding at 10.57%±2.5% (Figure 51) compared to 
3.7%±1.5% in males.  
Together, these results suggest that LPS induced small intestinal injury is 
enhanced by intact alternative pathway NFκB2 signalling, while canonical  
NFκB1 signalling may be necessary to suppress IEC apoptosis and cell 
shedding. c-REL may also be important in suppressing IEC apoptosis, as 
demonstrated in 10mg/kg LPS treated mice of this genotype, however at 
0.125mg/kg this seems to be the case only in female animals. 
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Figure 49: Bar charts of villus height measurements of duodenal villi for female, 
male, and combined gender groups, demonstrating the marked sensitivity of Nfb1-/- 
mice to 0.125mg/kg LPS and relative resistance of Nfb2-/- mice to 10mg/kg LPS-
induced small intestinal injury. Comparisons are between genotypes within same 
dosage group against WT controls by ANOVA and Holm-Sidak post-hoc test. * 
=P<0.05, n=6 female and n=6 male mice per group. N.B. green bar representing 
combined genders for c-Rel-/- treated with 0.125mg/kg LPS is absent due to 
statistically significant differences between genders at this dose. 
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Figure 50: Bar charts of relative percentage of apoptotic and shedding IECs in the 
duodenal villi of high dose (10mg/kg PE-LPS) treated male, female, and combined 
gender transgenic mice, demonstrating that there was less IEC apoptosis and cell 
shedding (albeit not statistically significant) observed in the Nfb2-/- genotype. n=6 
female and n=6 male mice per group. 
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Figure 51: Bar charts showing relative percentage of apoptotic and shedding IECs in 
the duodenal villi of transgenic mice at 1.5h after low dose (0.125mg/kg) PE-LPS, 
showing significantly increased IEC apoptosis and cell shedding in Nfb1-/-, and 
significantly decreased IEC apoptosis and cell shedding in Nfb2-/- mice. * =P value 
<0.05 based on ANOVA and Holm-Sidak post-hoc test. n=6 for females and n=6 for 
males except for Nfb1-/- (n=7 males, n=7 females) and c-REL-/- (n=8 males, n=6 
females). N.B. bar representing combined genders for c-Rel-/- treated with 
0.125mg/kg LPS is absent due to statistically significant differences between 
genders at this dose. 
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5.3 Nfb1-/- mice were highly sensitive, and Nfb2-/- 
mice more resistant to TNF induced small 
intestinal injury  
As well as acting as a transcriptional regulator downstream of TLR4 ligation, 
NFκB is also a major exponent of signalling downstream of TNFR receptor 
ligation. The responses of Nfb1-/- and Nfb2-/- female mice to TNF were 
therefore tested by administration of murine recombinant TNF by i.p. injection 
at 0.33mg/kg for 1.5h. This dose of TNF had been previously shown to 
induce IEC shedding by in vivo confocal microscopy in our own laboratories 
(Kiesslich et al. 2012). Duodenal villus heights, and villus IEC apoptosis and 
cell shedding were then quantified and compared between genotypes.  
Nfĸb1-/- mice were highly sensitive to TNF induced small intestinal injury 
(Figure 53) with a significant reduction in villus height to 160.1µm±7.3µm 
compared to TNF-treated WT mice at 268.4µm±20.9µm (P<0.05: ANOVA; 
Figure 53A). This correlated with increased IEC apoptosis and cell shedding 
of 9.9%±0.7% in TNF-treated Nfb1-/- mice compared to 7.0%±1.0% in WT 
(P<0.05: ANOVA; Figure 53B). Conversely, Nfb2-/- mice were resistant to 
TNF induced reduction in villus height, with only a small measurable 
decrease in villus height to 340.1µm±15.1µm (Figure 53A) when compared to 
398.2µm±15.7µm in untreated, and significantly reduced IEC apoptosis and 
cell shedding of 2.5%±0.7% (Figure 53B) compared to similarly treated WT 
animals at 7.0%±1.0% (both P<0.05). 
These data suggest that in response to TNF administration, IEC apoptosis 
and cell shedding are suppressed by classical NFκB activation via NFκB1, 
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and promoted by alternative NFκB activation via NFκB2. 
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Figure 52: Nfb1-/- mice were more sensitive, and Nfb2-/- mice more resistant to 
LPS or TNF induced IEC apoptosis and cell shedding. Representative active 
caspase-3 IHC photomicrographs of LPS treated WT, Nfb1-/-, and Nfb2-/- (A, B, 
and C) and TNF treated WT, Nfb1-/-, and Nfb2-/- (D,E, and F). Enhanced IEC 
apoptosis and cell shedding was present in Nfb1-/- mice, and reduced villus 
shortening and reduced IEC apoptosis and cell shedding in Nfb2-/- mice. 
Bars=100µm. 
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Figure 53: Villus heights (A) and IEC apoptosis and cell shedding (B) 1.5h after 
0.33mg/kg TNF in WT, Nfb1-/- and Nfb2-/- mice. *=P<0.05. n=4-6 female mice per 
group, comparisons by ANOVA and Holm-Sidak post-hoc correction. 
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5.4 Nfb1-/- mice exhibited crypt apoptosis in response 
to TNF 
An interesting further observation in TNF treated Nfb1-/- mice, was that in 
addition to the much greater villus IEC apoptosis and cell shedding seen in 
the duodenum of these mice, marked crypt apoptosis was also observed  
(Figure 54) when compared with WT and Nfb2-/- mice. Quantification 
demonstrated significantly increased apoptosis within crypts of Nfb1-/- mice, 
at 15.7%±2.9%, compared to 0.9%±0.5% in WT, and 1.4%±0.6% in Nfb2-/- 
mice (Figure 56). This suggests that both villus and crypt IECs exhibit a pro-
apoptotic phenotype in response to TNFR1 (and possibly TNFR2) ligation 
when canonical NFκB1 signalling is ablated. The inference from this finding is 
that NFκB1 is important in promoting survival of both villus IECs and crypt 
IECs when exposed to TNF. Interestingly, there is relative sparing of the 
IECs of the villus base to the mid-villus region, again perhaps pointing to 
villus IEC apoptosis and shedding not being caused indirectly by a TNFR1 
mediated vascular phenomenon, as it would perhaps be expected that there 
should be relatively uniform cell death along the crypt:villus axis if this were 
the case. Crypt apoptosis was however mainly observed in the crypt base 
(Figure 57) and appeared to include Paneth cells (Figure 54B), with 
maximum between cell position 3-5. Frequency of apoptotic crypt cells 
observed declined towards the crypt villus junction. 
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Figure 54: Photomicrographs of active caspase-3 immunohistochemistry in 
duodenal sections of WT (A), Nfb1-/- (B) and Nfb2-/- (C) female mice 1.5h 
following 0.33mg/kg TNF treatment. Large numbers of apoptotic crypt cells were 
observed in the crypt base of Nfb1-/- mice, compared to negligible amounts in WT 
and Nfb2-/- mice. Bars=25µm. 
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Figure 55: Quantification of crypt apoptosis induced by TNF (0.33mg/kg) in active 
caspase-3 IHC stained sections of duodenum, showing significantly increased crypt 
apoptosis in Nfb1-/- mice. Comparisons made against WT by ANOVA and 
Dunnett`s post-hoc test. n=4 female mice per group.  
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Figure 56: Nfb1-/- mice exhibited greatest crypt apoptosis in the crypt base (with 
maximum between cell position 3-5) which declined along the crypt axis. n=4 female 
mice per group. 
 
5.5 LPS caused small intestinal p100 processing to 
p52 in 1.5h 
As the relative sensitivity of Nfb1-/- and Nfb2-/- mice to LPS and TNF had 
now been established, further investigation of cellular NFκB signalling events 
in the IEC following LPS stimulation was undertaken. From the phenotypic 
responses characterised, it appeared that NFκB1 and NFκB2 differentially 
regulated villus IEC apoptosis and shedding. It was therefore hypothesised 
that p100/NFκB2 processing to the derivative p52 subunit and nuclear 
translocation in IECs may result in apoptosis. This was investigated by 
western blotting for presence of these protein subunits in small intestinal 
epithelial enriched extracts from mice in 1.5h 10mg/kg PE-LPS treated and 
untreated WT, Nfb1-/- and Nfb2-/- mice. With the major caveat that this was 
performed successfully once for n=1 untreated and treated mice from each 
genotype, and has not been repeated to confirm the result due to time 
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constraints, this western blot showed a positive band at the expected 
molecular weight for p52 in the treated lanes for WT and Nfb1-/- mice 
(Figure 57). These data suggest that there is processing of p100 (although 
band intensity for this protein was weak) to p52 after 1.5h of LPS treatment. It 
also supported the hypothesis that p52 dimers may translocate to the 
nucleus to promote IEC apoptosis and cell shedding. 
 
 
5.6 LPS treated Nfb2-/- mice exhibited increased 
amounts of RelB by western blot 
RelB is a member of the NFκB protein family which is the preferred binding 
partner of p100/p52. To further examine alternative pathway NFκB signalling, 
western blotting was again utilised to investigate relative protein abundance 
of RelB in 10mg/kg PE-LPS treated and untreated WT, Nfb1-/- and Nfb2-/- 
mice in epithelial enriched extracts. This showed the presence of a (double) 
band at the expected molecular weight for RelB protein of approximately 
70kDa in both treated and untreated lanes of all genotypes, but with stronger 
Figure 57: Western blotting demonstrated that there was 
processing of p100 to p52 in WT and Nfb1-/- mice 1.5h following 
LPS administration. Unt=untreated. Please note lane order. 
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bands present in the Nfb2-/- untreated lane, and particularly the treated 
Nfb2-/- lane (Figure 58). These data suggest that RelB is present within the 
small intestine to a greater extent in Nfb2-/- mice, and is also present in 
greater amounts 1.5h following LPS treatment. The inference is therefore that 
LPS treatment either promotes production of this protein at this site, or cells 
rich in this protein are infiltrating the intestine in response to LPS treatment.  
Again, this is with the major caveat that due to time constraints this blot has 
been performed once for n=1 and requires repeating for confirmation. 
 
 
5.7 Positive RelB immunolabelling was detectable in 
villus IECs in LPS treated Nfb2-/- mice 
To further investigate the role of NFκB2 in LPS-induced IEC apoptosis and 
shedding, immunohistochemistry for RelB (1:500; SC-226 Santa Cruz 
Heidelberg, Germany) was performed on formalin fixed paraffin embedded 
sections of duodenum from 1.5h 10mg/kg PE-LPS treated (n=2 for 1.5h and 
Figure 58: Western blot for RelB protein showing increased 
abundance in 10mg/kg PE-LPS treated, Nfb2-/- small intestinal 
epithelial enriched extracts 1.5h after administration. 
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untreated) for WT, Nfb1-/-, and Nfb2-/- female mice. Immunohistochemistry 
(performed by Envision™ method as detailed for active caspase-3 IHC), 
showed positive nuclear labelling of epithelial cells overlying lymphoid tissue 
(follicular associated epithelium), as has been reported previously (Yilmaz et 
al. 2003) and also some positive lamina proprial lymphocytes in duodenal 
sections of all genotypes examined. However, in LPS treated Nfb2-/- mice, 
positive nuclear immunolabelling of villus IECs was also observed. These 
mice appeared to exhibit increased labelling along the crypt-villus axis, being 
particularly prominent in the apical 50% of the villus.  
These findings suggest that the increased RelB protein expression detected 
by western blot, is more specifically correlated with activation of NFκB 
pathways that involve RelB in villus epithelial cells in Nfb2-/- mice. Since  
Nfb2-/- mice were shown to be more resistant to LPS-induced IEC apoptosis 
and cell shedding, this implies that RelB expression could be protective for 
IECs by preventing apoptosis and cell shedding. The relatively exclusive 
epithelial labelling again supports that it is the epithelial compartment in 
which NFκB signalling is critical in determining the fate of the IEC, rather than 
the immune or vascular compartment. 
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5.8 Discussion 
Data presented in this chapter provide evidence that NFκB signalling plays 
important roles in regulating pathological small intestinal epithelial cell 
apoptosis and cell shedding. It was demonstrated that Nfb1-/- mice exhibit 
greater sensitivity to LPS-induced IEC apoptosis and cell shedding than WT 
  
A B 
Figure 59: RelB immunohistochemistry in WT untreated mice 
demonstrated rare nuclear labelling of epithelial cells localised to 
follicular associated epithelium, and occasional lymphocytes. 
Bars=100 µm in A) and 25 µm in B).  
Figure 60: Immunohistochemistry for RelB protein in duodenal sections 
demonstrated increased nuclear staining in IECs of villus tips in 10mg/kg 1.5h 
PE-LPS treated Nfb2-/- mice. Bars=50 µm  
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mice. By contrast, Nfb2-/- mice were more resistant to IEC apoptosis and 
cell shedding than WT mice. This implies that NFκB subunits differentially 
regulate pathological IEC apoptosis and cell shedding. 
NFκB signalling in response to a diverse range of stimuli, results in increased 
transcription of hundreds of genes including inflammatory cytokines, and 
genes regulating apoptosis (www.nf-kb.org (accessed July 2013)). Much of 
the information regarding the activation of specific NFκB signalling pathways 
is derived from in vitro studies, and appears to conflict according to the cell-
line examined. Additional layers of complexity are added to the system by the 
large number of possible NFκB protein dimer combinations which may be 
formed, and that oscillatory shuttling of NFκB proteins between the cytoplasm 
and nucleus is dictated by NFκB transcriptional negative feedback (Nelson et 
al. 2004). All of this means that any of the mechanisms proposed to account 
for the findings in this chapter, are therefore likely to represent a gross over-
simplification of the vast complexity of NFκB signalling events that lead to 
pathological IEC apoptosis and cell shedding. 
Further confounding this interpretation is the fact that the strains of mice 
examined in this study, represented whole organism rather than tissue 
specific transgenic models. Therefore the influence of NFκB signalling in 
different tissues cannot be easily separated.  
However, as it had previously been established that LPS caused IEC 
apoptosis and cell shedding via TNFR1, it was possible to further clarify the 
relative sensitivity of Nfb1-/- and Nfb2-/- mice to LPS by administration of 
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exogenous TNF to these animals. This helped to separate the potential 
upstream NFκB mediated events in the innate immune cell compartment; 
such as LPS activation of TLR4 and TNF production in leukocytes, from 
downstream mechanisms involved in IEC apoptosis and cell shedding. By 
administering TNF directly, it was possible to theoretically disregard to some 
extent the differences in innate response to LPS between genotypes.  
One possible explanation for the greater sensitivity of Nfb1-/- mice to either 
LPS or TNF induced IEC apoptosis and cell shedding, is that these mice 
exhibit higher basal circulating TNF concentrations. The summation of 
endogenous and exogenous TNF therefore reaches a threshold and 
precipitates greater IEC apoptosis and cell shedding in this genotype. Indeed 
it has been shown that in untreated Nfb1-/- mice, there is significantly 
increased abundance of TNF mRNA in the gastric mucosa (Burkitt et al. 
2013). However, this would imply that unstimulated WT mice exhibit higher 
circulating or tissue TNF concentrations than Nfb2-/- mice; a scenario which 
seems less plausible.  
Alternatively, it could be that pathological IEC apoptosis and cell shedding is 
not caused directly by exogenously administered recombinant TNF, but that 
TNF caused rapid gene induction, or signalling pathway activation, and 
production of endogenous TNF by immune cells and intestinal epithelial cells.  
This hypothesis would postulate that it is the failure of Nfb1-/- to regulate 
exuberant stimulated TNF production, that results in the more severe 
phenotype observed in these mice. A potential mediator of this mechanism 
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could be the fact that p50 homodimer formation is necessary to produce 
TNF-alpha-inhibiting factor (TIF) and down-regulate TNF transcription (Baer 
et al. 1998). However, it may be that production of epithelial derived TNF is 
also heavily dependent on co-activation of other signalling pathways. Indeed, 
unchallenged mice with constitutive IκBα activity in the intestinal epithelium, 
also produce large amounts of intestinal TNF mRNA, 10-20 fold higher than 
WT mice (Guma et al. 2011). These mice do not exhibit increased circulating 
TNF or tissue damage until challenged, but exhibit exquisite sensitivity to low 
doses of LPS with severe small intestinal crypt apoptosis 4h following 
treatment. It was found that the transition from high transcriptomic 
abundance of TNF to epithelial production of TNF in these animals was 
dependent on additional activation of MAPK and p38 pathways. The authors 
speculated this was only provided on treatment with LPS or possibly LPS 
induced TNF. This study also provided some valuable insights into potential 
mechanisms by which NFκB may influence the fate of the IEC, and clinical 
outcomes in endotoxic shock. Firstly, the fact that the mice used in this study 
were epithelial specific transgenics again supports the hypothesis that TNF 
production and epithelial destruction can be epithelial dictated events, and 
not caused indirectly by vascular dysfunction. Secondly, these mice also had 
increased basal F4/80 positive dendritic cell populations and CD3 positive T-
cells in the lamina propria, suggesting that constitutive epithelial NFκB 
activity results in greater recruitment of these cells, which are likely to also be 
involved in the initial inflammatory response; particularly in the case of 
dendritic cells. Thirdly, these mice suffered 100% mortality 24h following 
5mg/kg LPS from E.coli O111:B4, compared to 100% survival in similarly 
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treated WT mice, demonstrating the importance of epithelial compartment 
NFκB signalling in preservation of small intestinal epithelial integrity and in 
dictating the outcome of endotoxic shock.  
The key mediator of pathological IEC apoptosis and shedding in response to 
LPS was shown in the previous chapter to be TNF via interaction with TNFR1 
(see 4.7). The sequence of events following TNFR1 ligation has been shown 
to include the formation of two separate complexes. Complex 1 is rapidly 
formed by TNFR1, TRADD, RIP, TRAF2, and c-IAP1, and induces the NFκB 
response. The second complex contains FADD, pro-caspase-10 and pro-
caspase-8, and it is this complex that causes apoptosis in the absence of an 
adequate NFκB response (Micheau and Tschopp 2003). These investigators 
also showed reduced expression of the anti-apoptotic protein c-FLIP (which 
prevents caspase-8/caspase-10 interaction) if canonical NFκB signalling from 
complex 1 is blocked. This results in caspase-8 and caspase-10 interaction, 
activation and apoptosis. The relationship between TNFR complexes and 
NFκB signalling is therefore highly complicated and reliant on feedback, as 
NFκB is itself responsible for transcriptional regulation of anti-apoptotic 
TRAF2, c-IAP1, and c-FLIP. However, this represents another potential 
mechanism which may account for the apparent pro-apoptotic phenotype in 
TNF treated Nfb1-/- mice, where canonical signalling and transcription of 
these anti-apoptotic proteins is blocked.  
Interestingly, another protein involved with the anti-apoptotic response in 
TNFR signalling that is under transcriptional control of NFκB, is c-IAP2, also 
known as Birc3, the gene for which was found to be +3 fold up-regulated in 
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LPS-treated WT mice (see 4.5). 
One of the unexpected findings to emerge from this study, was data to 
support a role for activation of the alternative pathway and p52 in 
pathological IEC apoptosis and shedding. Reports of this pathway being 
involved in apoptosis are scant in the literature. One study has however 
shown that a p100 death domain was essential for apoptosis induced by 
TNFR1 by complexing with this receptor, and mediating caspase-8 activation 
(Wang et al. 2002). Interestingly, it appeared from western blotting that there 
was a stronger band present for p100 in LPS treated Nfb1-/- mice; in which 
there was greater IEC apoptosis than for similarly treated WT mice (Figure 
57), perhaps supporting a hypothesis such as this. Activation of this pathway 
has nonetheless traditionally been associated with lymphocyte development 
and signalled exclusively by lymphotoxin B (LTβ) CD40L, and B-cell 
activating factor (BAFF)(Gilmore 2006). It has also been shown to exhibit 
delayed kinetics compared with canonical NFκB activation (Choudhary et al. 
2013). However, it has recently been shown that in TNF stimulated cells, 
there is negative cross-talk between canonical and non-canonical pathways, 
with it being possible for RelA to form dimers with RelB. The formation of 
these dimers prevents RelB DNA binding which may have important 
implications for the fate of the IEC in our model (reviewed by Sun (2012)). 
Western blotting performed on epithelial enriched extracts suggested that 
LPS caused activation of small intestinal p100, and subsequent processing to 
p52, 1.5h following administration. As RelB is the preferred binding partner of 
p52, the inference is that p52:RelB dimers probably promote apoptosis in 
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IECs. A20 may potentially be implicated in acting as a molecular switch that 
suppresses canonical signalling and initiates non-canonical NFκB signalling 
through stabilisation of NFκB initiating kinase (NIK) (Yamaguchi et al. 2013). 
Western blotting also showed increased small intestinal RelB expression in 
Nfb2-/- mice, which was particularly increased 1.5h following 10mg/kg PE-
LPS. Immunohistochemistry additionally showed increased nuclear labelling 
of RelB in villus IECs of LPS treated Nfb2-/- mice. This suggests that RelB 
may promote survival in villus IECs in response to TNF. RelB is an unusual 
member of the NFκB protein family, in that it is reported to only be capable of 
forming heterodimers (www.nf-kb.org (accessed July 2013)). The formation 
of RelA:RelB heterodimers, preventing RelB DNA binding, or potentially the 
formation of RelB:p50 dimers may potentially prevent apoptosis, and/or 
reduce TNF production in IECs. Indeed, it has been shown that embryonic 
fibroblasts from Relb-/- mice exhibit dramatically increased TNF production 
following LPS stimulation (Xia et al. 1999). Moreover, RelB reduced TNF 
production by stabilising IκBα in this study.  
It is however interesting that these results suggest RelB is important in 
suppressing IEC apoptosis and cell shedding, as generally it is considered 
that RelA is the critical subunit associated with the survival of IECs. This is 
because mice specifically lacking RelA in IECs have been found to exhibit 
profoundly increased IEC apoptosis, dysregulated IEC proliferation, and 
suffer spontaneous intestinal failure with loss of crypt:villus architecture 
(Steinbrecher et al. 2008). It has also been shown that nuclear translocation 
of RelA occurs in villus IECs that resist shedding in a Cryptosporidium 
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parvum model of IEC shedding in piglets (Foster et al. 2012). Additionally, 
evidence of the importance of canonical NFκB signalling has also been 
shown in mice specifically lacking IEC IKKα or IKKβ, which exhibit crypt 
apoptosis in response to either poly I:C (TLR3 agonist) or TNF (McAllister et 
al. 2013). This prompted the authors of this study to hypothesise that NFκB 
signalling does not protect villus IECs, but is required to protect crypt IECs. 
They speculated that this may be due to differing p50 isoforms or homodimer 
formation along the crypt:villus axis.  
Our own studies suggest that p50 is indeed protective in both villus and crypt 
IECs in response to TNF, as large amounts of crypt IEC apoptosis were 
observed in p50 deficient Nfb1-/- mice when compared to WT or Nfb2-/- 
mice. This also suggests that alternative RelA containing dimers cannot 
rescue the IEC from TNF-induced cell death. The highest frequency of 
apoptosis in the crypts of Nfb1-/- mice was observed within the crypt base, 
with maximum between cell position 3 and 5, and appeared to include 
Paneth cell apoptosis. This perhaps suggests particular sensitivity of stem-
cell IECs and Paneth cells lacking canonical NFκB signalling within this 
compartment, to TNF induced cell death. Although here we demonstrate 
active caspase-3 dependent apoptosis, necroptosis has been shown in the 
crypt base in response to TNF in caspase 8 deficient mice, and these mice 
also lack Paneth cells (Gunther et al. 2011). Our findings may perhaps 
suggest that NFκB1 may be necessary to prevent a caspase-8 independent 
form of apoptosis in response to TNF in the crypt base. 
Interestingly, in both male and female mice, the greatest villus injury caused 
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by 10mg/kg PE-LPS was in the c-Rel-/- genotype. However, at 0.125mg/kg 
PE-LPS, there appeared to be divergent sensitivity in male and female mice, 
with the latter appearing to be more sensitive to LPS induced IEC apoptosis 
and cell shedding. In another study which investigated the response of 
female c-Rel-/- mice to septic shock (by caecal ligation puncture), it was also 
found that these mice exhibit increased mortality compared to WT mice 
(Courtine et al. 2011). In this study c-Rel-/- mice exhibited sustained depletion 
of splenic dendritic cells from 24h following caecal ligation, and in the acute 
phase of the inflammatory response, exhibited enhanced secretion of 
inflammatory cytokines including TNF. This study also showed that there was 
activation of RelA, p50 and c-REL 2h following LPS stimulation in vitro, 
supporting the theory that both canonical and non-canonical pathways are 
simultaneously activated in response to LPS.  
These investigators also performed microarrays in treated c-REL-/- mice, and 
found a failure to up regulate Bcl-2l11 in c-Rel-/- mice compared to WT 
(consistent with qPCR data in Section 4.5), as up regulation of this gene is 
associated with “organism survival” in septic shock. The relative sensitivity of 
c-Rel-/- mice suggests that p50:c-REL dimers or RelA:c-REL dimers could 
also be important in suppressing apoptosis and/or TNF production. What is 
not clear, is why there was a divergent response in males and females at low 
dose. However, it has been shown that in mouse splenocytes, 17-β estradiol 
inhibits the nuclear translocation of RelA/p65, c-Rel, and RelB. The overall 
affect is thought to up regulate NF-κB signalling, as p50/p50 and p52/p52 
may still signal in association with up regulated Bcl3 (Dai et al. 2007). This 
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could suggest that it is the inhibition of RelA containing dimers that increased 
susceptibility to IEC apoptosis and cell shedding in c-Rel-/- female mice. 
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6. DISCUSSION 
197 
6.1 Summary of Major Findings and Conceptual 
Advances 
The initial aims of this study were to investigate LPS as a potential stimulus 
for inducing pathological epithelial cell shedding. This phenomenon has been 
poorly characterised, despite the fact that it probably represents the acute 
phase of many forms of epithelial injury in the small intestine, which result in 
villus atrophy. Indeed, the relationships between IEC cell shedding and gut 
permeability, gut immune defence, and tissue homeostasis, remain poorly 
understood.  
It was demonstrated, that LPS-induced villus IEC apoptosis and cell 
shedding occurred far earlier and in much greater amounts than the crypt 
apoptosis which was observed at later time points. The first evidence of IEC 
apoptosis occurred at approximately 1 hour after LPS administration, was 
maximal at 1.5h following administration and showed a marked reduction 
from 3h onwards. LPS administration caused this effect via TLR4 ligation in 
cells peripheral to the intestinal epithelium, and induced marked intestinal 
TNF transcription. It was further established that LPS-induced IEC apoptosis 
and cell shedding were mediated by TNF and TNFR1. These data provided 
novel insights into the mechanisms of LPS-induced villus IEC apoptosis and 
cell shedding, as this effect had not previously been exclusively attributed to 
TNF and TNFR1 in WT mice. NFκB signalling downstream of TNFR was also 
important in determining the sensitivity of IECs to apoptosis and cell 
shedding, with NFκB2 (p100/p52) apparently promoting apoptosis and  
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NFκB1 (p105/p50) and c-REL apparently suppressing apoptosis 
(summarised in Figure 61).  
Preliminary protein analysis data has suggested that p100 is processed to 
p52 within 1.5h of LPS administration, and that RelB activation may be 
involved in the resistance of Nfb2-/- mice to LPS-induced small intestinal 
injury. Apoptosis occurred specifically, and relatively uniformly within different 
regions of the small intestine at the early time points examined. It was 
generally observed within the apical 50% of the villus, and occurred in 
conjunction with villus atrophy. This suggests that small intestinal epithelial 
cells are the most sensitive cells to LPS-induced apoptosis, and that other 
factors such as the length of the villus, proximity to lymphoid tissue, and 
blood flow do not seem to have major influences on this process.  
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The biological significance of LPS-induced IEC apoptosis and cell shedding 
was demonstrated by acute onset diarrhoea at 1.5h-2h. This correlated 
temporally, albeit with a slight time lag, with peak IEC apoptosis and cell 
shedding in LPS treated mice. Furthermore, resultant villus atrophy was 
seen, and gut permeability was significantly increased at 5h following LPS 
administration. These findings provided strong evidence that LPS-induced 
IEC apoptosis and cell shedding cause serious disturbances in fluid 
homeostasis within the gastrointestinal tract, and can allow entrance of 
molecules of at least 4kDa in size through the intestinal barrier at later time 
Figure 61: Diagram summarising putative mechanism by which LPS induces 
apoptosis in IECs. Systemically delivered LPS is first recognised predominantly 
by resident TLR4 expressing mononuclear cells (such as dendritic cells, 
macrophages, and monocytes) which produce TNF. TNF is released into the 
systemic circulation and binds with TNFR1 on intestinal epithelial cells, triggering 
IEC apoptosis and cell shedding if NFκB2 signalling dominates, or cell survival if 
NFκB1 (or c-Rel) signalling dominates. 
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points. The resultant villus atrophy may also lead to malabsorption over a 
longer time period than examined herein. 
6.2 Limitations of the Study 
Although mice were ideally suited to this study in terms of recapitulating the 
morphology of human IEC shedding (Mayhew et al. 1999), there are obvious 
limitations to utilising a mouse model of a human disease process. Apart 
from the obvious anatomical differences which exist in the structure and 
scale of the small intestine in the two species, humans are far more sensitive 
than mice in terms of their immunological responses to LPS (Copeland et al. 
2005). The dosages of LPS that were utilised to induce endotoxic shock in 
mice were therefore larger than would be expected in a human physiological 
or pathological context. This has previously led to criticism of the clinical 
relevance of murine endotoxic shock models in the literature. An alternative 
model, more specifically of septic shock, would have been that of caecal-
ligation puncture. In this model, individual animals are anaesthetised and 
ligation and puncture of the caecum via laparotomy is performed to induce a 
polymicrobial peritonitis, followed by recovery. Although more clinically 
relevant to septic shock, this model would have presented many 
disadvantages for the current area of study. The need for recovery of the 
animal and the serious morbidity and pain associated with this procedure 
would have had a serious negative impact on animal welfare and therefore 
be considered a severe procedure by the UK Home Office. The logistics 
would have also been extremely difficult, with confounding issues of serosal 
inflammation and tissue handling which could also affect the interpretation of 
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IEC apoptosis and cell shedding.  
For the purposes of studying IEC apoptosis and cell shedding, the LPS 
model was therefore deemed to be more suitable. Ultimately, it was also 
established that the mediator of this process was TNF, which therefore 
negates the criticisms of the LPS model to some extent. This is because by 
utilising LPS (albeit in high doses), to initiate the acute inflammatory 
response, the resulting endogenous TNF production was within the 
capabilities and dynamics of the innate immune system. By contrast, the 
exogenous administration of recombinant TNF as a bolus injection, has the 
potential to grossly exceed the timescale and magnitude of endogenous 
pathophysiological TNF production. 
Due to economic constraints, the majority of LPS utilised during the course of 
these experiments was phenol-extracted. This form also contains impurities, 
most notably bacterial RNA. Although this was the form of LPS commonly 
utilised in many published studies examining a murine model of endotoxic 
shock (see Appendix Table 8.1), ideally the highest purity grade of LPS 
should have been used for all experiments, as impurities could interact with 
other TLRs or cause other non-TLR mediated effects.  
However, further experiments involving administering ion-exchange LPS to 
both WT and Tlr4-/- mice, confirmed that the effect of these impurities did not 
appreciably alter the findings of the project.  
Another issue faced during the course of this project, was that with the 
exception of the vil-Cre Myd88-/- mice, the experimental animals were not 
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epithelial specific transgenics. This meant that it was not possible to 
categorically confirm whether the effects we observed were immune or 
epithelial mediated. Obviously, if epithelial specific transgenics had been 
available, these would have been preferable, and would be useful for 
conducting future studies of this phenomenon. 
The technique ultimately chosen for quantifying and comparing LPS-induced 
apoptosis and shedding between genotypes was that of active caspase-3 
immunohistochemical scoring. The advantages of this method were that it 
was relatively easy to interpret, and produced data on IEC apoptosis and 
shedding on a cell positional basis. However, disadvantages included the 
slowness of data collection, with it being necessary to count up to 80 cells 
per hemivillus amounting to up to 1600 cells per intestinal section. Due to 
time constraints, certain assumptions were therefore made during the course 
of this study. These assumptions were built upon findings of the time course 
study, and included the assumption that the duodenum would be 
representative of apoptosis and cell shedding across the entire small 
intestine. The duodenum was chosen as the representative segment, as it 
was also shown to exhibit detectable villus shortening, which could be used 
as an additional measurement parameter to further support IEC apoptosis 
and shedding data.  
It was also assumed that the same dynamics, (i.e. that peak apoptosis and 
cell shedding would be observed at 1.5h following LPS administration), would 
hold true for different dosages and purifications of LPS, and between the  
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different mouse genotypes tested. This may not necessarily have been the 
case. 
Potentially, after showing that the apoptosis and cell shedding were largely 
confined to the apical 50% of the villus, it may have been preferable to only 
count apoptotic/shedding IECs per villus, rather than including “normal” IECs 
and expressing positively labelled cells as a percentage of the total counted. 
This would have made for more expedient data collection, and therefore 
allowed counting of IECs in a greater number of villi, and potentially over 
more intestinal segments (i.e. jejunum and ileum). Another potential criticism 
of immunohistochemistry as a quantitative method, is that although most 
staining can be considered relatively categorically as positive or negative, 
and that scoring was based on scoring criteria (see Materials and Methods), 
there were instances where it was necessary to subjectively decide whether 
a cell was positively or negatively stained, which could potentially lead to 
variation in scoring. In the context of this study, these decisions were based 
largely on background staining of adjacent cells. A major weakness of 
hemivillus scoring, is that it quantifies only apoptotic or shedding IECs 
confined within the epithelium. Of course, this represents a massive under-
representation of the number of apoptotic and shed IECs (see Section 3.3), 
as a much larger number of cells have been sloughed into the lumen by 1.5h 
after LPS administration. It was however thought necessary to disregard 
these cells from the quantification process, as it was considered to introduce 
greater variability between animals. This included variability in how efficiently 
the intestine had been flushed with saline prior to fixation, how much digesta 
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was present within the lumen, and potentially intestinal mucus quality or 
quantity. The role of intestinal mucus, which may also be important in 
preservation of the gut barrier during IEC apoptosis and shedding, has also 
been largely disregarded during this project due to the fixation and 
examination techniques employed, and may warrant further investigation.  
Some studies have approached the problem of quantification of cell shedding 
differently, and have actually studied the flushed material for apoptotic cells 
(Piguet et al. 1998). There are therefore some possible alternative methods 
to traditional light microscopy for quantifying pathological epithelial cell 
shedding. These would include the analysis of flushed material for shed 
epithelial cells, potentially by cell counts, or by enzyme linked immunosorbent 
assay (ELISA) for active caspase-3. However, such methods would involve 
greater tissue handling and delay in fixation, and although they would 
potentially provide a better representation of epithelial cells sloughed into the 
intestinal lumen, they probably would not yield as much information as 
histopathological assessment. Confocal microscopy has also been 
advocated as a useful method for imaging IEC apoptosis and cell shedding, 
with the capability of imaging events over time in individual animals. This 
method was unfortunately poorly suited to maintaining a single field of view, 
or allowing quantification of shedding events. It may yet however prove to be 
a useful technique in the context of imaging mice that express fluorescent 
tagged proteins, to verify mechanisms underlying IEC apoptosis and cell 
shedding. 
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6.3 Translational Impact 
With the major caveat that these findings have been made in a mouse model, 
important concepts derived from this study may be translatable to human 
pathology. The most direct implication is that IEC apoptosis and cell 
shedding, as a process, may be an important contributor to the pathogenesis 
of the acute inflammatory response during endotoxic or septic shock. It may 
be particularly important with respect to the disturbed fluid and electrolyte 
homeostasis that manifests as diarrhoea. IEC apoptosis and cell shedding, 
although studied over a short time course here, could also potentially lead to 
disturbed tissue homeostasis and gut barrier function in chronicity. Increased 
IEC shedding has been shown in the chronic disease processes of 
inflammatory bowel disease (IBD) including Crohn`s disease and ulcerative 
colitis, and TNF antagonists have been used successfully in the management 
of these conditions. Indeed, the importance of TNFR1 in initiating IEC 
apoptosis and cell shedding in this mouse model, potentially suggests that a 
common mechanism may underly this process in both species. It also 
suggests that better epithelial targeted prevention of TNFR1 signalling or 
TNF production, may allow a more focused therapeutic strategy to prevent 
IEC apoptosis and cell shedding. 
Processes including dysregulated inflammatory responses to normal luminal 
flora, and increased gut permeability, have been heavily implicated in the 
development of chronic intestinal diseases such as IBD. The finding that 
increased gut permeability can occur following pathological IEC apoptosis 
and cell shedding in mice, suggests firstly that this process could lead to 
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disease, but also that it could initiate a positive feedback loop.  
This scenario would mean that epithelial damage could lead to increased gut 
permeability, which could lead to failure of gut barrier function and exposure 
of the immune system to gut luminal antigens. This could then promote TNF 
secretion, further exacerbating pathological IEC apoptosis and cell shedding, 
leading to chronic inflammation. This also may predispose to bacterial 
translocation from the gut in acute inflammatory responses, as has been 
shown in LPS treated mice at later time points (Deitch et al. 1987). Findings 
from transgenic mice have also provided valuable insights into NFκB 
regulation of IEC apoptosis in response to TNF, particularly that NFκB2 
inhibition could potentially be used to suppress this process.  
6.4 Future Investigations 
There are many intriguing questions which have been raised during the 
course of this study which remain unresolved. Although the work outlined 
herein establishes a robust animal model of IEC apoptosis and cell shedding, 
detailing the temporally associated diarrhoea and subsequent gut barrier 
dysfunction, cause and effect have not been definitively established. 
Although increased IEC shedding has been shown in IBD, it is also not clear 
whether this is simply an accompanying process of the disease, or whether it 
initiates or contributes to disease progression.  
Some important questions that therefore remain include: 
 Does excessive IEC apoptosis and cell shedding lead directly to 
increased intestinal permeability? 
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 Does the epithelium itself regulate this process? 
 Can IEC apoptosis and cell shedding lead directly to development of 
chronic intestinal disease? 
 Can bacteria exploit gaps in the epithelium in vivo, and how quickly 
can they do this? 
 How can the process of IEC apoptosis and cell shedding be 
suppressed? 
 Does blocking this process prevent intestinal/systemic disease?  
 Does IEC apoptosis and cell shedding occur in acute disease in 
humans? 
The first question which is currently unanswered is whether IEC apoptosis 
and shedding are the direct cause of gut barrier dysfunction in this endotoxic 
shock model. Investigators have implicated various cytokines, chemokines 
and reactive oxygen species (ROS) in the development of tight junction 
rearrangement and gut barrier failure in murine endotoxic shock. However, 
as these studies investigated later time points, the relationship with IEC 
apoptosis and shedding is not clear. This is a difficult question to address, as 
an experiment is required where the acute inflammatory response is elicited, 
but IEC apoptosis and cell shedding is blocked. An interesting possible way 
of addressing this would be to test gut barrier function in Tnfr1-/- mice at 5 
hours after LPS administration. These mice should produce many of the 
cytokines, chemokines and ROS elicited in the inflammatory response, but 
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should exhibit little or no IEC apoptosis and cell shedding. A more focused 
experiment would utilise a vil-Cre Tnfr1-/- knockout mouse which would give 
even greater specificity to the blocking of purely epithelial events.  
It would be fascinating to examine whether the blocking of epithelial TNFR1 
preserves gut barrier function in this model, as this would potentially directly 
demonstrate that the process is orchestrated by the epithelium. However, to 
the author`s knowledge, these mice are not currently available.  
Also yet to be established is whether a single episode of IEC apoptosis and 
cell shedding is capable of eliciting chronic inflammation of the intestinal 
tract. We could therefore potentially perform longer term experiments to 
establish whether full restitution to normal intestinal morphology and function 
occurs in all mice following LPS administration.  
In addition to gut barrier function studies, it could also be tested whether 
bacteria can exploit gaps in the epithelium, and whether luminal bacteria may 
undergo translocation via these gaps. Again, this is a difficult question to 
address experimentally, but could involve testing whether green fluorescent 
protein (GFP) labelled bacteria administered by oral gavage enter either the 
blood, or translocate to peripheral organs after LPS administration. This 
however still does not conclusively demonstrate whether these bacteria 
exploit small intestinal epithelial gaps. Two other possible approaches would 
be to image bacterial invasion by in vivo confocal microscopy of the intestinal 
mucosa, or to examine by scanning electron microscopy the morphology of 
the mucosa following cell shedding, and whether bacteria are associated with 
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mucosal erosions.  
With regards to potential suppression of IEC apoptosis and cell shedding, 
one of the most intriguing findings to emerge from this study was the 
apparent resistance of Nfb2-/- mice to this process. It would therefore be 
very interesting to further characterise the mechanism of this resistance. 
Ideally this would again be tested in a vil-Cre epithelial specific knockout of 
p100/p52. It would then be tempting to test whether protection from IEC 
apoptosis and cell shedding is conferred to LPS treated WT mice by specific 
inhibitors of the alternative pathway of NFκB signalling. A potential enzyme of 
the non-canonical pathway that could be targeted, for which pharmacological 
inhibition is being developed (Li et al. 2013), is NFκB inducing kinase (NIK). 
Another interesting finding warranting further investigation was the enhanced 
crypt apoptosis induced by TNF in Nfb1-/- mice. This suggests that NFκB is 
also important in determining the survival of crypt epithelial cells in the 
context of high TNF concentrations. Further experiments should firstly aim to 
address whether differences in TNF production underlie these variations 
between genotypes. Potentially, the role of the MAPK pathway in translating 
TNF transcription into TNF production could also be tested by administration 
of MAPK inhibitors. It would also be interesting to compare gene expression 
arrays between small intestinal epithelial extracts from untreated and treated 
NFκB transgenic strains, particularly to elucidate the genetic basis of the 
resistance of Nfb2-/- mice to LPS.  
Finally, efforts to establish by confocal endomicroscopy whether IEC 
shedding occurs in acute human diseases, such as acute pancreatitis, are 
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on-going. However, due to the very nature of the acute inflammatory 
diseases where this process might occur, justifying supplementary invasive 
investigations such as this without establishing the direct relevance to 
disease progression is difficult.  
6.5 Conclusions 
This project has studied in detail the very early time course of villus IEC 
apoptosis and cell shedding in response to systemic LPS administration. It 
has established a robust and reproducible animal model for the study of this 
phenomenon. It has refined the time course to be studied in mouse models of 
endotoxic shock for investigators interested in examining small intestinal 
apoptosis, and has provided the basic underlying mechanism. Intriguingly, 
despite the highly complex acute inflammatory response induced by LPS, 
and the many mediators implicated in gut barrier failure in endotoxic shock, it 
was TNF which was shown to be the critical mediator of this process. This 
additionally implies that any acute inflammatory response which elicits a 
threshold concentration of TNF in mice, is likely to cause this affect in the 
small intestine, and may therefore initiate the clinical manifestation of 
diarrhoea. This may also be true of humans, and could result from many 
different TLR agonists or acute infections that trigger inflammatory responses 
that include a threshold concentration of TNF.  
In summary, the establishment of this mouse model is important not only 
because IEC shedding in this species reflects the morphology of shedding 
observed in humans, but also because of the vast number of transgenic mice 
which may be utilised to examine the regulation of this process further. It will 
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also now be possible to test potential new therapeutic interventions in this 
murine model. These interventions may in the future be applicable to the 
management of human diseases. 
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8. APPENDICES 
8.1 Lipopolysaccharide Administration in Mice 
Mouse 
strain 
Gender LPS type Manufacturer Dose Route Findings Reference 
C57BL/6  N/A Salmonella 
enterica 
serovar 
Typhimurium 
Difco Labs 
Westphal 
purified 
60-
350µg 
per 
mouse 
IP Microvascular 
endothelial apoptosis by 
6h and mortality 
Haimovitz-
Friedman 
et al. 1997 
C57BL/6 Male E. coli 
O111:B4 
Sigma 1mg/kg IP Decreased cyp450 and 
increased HETE by 6h 
Theken et 
al. 2010 
CD14
-/-
  
C57BL/6 
N/A N/A Sigma 
 
5mg/kg 
 
IP Up regulation of IL-6 at 
3h and internalisation of 
CD14+TLR4 
Mollen et 
al. 2008 
C57BL/6 Female Salmonella 
minnesota 
R595 
List Biological 
Laboratories  
50µg/kg IV Increased 
steroidogenesis 
Hoekstra 
et al. 2010 
 
Balb/c Female  E. coli 
055:B7 
Sigma 60mg/kg  
 
IP Mortality after 12h Xiang et al. 
2010 
C57BL/6 Male E. coli 
O127:B8 
Sigma 1mg/kg 
 
IP Intestinal apoptosis at 
12h 
Song et al. 
2008 
CF-1  Male N/A N/A 30mg/kg  IP 85% mortality at 48h. 
Vacuolation of intestinal 
epithelium with 
inflammatory infiltrate at 
24h 
Kruzel et 
al. 2000 
 
C57BL/6 N/A E. coli O55:B5 Sigma 60mg/kg IP Mortality at 24h Garlanda 
et al. 2004 
C57BL/6 Male E.coli N/A 10mg/kg
 
IP SR141716 inhibition of 
TNF 
Croci et al. 
2003 
Siglecg 
null 
C57BL/6  
Male  E.coli 055:B5 Sigma 450µg 
per 
mouse 
IP Lethality from 18h Chen et al. 
2009 
 
C57BL/6 Male  E.coli 0111:B4  N/A 2mg/kg  IP Decreased tight junction 
staining from 6h 
Han et al. 
2004 
CD-1 Male  E.coli 
0111:B4 
N/A 4mg/kg IP Intestinal apoptosis at 6h 
(H&E) 
Alscher et 
al. 2001 
C57BL/6 Male  E.coli O55:B5 Sigma 10mg/kg IP Intestinal apoptosis and 
villus shortening 24h 
Perrone et 
al. 2010 
C57BL/6 Male E. coli 0111:B4 Calbiochem 10mg/kg  IP Increased intestinal IL6 
at 4h 
Huber et 
al. 2010 
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INTRODUCTION
The gut barrier consists of a single layer of intestinal epithelial cells
(IECs) and the tight junctions between them. It allows absorption
of nutrients from the intestinal lumen into the circulation, while
preventing the entry of injurious microorganisms, toxins and
antigens. In the small intestine, IECs are generated in the crypt,
migrate up the villus and are shed at the villus tip (Leblond and
Stevens, 1948). In mice, which exhibit whole IEC shedding similar
to that which occurs in humans (Bullen et al., 2006), ~1400 IECs
are estimated to be shed in this way from a single villus tip per day
(Potten and Loeffler, 1990). The small intestine therefore has one
of the highest cell turnover rates in the body, with an estimated
1011 and 2×108 cells being shed per day from the small intestine of
humans and mice, respectively (Potten and Loeffler, 1990). During
the process of physiological cell shedding, the highly coordinated
process of tight junction rearrangement that is required to allow
the detachment and release of IECs from the epithelium maintains
the gut barrier (Madara, 1990).
In various inflammatory conditions, however, the loss of IECs
from the villus exceeds the rate of epithelial generation in the crypt.
This process, which we have termed ‘pathological IEC shedding’
remains poorly understood. Such pathological IEC shedding might
represent the earliest intestinal injury in a variety of intestinal
diseases and is likely to have important consequences, potentially
resulting in gap formation in the epithelium, permeability defects
and villus shortening (villus atrophy). Indeed, increased numbers
of shedding IECs with corresponding focal permeability defects and
epithelial gaps have been observed in inflammatory bowel disease
(IBD), including both Crohn’s disease (CD) and ulcerative colitis
(UC) (Kiesslich et al., 2012; Liu et al., 2011). It has also been shown
that individuals at high risk of developing IBD exhibit increased
gastrointestinal permeability (Hollander et al., 1986). Similarly, IL-
10-deficient mice exhibit increased small intestinal permeability
prior to the development of spontaneous colitis. In this animal
model, colitis severity can be markedly reduced by administering
a specific pharmacological inhibitor that reduces small intestinal
permeability by preventing the opening of tight junctions, and is
prevented completely by rearing animals in germ-free conditions
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SUMMARY
The gut barrier, composed of a single layer of intestinal epithelial cells (IECs) held together by tight junctions, prevents the entrance of harmful
microorganisms, antigens and toxins from the gut lumen into the blood. Small intestinal homeostasis is normally maintained by the rate of shedding
of senescent enterocytes from the villus tip exactly matching the rate of generation of new cells in the crypt. However, in various localized and
systemic inflammatory conditions, intestinal homeostasis can be disturbed as a result of increased IEC shedding. Such pathological IEC shedding
can cause transient gaps to develop in the epithelial barrier and result in increased intestinal permeability. Although pathological IEC shedding has
been implicated in the pathogenesis of conditions such as inflammatory bowel disease, our understanding of the underlying mechanisms remains
limited. We have therefore developed a murine model to study this phenomenon, because IEC shedding in this species is morphologically analogous
to humans. IEC shedding was induced by systemic lipopolysaccharide (LPS) administration in wild-type C57BL/6 mice, and in mice deficient in TNF-
receptor 1 (Tnfr1−/−), Tnfr2 (Tnfr2−/−), nuclear factor kappa B1 (Nfκb1−/−) or Nfĸb2 (Nfĸb2−/−). Apoptosis and cell shedding was quantified using
immunohistochemistry for active caspase-3, and gut-to-circulation permeability was assessed by measuring plasma fluorescence following
fluorescein-isothiocyanate–dextran gavage. LPS, at doses ≥0.125 mg/kg body weight, induced rapid villus IEC apoptosis, with peak cell shedding
occurring at 1.5 hours after treatment. This coincided with significant villus shortening, fluid exudation into the gut lumen and diarrhea. A significant
increase in gut-to-circulation permeability was observed at 5 hours. TNFR1 was essential for LPS-induced IEC apoptosis and shedding, and the fate
of the IECs was also dependent on NFκB, with signaling via NFκB1 favoring cell survival and via NFκB2 favoring apoptosis. This model will enable
investigation of the importance and regulation of pathological IEC apoptosis and cell shedding in various diseases.
A mouse model of pathological small intestinal
epithelial cell apoptosis and shedding induced by
systemic administration of lipopolysaccharide
Jonathan M. Williams1, Carrie A. Duckworth1, Alastair J. M. Watson2, Mark R. Frey3, Jennifer C. Miguel3, Michael D. Burkitt1,
Robert Sutton4, Kevin R. Hughes2,5, Lindsay J. Hall2,5, Jorge H. Caamaño6, Barry J. Campbell1 and D. Mark Pritchard1,*
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(Arrieta et al., 2009). This suggests a crucial link between small
intestinal permeability, luminal antigens and the development of
chronic colitis.
Although recombinant tumor necrosis factor (TNF) has been
previously shown to induce pathological intestinal villus epithelial
cell shedding in mice (Kiesslich et al., 2007), the exogenous
administration of this cytokine in isolation does not reflect the
complexity of the mammalian inflammatory response that is
present in most disease states. In addition, the concentrations of
exogenous TNF required to induce IEC shedding are higher than
found in vivo, making such experiments expensive and possibly
yielding artefactual results. We have also found TNF to be an
inconsistent stimulus of IEC shedding. We therefore sought to find
a simple, inexpensive, rapid, reproducible and pathologically
relevant stimulus to investigate the process of IEC shedding in detail
in an animal model.
Lipopolysaccharide (LPS) is an integral component of Gram-
negative bacteria and is a potent activator of the innate immune
system. It represents a pathogen-associated molecular pattern
(PAMP) recognized by Toll-like receptor 4 (TLR4) (Beutler et al.,
2001), which initiates a systemic inflammatory response, with
nuclear factor kappa B (NFκB) signaling pathways playing a central
role in cell responses downstream of both TLR (Chow et al., 1999)
and subsequent cytokine receptor ligation (Jacque et al., 2005). We
therefore hypothesized that the mammalian systemic inflammatory
response was capable of causing IEC apoptosis and shedding at the
villus tip when triggered by LPS, and that this occurred prior to
the onset of apoptosis in the crypt.
We have therefore examined in detail the earliest phase of LPS-
induced murine gut injury. We demonstrate that intraperitoneally
administered LPS is a simple, rapid and consistent stimulus of villus
IEC apoptosis and shedding in the murine small intestine and that
this occurs several hours prior to the onset of crypt apoptosis. This
early response coincides with fluid effusion into the small intestinal
lumen and diarrhea. We have subsequently characterized the dose
response and the kinetics of this highly dynamic phenomenon.
Using knockout mouse models, we have found that TNFR1-
mediated signaling is essential for these events, with an NFκB2-
dominant response favoring apoptosis. These data provide
interesting insights into the control of IEC homeostasis in
inflammatory disease, because the NFκB2 pathway has not
previously been linked to IEC apoptosis and shedding.
RESULTS
Systemic LPS caused clinical signs and gross pathological changes
from 1.5 hours, with fluid exudation into the intestinal lumen
To establish the time-dependent intestinal effects of LPS, we
administered 10 mg phenol-extracted LPS (PE-LPS)/kg body weight
by intraperitoneal (i.p.) injection to adult female wild-type (WT)
mice, and euthanized them after 1, 1.5, 2, 3, 4 and 6 hours. Diarrhea
was observed from 1.5-2 hours. At necropsy, there was serosal pallor
of the small intestine (Fig. 1A), which exhibited distension with
watery yellow fluid. These observations showed that LPS caused
acute fluid exudation into the gut lumen with acute onset diarrhea.
LPS caused small intestinal villus IEC loss and shedding from
1.5 hours
We performed histopathological examination of hematoxylin and
eosin (H&E)-stained sections to characterize intestinal injury. At
1.5 hours (Fig. 1A) there was marked villus shortening, clubbing
and blunting. IECs at the villus tip exhibited variable separation
and detachment from neighboring cells, often with a teardrop
morphology and an apically positioned nucleus (consistent with
cell shedding and apoptosis). Large numbers of shed IECs were
present within the lumen. Comparable injury was not observed in
the stomach, colon or other organs investigated (supplementary
material Fig. S1). These observations suggest that LPS causes rapid
and specific small intestinal villus epithelial injury, and that peak
shedding correlates with the onset of clinical diarrhea.
LPS caused rapid villus shortening with IEC loss in the duodenum,
jejunum and ileum
Because villus shortening is commonly utilized as a measure of
small intestinal damage, we measured villus heights after LPS
TRANSLATIONAL IMPACT
Clinical issue
Epithelial cell loss and defects in the epithelial barrier are common early
events in the pathogenesis of acute intestinal or diarrheal diseases as well as
chronic intestinal inflammatory disorders, such as Crohn’s disease and
ulcerative colitis. Increased intestinal epithelial cell (IEC) shedding, which is
potentially associated with increased gut permeability, is thought to be a key
contributor to these initial injuries. However, the molecular events underlying
IEC shedding and disruption of intestinal barrier integrity during inflammatory
disease states remain poorly understood. A robust animal model would greatly
facilitate in-depth investigation of these processes. Mice exhibit a
morphologically analogous form of small intestinal villus epithelial cell
shedding to that observed in humans and have the potential to allow
important mechanistic insights because of the availability of established
transgenic and conditional mutant models.
Results
Utilizing the inflammatory response induced by systemic administration of
lipopolysaccharide (LPS) in mice, the authors developed a new model for the
investigation of IEC shedding. A threshold dose of ≥0.125 mg LPS/kg body
weight delivered by intraperitoneal injection induced rapid and dynamic villus
IEC apoptosis and shedding, which peaked at 1.5 hours post-administration.
This coincided with significant villus shortening, fluid exudation into the gut
and the onset of diarrhea. Activation of caspase-3 occurred concomitantly
with IEC shedding in virtually all affected cells, suggesting that apoptosis is
triggered within the epithelium prior to cells being shed. By examining the
responses to LPS in transgenic mice, the authors showed that TNFR1 is
essential for the induction of apoptosis and shedding. Furthermore, the fate of
IECs is dependent on NFκB signaling, with signaling by NFκB1 favoring cell
survival and signaling via NFκB2 favoring apoptosis. 
Implications and future directions
Systemic LPS administration in mice provides an effective and reliable trigger
of pathological IEC shedding that parallels that observed in human intestinal
diseases. The authors’ detailed characterization of affected mice confirms that
villus epithelial apoptosis and cell shedding occurs with acute fluid exudation
into the gut, leading to diarrhea. Furthermore, they provide evidence that
TNFR1 and NFκB2-dominant signaling pathways are important in IEC
apoptosis and shedding. By conducting an in-depth investigation of the
kinetics, dose response and signaling mechanisms underlying these processes,
they have established a novel and robust model that will facilitate further
investigation of epithelial gap formation and barrier dysfunction in the
inflamed intestinal epithelium. Further studies using this model are likely to
provide insights into disease pathogenesis and support the development of
more targeted treatments for inflammatory disorders.
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administration. In the duodenum at 1.5 hours after LPS
administration, mean villus height was reduced by 29% (Fig. 1B)
to 260.5±15.0 μm compared with villi from untreated mice
(365.9±6.6 μm) (P<0.01: ANOVA). The reduction in villus height
was still evident in treated versus non-treated mice through to 6
hours post-LPS (all P<0.05: ANOVA). A similar trend was also
observed in both the jejunum and ileum, but differences did not
reach statistical significance.
Villus shortening was associated with lower numbers of IECs
lining the duodenal villi, with a 21% reduction in mean cell number
observed at 1.5 hours post LPS administration compared with
controls (62.7±3.7 versus 78.5±1.8 IECs in untreated mice), reaching
significance at 3 hours, at which point a 40% decrease was observed
(47.0±4.7 IECs, P<0.05: Kruskal-Wallis) (Fig. 1C). This correlated
with large numbers of shed IECs within the intestinal lumen,
suggesting that cell shedding occurs contemporaneously with villus
shortening.
LPS significantly increased gut-to-circulation permeability by 
5 hours
In order to measure gut-to-circulation permeability, mice were
administered fluorescein-isothiocyanate-conjugated dextran (FD4)
by oral gavage, followed by 10 mg LPS/kg body weight. At 5 hours
post-LPS (5 hours FD4), there was a fivefold increase (P<0.05:
Kruskal-Wallis) in plasma fluorescence, at 76.3±21.7 fluorescent
units (Fig. 1D), compared with untreated mice (16.4±2.9 at 5 hours
FD4), suggesting that gut barrier dysfunction allows large molecules
to enter the bloodstream at around 5 hours post-LPS.
LPS caused activation of caspase-3 with concomitant apoptosis
and shedding of villus IECs, and relatively spared the crypts
To investigate the type of cell death responsible for IEC shedding
and loss from the villus, we performed immunohistochemistry
(IHC) for active caspase-3. Large numbers of villus IECs exhibited
positive immunolabeling as early as 1 hour, with almost universal
immunolabeling of shed cells seen within the small intestinal lumen
(Fig. 2A). Villus IECs were quantified by microscopy as ‘apoptotic’
or ‘shedding’ (as defined in Materials and Methods and summarized
in Fig.  2B) and expressed as a percentage of total villus IECs
counted.
Maximal active caspase-3 labeling of 12.5±1.7% villus IECs was
found in the duodenum 1.5 hours after LPS (Fig. 2C), representing
a 21-fold increase compared with untreated mice (0.6±0.2%,
P<0.05: Kruskal-Wallis). Comparable IEC apoptosis and cell
shedding were also observed at 1.5 hours after LPS treatment in
the jejunum and ileum (12.1±2.4% and 11.2±1.3%, respectively).
We therefore concluded that LPS caused dynamic villus IEC
apoptosis and shedding, and that this occurred relatively
uniformly throughout the small intestine. The almost universal
positive labeling of IECs undergoing shedding additionally
suggests that activation of the terminal pathway of apoptosis
occurs prior to shedding in this model, rather than being triggered
by detachment as occurs during the process of anoikis.
Interestingly, crypt IEC apoptosis as interpreted by active caspase-
3 IHC did not show a comparable magnitude of increase to that
observed in villi at 1.5 hours (Fig.  2D), although there was an
~threefold increase by 6 hours post-LPS (1.2±0.3% versus
Fig. 1. LPS at 10 mg/kg body weight
caused acute diarrhea, villus epithelial
cell loss, villus shortening and
increased gut permeability. (A)Small
intestine of an untreated control (white
arrow) and a WT mouse 1.5 hours after
LPS treatment exhibiting a fluid-filled
small intestine devoid of digesta (blue
arrow) with diarrheic feces at anus (blue
arrowhead). Caeca are indicated by white
arrowheads. H&E-stained sections of
duodenum (100×) show normal villi in an
untreated control and shortened,
blunted and clubbed villi with shed IECs
in the lumen at 1.5 hours post-LPS. Scale
bars: 200 μm. Villus tips (630×) are shown
in an untreated control, and shedding
IECs are seen at 1.5 hours post-LPS
(arrows). Scale bars: 25 μm. (B)Villus
heights for duodenum, jejunum and
ileum (n=6). (C)Hemivillus IEC counts
from base to apex for duodenum,
jejunum and ileum (n=6). (D)Plasma
fluorescence measured after 10 mg PE-
LPS/kg body weight and gavage of FD4.
n=6, one outlier excluded at 1.5 hours.
*P<0.05, **P<0.01. Comparisons by
ANOVA in A, and Kruskal-Wallis in B-D.
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0.4±0.1% in untreated). Accordingly, crypt counts did not alter
significantly throughout the time course studied (Fig.  2E), in
contrast to villus IEC counts.
LPS-induced apoptosis and cell shedding increased towards the
villus tip
Administration of LPS (10 mg/kg body weight) increased the
number of apoptotic and/or shedding IECs with similar
distribution along the villus axis in the duodenum, jejunum and
ileum (Fig. 2C). Apoptosis was markedly increased in the apical
50% of the villus, particularly at 1.5 hours, with a sharp increase
in IEC shedding being observed at the villus tip, compared with
controls.
LPS caused maximal apoptosis and shedding at a threshold dose
We administered 0.125-20 mg PE-LPS/kg body weight to WT mice
and euthanized them after 1.5 hours to test whether LPS-induced
IEC apoptosis and shedding was dose dependent. LPS at 0.125
mg/kg caused a minimal (5%) reduction in villus height [348.1±17.1
μm versus 399.0±35.5 μm in vehicle-treated control mice (Fig. 3A)]
but with a tenfold observed increase in IEC apoptosis and cell
shedding at 6.0±1.7% (P<0.05: ANOVA) (Fig. 3B). LPS doses ≥0.25
mg/kg body weight caused ~30% reduction in villus height
compared with controls, and IEC apoptosis and cell shedding of
~12%. We concluded that LPS-induced small intestinal injury is
initiated by a threshold dose of ~0.125 mg/kg body weight. Villus
IECs therefore seem to be extremely sensitive to LPS-induced
Fig. 2. LPS caused activation of caspase-3 with concomitant apoptosis and shedding of villus IECs, and relatively spared the crypts. (A)Duodenal
sections labeled for active caspase-3 by IHC. Arrowhead indicates a positively labeled apoptotic IEC with unaltered morphology, and arrow indicates a positively
labeled IEC with shedding morphology. Scale bars: 200 μm (50×), 25 μm (630×). (B)Example of a duodenal villus 1.5 hours following administration of 10 mg PE-
LPS/kg body weight to a C57BL/6 female mouse. Individual cells were counted along the epithelial monolayer lining one side of a villus (delineated by red line)
from base to tip, and therefore referred to as a ‘hemivillus’. Cells were categorized as ‘normal’, ‘apoptotic’ or ‘shedding’. A total of 18-20 hemivilli were analyzed for
each intestinal segment for each individual animal. (C)Quantification of apoptotic and shedding IECs in the duodenum, jejunum and ileum (bar graphs), and cell
positional quantification of ‘apoptotic’ or ‘shedding’ IECs in the duodenum, jejunum and ileum along villus length (line graphs; 0% villus length represents the
villus base, 100% represents the villus tip). (D)Quantification of active-caspase-3-positive cells in villus versus crypt IECs. (E)Villus versus crypt IEC counts. n=6
female mice/group; *P<0.05, comparisons by ANOVA.
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apoptosis and cell shedding, whereas concomitant villus shortening
only occurs at higher dosages of LPS.
LPS purity did not significantly affect IEC apoptosis and shedding
To assess whether the LPS purification and/or extraction method
altered IEC apoptosis and shedding, we administered high-purity
ion-exchange chromatography extracted LPS (IE-LPS; 10 mg/kg
body weight) to WT mice for 1.5 hours. This preparation caused
similar villus shortening to 10 mg PE-LPS/kg body weight
(298.0±39.1 μm compared with 260.5±36.8 μm, respectively)
(Fig. 3C). IEC apoptosis and shedding post IE-LPS administration
were also significantly increased (10.8±2.8%) compared with
untreated WT, as observed for PE-LPS (12.5±1.7%) (Fig. 3D).
LPS-induced apoptosis and cell shedding was significantly decreased 
in Tlr4−/− mice and was due to TLR ligation peripheral to IECs
Because TLR4 is necessary for the innate immune system to
respond to LPS (Beutler et al., 2001), we investigated whether
Tlr4−/− mice would exhibit LPS-induced small intestinal injury, to
exclude the possibility of alternative mechanisms. IE-LPS (10
mg/kg body weight) caused negligible change in villus height in
Tlr4−/− mice (Fig. 3C) and negligible IEC apoptosis and shedding
compared with WT mice (Fig. 3D). However, it should be noted
that, when Tlr4−/− mice were administered 10 mg PE-LPS/kg body
weight, although this resulted in negligible change in villus height
compared with untreated Tlr4–/– mice (Fig.  3C), moderate IEC
apoptosis and shedding of 7.0±1.0% IECs was seen (Fig. 3D). To
exclude the possibility that IEC apoptosis and shedding was affected
by direct TLR ligation in IECs, we additionally tested the response
of Villin-Cre (Vil-Cre) Myd88−/− mice, which lack the TLR signaling
adapter molecule Myd88 in IECs, to systemic administration of 10
mg PE-LPS/kg body weight. These mice showed very comparable
amounts of apoptosis and shedding (14.1±1.1% IECs) to their WT
and heterozygous counterparts (Fig. 3E). Furthermore, we tested
the small intestinal response to LPS by alternative routes of
administration at 1.5 hours. We found that, although
Fig. 3. LPS caused a plateau in apoptosis and shedding at a threshold dose through TLR4 signaling peripheral to epithelial cells. (A)Heights of duodenal
villi 1.5 hours after PE-LPS administration at the indicated doses and (B) quantification of percentage apoptotic and shedding IECs by assessment of duodenal
sections labeled for active caspase-3 by IHC. n=6 female mice/group for PBS, 0.125 mg/kg and 10 mg/kg, and n=4 female mice for all other groups. (C)Villus
heights in WT or Tlr4−/− mice 1.5 hours after PE-LPS or IE-LPS treatment at 10 mg/kg, and (D) quantification of IEC apoptosis and shedding in IHC-labeled
duodenal sections (n=6). (E)Quantification of apoptotic and shedding IECs in WT (n=6), Vil-Cre Myd88−/− (n=3) and Vil-Cre Myd88+/− (n=3) mice by assessment of
duodenal sections labeled for active caspase-3 by IHC. (F)Small intestinal villi from WT female mice 1.5 hours post-PE-LPS by subcutaneous (s.c.) or intravenous
(i.v.) routes exhibited villus IEC apoptosis and shedding, but not when LPS was instilled intraluminally [active caspase-3 IHC, duodenum shown for s.c. and i.v. LPS
(n=3 per group), ileum shown for intraluminal administration instilled with 1 mg/ml LPS (n=4 per group)]. Scale bars: 25 μm. *P<0.05, **P<0.01. Comparisons by
ANOVA in A-C, and by Kruskal-Wallis and pairwise comparison of LPS-treated mice only in D.D
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intraperitoneal, intravenous or subcutaneous LPS administration
caused IEC apoptosis and shedding, when LPS was delivered
directly into the lumen of a ligated segment of small intestine in
terminally anesthetized WT mice, this did not initiate apoptosis
and shedding (Fig. 3F).
These results suggest that LPS-induced small intestinal injury is
dependent on TLR4 signaling peripheral to IECs and that additional
bacterial components in PE-LPS cause IEC shedding via TLR4-
independent mechanisms.
Nfĸb1−/− mice were more sensitive, and Nfĸb2−/− mice more
resistant, to LPS-induced intestinal injury
NFκB is a major transcriptional regulator downstream of TLR4.
We therefore administered PE-LPS to Nfĸb1−/− and Nfĸb2−/− mice,
to establish whether either of these subunits, integral to the
canonical and non-canonical NFĸB signaling pathways,
respectively, is necessary for LPS-induced small intestinal injury.
After administration of 10 mg LPS/kg body weight, similar villus
shortening was seen in Nfĸb1−/− and WT mice (Fig. 4A). This
genotype also showed similar IEC apoptosis and shedding to WT
mice (Fig. 4B). In contrast, Nfĸb2−/− mice showed a significantly
attenuated 11% villus height reduction in treated versus untreated,
compared with 32% in treated versus untreated WT (P<0.05:
Kruskal-Wallis) (Fig. 4A), and reduced IEC apoptosis and shedding
compared with WT mice (Fig. 4B). Interestingly, when 0.125 mg
LPS/kg body weight was administered, Nfĸb1−/− mice showed
greater villus shortening (supplementary material Fig. S2) of 27%
in treated versus untreated (P<0.05: Kruskal-Wallis) compared with
5% shortening in treated versus untreated WT mice (Fig. 4A), and
significantly greater IEC apoptosis and shedding at 12.9±1.7% IECs
(P<0.05: Kruskal-Wallis) (Fig.  4C) compared with WT mice
(5.5±1.3%). IEC apoptosis and shedding in Nfĸb2−/− mice
administered 0.125 mg LPS/kg body weight were negligible
(0.8±0.2% IECs; P<0.05: Kruskal-Wallis) compared with WT mice.
Together, these results suggest that LPS-induced intestinal injury
is dependent on NFκB2, whereas NFκB1 might be necessary to
suppress IEC apoptosis and shedding.
LPS induced a significant increase in small intestinal Tnf mRNA
Because activation of caspase-3 does not categorically confirm that
cell death has occurred by apoptosis, we performed an array analysis
of 89 genes associated with various cell death pathways in PE-LPS-
treated compared with untreated WT animals. We found that LPS
predominantly altered expression of genes associated with
apoptosis, rather than those associated with autophagy or necrosis
(Fig. 5A). Tnf and Cd40 showed marked upregulation, and we
therefore analyzed these two proapoptotic genes by quantitative
PCR (qPCR) using triplicate samples from individual animals
(Fig. 5B). This showed a mean normalized gene expression ratio
of +32.0 for Tnf mRNA (P<0.05: randomization test). qPCR also
showed a non-significant increase of +2.1 for Cd40. These data, in
conjunction with histopathological findings and activation of
caspase-3, suggest that apoptosis is the predominant form of cell
death occurring in LPS-induced small intestinal injury.
TNF caused small intestinal injury equivalent to LPS
Because TNF is a key mediator of endotoxic shock, and was
markedly upregulated at the mRNA level in our array, we tested
whether TNF would cause comparable enteric injury to LPS. At
1.5 hours, TNF (0.33 mg/kg body weight; i.p.) caused equivalent
duodenal villus shortening (Fig. 6A) to that seen with 10 mg PE-
LPS/kg body weight (268.4±20.9 μm and 260.5±15.0 μm,
respectively). Although less IEC apoptosis and shedding were
observed with TNF (7.0±1.0% IECs) compared with 10 mg PE-
LPS/kg body weight (12.5±1.7% IECs) (Fig. 6B), this reflects a faster
small intestinal response to exogenously administered TNF
(supplementary material Fig. S3) than caused by LPS.
These data, together with significant induction of intestinal Tnf
mRNA, suggest that TNF is central in the pathogenesis of LPS-
induced small intestinal injury.
Fig. 4. Nfĸb1−/− mice were more sensitive, and Nfĸb2−/− mice more
resistant, to LPS-induced small intestinal injury. (A)Villus heights of
duodenal villi 1.5 hours after 0.125 mg/kg or 10 mg/kg PE-LPS in WT, Nfκb1−/−
and Nfκb2−/− mice (comparisons between genotypes within same dosage
groups only). (B,C)Quantification of apoptotic and shedding IECs in duodenal
sections labeled for active caspase-3 in WT, Nfĸb1−/− and Nfĸb2−/− mice 1.5
hours after 10 mg/kg PE-LPS (B) and after 0.125 mg/kg PE-LPS (C). n=12-14
(male and female equally represented); *P<0.05, comparisons by Kruskal-
Wallis.
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Tnfr1−/− mice were completely resistant to LPS-induced apoptosis
and cell shedding
We decided to further examine the role of TNF by testing whether
the TNF receptors TNFR1 (p55) or TNFR2 (p75) were required to
cause LPS-induced gut injury. When Tnfr1−/− mice were
administered 10 mg PE-LPS/kg body weight for 1.5 hours, there
was no villus shortening (Fig.  6C) and significantly less IEC
apoptosis and shedding were seen relative to WT animals
(0.1±0.1%, P<0.05: Kruskal-Wallis; Fig. 6D). By contrast, the same
dose administered to Tnfr2−/− mice caused 68% of the response
caused in WT, at 8.5±1.0% IEC apoptosis and shedding, although
this did not cause a significant change in villus height (Fig. 6C).
These findings suggest that TNFR1 signaling is required to drive
LPS-induced IEC apoptosis and shedding, with potential
enhancement by TNFR2.
Nfĸb1−/− mice were highly sensitive, and Nfĸb2−/− resistant, to TNF-
induced small intestinal injury
NFκB is also a major exponent of downstream TNFR signaling.
We therefore administered TNF to Nfĸb1−/− and Nfĸb2−/− mice.
Nfĸb1−/− mice were highly sensitive to TNF (supplementary
material Fig.  S2) and exhibited a significant reduction in villus
height compared with TNF-treated WT mice (villus heights of
160.1±7.3 and 268.4±20.9 μm, respectively; P<0.05: ANOVA;
Fig. 6E). This correlated with increased IEC apoptosis and shedding
in Nfĸb1−/− versus WT mice (9.9±0.7 and 7.0±1.0% IECs,
respectively; P<0.05: ANOVA). Conversely, Nfĸb2−/− mice were
resistant to the TNF-induced reduction in villus height (340.1±15.1
μm) and IEC apoptosis and shedding (2.5±0.7%) compared with
similarly treated WT animals (both P<0.05; Fig. 6F).
These data suggest that IEC apoptosis and shedding in response
to LPS or TNF are regulated by a common NFκB signaling pathway,
being suppressed by NFκB1 but promoted by NFκB2.
DISCUSSION
We present a detailed study of acute LPS-induced murine gut injury.
Systemic LPS administration caused rapid IEC apoptosis and
shedding in the murine small intestinal villus, and this resulted in
shortening of the villus, fluid effusion into the small intestinal lumen
and diarrhea.
We have characterized the dose response and kinetics of this
highly dynamic phenomenon and demonstrate that it occurs within
a tightly defined time period. All regions of the small intestine
responded in a similar manner to LPS and in all cases apoptosis
and cell shedding occurred in the apical 50% of the villus rather
than exclusively at the tip. Using knockout mouse models, we
confirmed that TLR4 signaling peripheral to the IEC was required,
and that TNFR1-mediated signaling was essential for these events,
with an NFκB2-dominant response favoring apoptosis.
Although there is an abundance of literature describing small
intestinal crypt apoptosis several hours after the induction of
endotoxic or septic shock (Cinel et al., 2002; Coopersmith et al., 2003;
Guma et al., 2011), we present novel observations that the villus IECs
respond much more rapidly than crypt IECs, and exhibit exquisite
susceptibility to apoptosis and cell shedding in the earliest phases
following LPS administration. The only other study to date that has
examined small intestinal villus epithelial shedding in response to
LPS studied this response from 5.5 hours post-LPS-administration
by in vivo confocal microscopy, correlating gap formation with gut
barrier dysfunction (Lai et al., 2013). This highlights the necessity of
a detailed study of the kinetics of this response because, in our model,
we found that the number of shedding events was profoundly reduced
by 4 hours after LPS administration and the maximum response was
observed as early as 1.5 hours. We found that, although multiple
organ failure in the context of endotoxic shock has been extensively
investigated, most commonly by biochemical parameters, obvious
organ injury in terms of apoptosis was confined to the small intestine
at the early time points examined herein. The reasons underlying
this selective early injury to the villus IECs of the murine small
intestine are not entirely clear. However, this phenomenon has been
attributed to the greater sensitivity of the intestinal epithelium to
mitochondrial damage than epithelia found in other commonly
injured organ systems such as the lung. Interestingly, in the feline
septic shock model in which this was demonstrated, other obvious
hemodynamic derangements to which this effect might have been
attributed, such as hypotension, intestinal hypoperfusion and
hypoxia, were shown not to be responsible (Julian et al., 2011).
Additionally, in our own studies, this small intestinal injury occurred
by 1.5 hours not only when LPS was administered intraperitoneally,
but also when given intravenously or subcutaneously, suggesting that
this injury is not due to a localized phenomenon.
Clinically, we found that the onset of diarrhea correlated
temporally with IEC apoptosis and shedding. This suggests that
the shedding of IECs permits the net movement of fluid from the
plasma into the intestinal lumen. This might be directly due to the
rapid and uncoordinated shedding of IECs, potentially in
Fig. 5. LPS induced a significant increase in small intestinal Tnf mRNA.
(A)qPCR array data for selected genes that exhibited a ≥twofold expression
ratio out of 89 cell-death-pathway-associated genes assessed in pooled
epithelial enriched extracts. (B)Mean gene expression ratio of PE-LPS-treated
(10 mg/kg, 1.5 hours) versus untreated WT female mice for Cd40 and Tnf. n=4,
*P<0.05: randomization test.
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conjunction with increased vascular permeability, which causes
disruption of both tight junctions and the paracellular space. Our
own studies have previously shown that barrier loss in the intestine
occurs at sites of excessive cell shedding (Kiesslich et al., 2012), and
that the direction of fluid movement through epithelial defects is
highly dependent on the osmotic and hydrostatic gradients across
the epithelium. The concept of acute fluid exudation into the
intestinal lumen after the administration of inflammatory stimuli
has also been recognized in other studies utilizing LPS or TNF
(Gadjeva et al., 2007; Kiesslich et al., 2012). It was not until 5 hours
after LPS administration, however, that we found movement of
larger molecules (FD4) from the lumen to the plasma. This is in
agreement with findings from in vivo confocal microscopy that,
from 5.5 hours after LPS administration, FD4 entered cell-free gaps
and paracellular spaces (Lai et al., 2013).
In our model, a high-purity preparation of LPS caused villus IEC
apoptosis and shedding through a TLR4-dependent mechanism,
but PE-LPS of lower purity was capable of inducing a moderate
response via TLR4-independent mechanisms, most likely due to
ligation of alternative TLRs by residual impurities such as bacterial
RNA. In support of other PAMPs causing this type of response,
another recent study has demonstrated that the apoptosis in the
intestinal villus by the viral PAMP, double-stranded RNA, occurred
via TLR3 (McAllister et al., 2013). TLR3, in contrast to other TLRs,
signals exclusively via the TRIF pathway rather than the Myd88
pathway (Kawai and Akira, 2011). As such, this agonist represents
an unusual type of inflammatory response. It caused apoptosis by
a TRIF-dependent and TNF-independent mechanism, which
peaked at 2 hours post-administration, possibly reflecting delayed
activation of the TRIF pathway compared with the Myd88 pathway
(Pålsson-McDermott and O’Neill, 2004).
Most previous studies have found only low-level expression of
TLR4 in IECs (Abreu, 2010). Therefore, rather than occurring in
IECs themselves, initial recognition of systemically delivered LPS
likely occurs via TLR4 ligation in monocytes and macrophages,
which in turn rapidly secrete cytokines, including TNF (Beutler et
al., 1985). To confirm this mechanism in our model, we
administered LPS by i.p. injection to Vil-Cre Myd88−/− mice that
specifically lacked intestinal TLR signal transduction (Fig. 3E). They
showed comparable IEC apoptosis and shedding to their
Fig. 6. LPS induced small intestinal IEC apoptosis and shedding
via TNF and TNFR1, and was regulated by NFκB. Villus heights and
IEC apoptosis and shedding 1.5 hours after 10 mg/kg PE-LPS or 0.33
mg/kg TNF in WT mice (A,B), after 10 mg/kg PE-LPS in WT, Tnfr1−/−
and Tnfr2−/− mice (C,D), and after TNF administration in WT, Nfκb1−/−
and Nfĸb2−/− mice (E,F). *P<0.05; n=4-6 mice per group; comparisons
by ANOVA, except in D (Kruskal-Wallis).
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heterozygous counterparts and WT mice of the same strain,
demonstrating that peripheral TLR signaling is required for LPS-
induced small intestinal injury.
LPS signaling is additionally dependent on delivery of LPS to the
cell membrane in a bioactive form by lipopolysaccharide binding
protein (LBP) and the adapter molecules CD14 (Wright et al., 1990)
and MD-2 (Shimazu et al., 1999). TLR4 signaling might also therefore
be fundamentally different in IECs, preventing what would be
constant stimulation by the luminal Gram-negative bacterial
population. Indeed, in cell culture of m-ICcl2 murine IECs, TLR4
was found to reside within the Golgi apparatus, rather than at the cell
membrane (Hornef et al., 2002). In our studies, we found that LPS (1
mg/ml) instilled directly into the lumen of a ligated segment of small
intestine for 1.5 hours did not cause apoptosis and cell shedding.
Similarly, double-stranded RNA has failed to elicit apoptosis and
shedding when administered orally (McAllister et al., 2013).
The rapid increase in plasma TNF concentration after LPS
administration has been previously characterized (Copeland et al.,
2005). In the current study, we also demonstrated a large fold change
in Tnf mRNA abundance in small intestinal epithelial enriched
extracts 1.5 hours after LPS administration. The significance of TNF
as the crucial mediator in our model was further demonstrated by
the fact that TNF administration caused very comparable IEC
apoptosis and shedding as did LPS, consistent with previous results
(Garside et al., 1993; Piguet et al., 1998). In the intestinal epithelium,
and in intestinal cell lines, TNFR1 is expressed to a greater extent
than TNFR2 (Lau et al., 2011; Mizoguchi et al., 2002), although the
latter can be induced by inflammatory cytokines (Mizoguchi et al.,
2002). TNFR1 has well-defined proapoptotic effects (Locksley et al.,
2001) and, in our model, was essential for LPS-induced IEC apoptosis
and shedding. This suggests that direct TNFR1 ligation occurs at
the level of the IEC, although interactions in intermediary cell types,
such as endothelial or myofibroblast cells, cannot be excluded. The
role of TNFR2 has been less well characterized and interestingly the
intestinal epithelial response to LPS was moderate in Tnfr2−/− mice,
suggesting that this receptor does participate in LPS-induced IEC
apoptosis, possibly by enhancing TNFR1 signals through degradation
of TRAF2, resulting in termination of NFκB signaling (Rodríguez et
al., 2011).
Mice deficient in NFκB1, an individual NFκB family member that
signals via the canonical activation pathway, developed more IEC
apoptosis and shedding in response to TNF than did WT mice. This
is not surprising because TNFR1, as well as initiating apoptosis, also
induces the expression of anti-apoptotic genes via NFκB (Wang et
al., 1998). However, an interesting finding to emerge from our study
was that mice deficient in NFκB2, an NFκB family member that
signals via the alternative activation pathway, were more resistant to
villus IEC apoptosis and shedding in response to TNF, compared
with WT mice. This suggests that alternative NFκB2 pathway
activation contributes to cell shedding and apoptosis. A possible
mechanism to account for this effect could be due to the NFκB2
precursor acting as an inhibitor of NFκB activity (Basak et al., 2007;
Fukushima et al., 2012). Absence of NFκB2 might therefore result
in an extended expression of p65 (RelA)-induced anti-apoptotic genes
(summarized in Fig. 7). The importance of p65 nuclear translocation
in IECs that do not undergo shedding has been previously
demonstrated in Cryptosporidium parvum infection (Foster et al.,
2012). Alternatively, NFκB2-containing dimers might directly
terminate the transcription of anti-apoptotic genes or induce the
expression of proapoptotic genes.
In conclusion, we provide a detailed description of the early
events and mechanisms that are responsible for acute, LPS-induced
small intestinal injury. LPS therefore represents a robust, rapid and
consistent stimulus for inducing pathological small intestinal
epithelial cell apoptosis and shedding. Further study of this
phenomenon could be highly relevant to our understanding of the
initial pathogenesis of acute small intestinal disease states and
diarrheal illnesses, and the intestinal manifestations of acute
systemic disease states such as septic and endotoxic shock.
Additionally, the very acute small intestinal lesions documented in
this study might also contribute to development of chronic
inflammation, such as is observed in IBD. Indeed, defective small
intestinal permeability such as that which might occur in IEC
shedding has been shown to contribute to the development of
chronic colitis (Arrieta et al., 2009), meaning that this model might
have relevance in CD or UC development. Ultimately, this could
lead to the development of novel therapeutic strategies to
ameliorate pathological villus epithelial cell apoptosis and shedding,
and gut barrier dysfunction.
MATERIALS AND METHODS
Animals
Wild-type (WT) C57BL/6 mice supplied by Charles River (Margate,
UK), and transgenic strains on a C57BL/6 background, including
Nfĸb1−/− and Nfĸb2−/− mice (Caamaño et al., 1998; Sha et al., 1995)
Fig. 7. Diagram summarizing the putative mechanism by which LPS
induces apoptosis in IECs. Systemically delivered LPS is first recognized
predominantly by resident TLR4-expressing mononuclear cells
(monocytes/macrophages/dendritic cells), which produce TNF. TNF is released
into the systemic circulation and binds with TNFR1 on IECs, triggering
apoptosis and shedding if NFκB2 signaling dominates, or cell survival if NFκB1
signaling dominates.
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and Tlr4−/− mice (Hoshino et al., 1999) (generated by Shizuo Akira
and supplied by Mark Taylor) were maintained at the University
of Liverpool. Tnfr1−/− and Tnfr2−/− mice (Peschon et al., 1998) were
maintained at the Saban Research Institute at Children’s Hospital
Los Angeles. Vil-Cre Myd88−/− mice were maintained at the
Disease Modelling Unit, University of East Anglia. All procedures
were performed on adult mice (minimum age 9 weeks) under
appropriate UK Home Office licenses or with approval and
monitoring by the Children’s Hospital Los Angeles Institutional
Animal Care and Use Committee.
Generation of Vil-Cre Myd88−/− mice
Myd88fl/fl, which express a truncated mutant Myd88 protein
following removal of the floxed region, were bred with Vil-Cre mice,
which conditionally express Cre recombinase under control of the
villin promoter. Offspring were genotyped for the presence of WT
Myd88, mutated Myd88 and Cre alleles. Mice were on a C57BL/6
genetic background.
Lipopolysaccharide
LPS from Escherichia coli O111:B4 purified by phenol-extraction (PE-
LPS) or ion-exchange chromatography (IE-LPS) (Sigma-Aldrich,
Gillingham, UK) was diluted in sterile phosphate-buffered saline
(PBS) and administered to mice by intraperitoneal (i.p.) injection.
TNF
Murine recombinant TNF (Peprotech Ltd, London, UK) was
diluted in sterile water and administered by i.p. injection to mice
at 0.33 mg/kg body weight.
Tissue processing
Following euthanasia, the intestinal tract was dissected en bloc. The
intestinal lumina were flushed with PBS and immediately fixed in
10% neutral buffered formalin with selected organ samples. After
24 hours fixation, tissue was routinely processed and embedded in
paraffin wax. Tissue sections (3-5 μm thickness) were prepared and
stained either with H&E or used for immunohistochemistry (IHC).
Immunohistochemistry for apoptotic IECs
Tissue sections were treated with 1% hydrogen peroxide in
methanol to block endogenous peroxidases, followed by heat-
induced antigen retrieval in 0.01 M citrate acid buffer (pH 6) 
and incubation with a rabbit polyclonal anti-active-caspase-3
antibody (AF835: R&D Systems, Abingdon, UK). Peroxidase-
labeled anti-rabbit EnVision™ (Dako, Cambridge, UK) and 3,3-
diaminobenzidine were used for visualization.
Quantification of active-caspase-3-positive cells
For quantification of apoptotic and shedding IECs, individual
epithelial cells were counted from the base of the villus (above crypt
level) to the mid-point of the villus tip in 18-20 well-orientated
hemivilli at 400× magnification (delineated by red line in Fig. 2B).
IECs were categorized according to the following criteria:
• ‘normal’ if there was no or weak diffuse non-specific brown
staining and cells had a basally located basophilic nucleus;
• ‘apoptotic’ if there was defined positive staining that was
confined to cytoplasmic or nuclear borders when compared with
any background staining of neighboring IECs;
• ‘shedding’ if there was defined positive staining that was
confined to cytoplasmic or nuclear borders and in addition there
was apical elevation of the cytoplasmic membrane, and/or an
apically positioned nucleus.
Crypt IECs were counted from the crypt base to the crypt-villus
junction in 19-20 well-orientated duodenal hemicrypts per mouse.
Crypt IECs were simply categorized as ‘normal’ or ‘apoptotic’
because no discernible evidence of shedding was observed within
crypts.
Cell positional data
To allow comparison of cell positional data, villi were adjusted to
a fixed length of 100 cells by using Wincrypts© software (Cancer
Research Campaign 1999). Data are then represented as percentage
of villus length, 0% therefore representing the villus base and 100%
representing the villus tip.
Measurement of villus height
ImageJ (Schneider et al., 2012) was used to assess images captured
by a Leica DMLA microscope, by setting the scale with a
hemocytometer at 100× magnification. All images were captured
at 100× magnification, and villi were measured by using the
segmented line tool. Each segmented line was placed to originate
at the base of the villus, above the level of adjoining crypts, and a
segmented line extended to the villus tip, following any curvature
of the villus. The mean of these segmented line lengths for ten well-
orientated villi was calculated for each animal, and a mean value
was then calculated for each group.
Gut permeability assessment
Fluorescein-isothiocyanate-conjugated dextran (FD4: Sigma-
Aldrich, Gillingham, UK) was diluted to 22 mg/ml in PBS and
administered at 20 ml/kg body weight by oral gavage ± i.p. injection
of LPS. Plasma fluorescence was measured by a TECAN Infinite®
F200 plate reader (excitation 485 nm, emission 535 nm) from blood
collected post-mortem at 5 hours after gavage in order to allow
FD4 to be distributed throughout the intestinal tract. Mice were
euthanized via a rising CO2 concentration and blood taken by
cardiac puncture. To assess the effect of LPS on permeability, it
was administered at set time points prior to the end of the
experiment, i.e. at 1.5 hours, 3 hours and at the same time as FD4
for the 5-hour time point. Plasma was separated from heparinized
whole blood by centrifugation at 5000  rpm for 2  minutes in a
minicentrifuge.
Real-time PCR
Small intestinal extracts were isolated with chelation buffer
solution as previously described (Flint et al., 1991), and RNA was
isolated with a High Pure RNA Tissue Kit (Roche, Burgess Hill,
UK). Reverse-transcription was performed with an RT2 reverse-
transcription kit (SABiosciences, Crawley, UK). An 89 gene 
Cell-Death Pathway Finder array (SABiosciences) was performed
on a Roche LightCycler®480 followed by validation with 
replicate samples using TaqMan® gene expression assays for 
β-actin (Mm01205647_g1), TNF (Mm00443260_g1) and 
CD40 (Mm00441891_m1; Life Technologies, Paisley, UK). 
Cycling conditions were performed as per the manufacturer’s
instructions.
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Data analysis
Data represent mean ± s.e.m. Comparisons were made between
treatment groups and controls using SigmaPlot 12© (Systat
Software, London, UK). Normally distributed data were assessed
by ANOVA with Holm-Sidak post-hoc test, and non-parametric
data were analyzed by ANOVA on ranks (Kruskal-Wallis) with
Dunn’s post-hoc test. P<0.05 was considered significant. REST©
software was used for comparison of qPCR data from
individualized samples by randomization test as previously
described (Pfaffl et al., 2002). n numbers indicate the total
number of mice studied.
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